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ABSTRACT 
 
The two pore-domain potassium channel TASK-3 provides a potassium leak 
conductance in the mammalian brain and is activated by volatile anaesthetics. 
Previous studies have shown that TASK-3 knockout (KO) mice have a number of 
physiological and behavioural abnormalities. In particular, TASK-3 KO mice lack the 
type-2 theta oscillation (4-8 Hz) usually present in the electroencephalogram (EEG) 
under halothane anaesthesia, while the higher frequency type-1 theta oscillation (8-12 
Hz) recorded during exploratory behaviour is unaffected. That TASK-3 KO mice also 
have moderate memory impairments, led us to ask whether there might be a link 
between type-2 theta deficits and impaired mnemonic behaviour. 
Our results indicate that TASK-3 KO mice also have impaired type-2 theta 
oscillations during freezing behaviour in a predator exposure test, suggesting possible 
sensorimotor integration problems. TASK-3 KO mice were found to have a mild 
impairment in working memory in the T-maze, but object recognition and emotional 
memory were intact, excluding a role for the TASK-3-dependent theta oscillation in 
these processes. 
 Further studies then sought to understand the mechanistic role of TASK-3 in 
the theta oscillation using recombinant Adeno-associated viruses (rAAVs). We first 
investigated a possible functional role for the type-2 theta oscillation in mediating 
anaesthesia, and then confirmed that the halothane-associated theta oscillation was 
dependent upon cholinergic input from the medial septum to the hippocampus. 
TASK-3 was then re-expressed via rAAV in the medial septum in KO mice, resulting 
in partial rescue of the type-2 theta oscillation. 
Our results show that (1) the type-2 theta oscillation plays a redundant role in 
halothane anaesthesia, (2) type-2 theta deficits in TASK-3 KO mice have minimal 
effect on memory processing, and (3) that TASK-3 channels in the medial septum 
play a facilitatory role in type-2 theta oscillations.  
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0.2 Cover illustration  
 
The Persistence of Memory (MoMA, New York City) by the Spanish surrealist 
Salvador Dali, painted in 1931, depicts a dreamscape with numerous melting pocket 
watches. To me, this has connotations of an anaesthetised state where time fades away 
to nothing. Dali is said to have gained inspiration for his paintings from various states 
of consciousness including dreams and so his works often contain Freudian symbols. 
Furthermore, the passage of time is nuanced by our memories of our experiences and 
the processes involved require the hippocampus and the theta rhythm. In a way, the 
hippocampus is a spatio-temporal clock that is important in many aspects of 
integrated behaviour, and so provides a possible target for inducing anaesthesia. It is 
therefore appropriate then to use this painting as a cover illustration for this report. 
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1.1 Anaesthesia 
 
1.1.1 Anaesthesia and unconsciousness 
The ability to induce reversible loss of consciousness – general anaesthesia – through 
pharmacological means is a cornerstone of modern clinical and veterinary practice, 
such that every year tens of millions of patients are safely anaesthetised for a variety 
of medical reasons. 
 Used in crude herbal formulations for thousands of years, anaesthesia became 
an important discipline in its own right in the nineteenth century, with the first public 
demonstration of general anaesthesia in 1846 when William T.G. Morton successfully 
administered diethyl ether to Ebenezer Frost. Practically all surgical innovations of 
the last 150 years have depended upon this arresting phenomenon. And yet, to this 
day, the mechanisms of how diethyl ether, or the diverse multitude of other 
anaesthetic agents, cause loss of consciousness (LOC) remains unknown and ripe for 
investigation. 
 LOC in humans can be defined as the inability to respond meaningfully to a 
verbal command, an empirical endpoint that attempts to avoid the philosophical 
ambiguity raised by questions of consciousness. Typically, anaesthetic-induced LOC 
is a dose dependent phenomenon which proceeds through qualitatively distinct states 
such as delirium (hyperactivity and confusion) and sedation (sleepiness) to hypnosis 
(unconsciousness). Anaesthetic agents also provide various degrees of analgesia, 
amnesia and immobility and are often titrated in combination in the clinic to satisfy 
surgical or intensive care requirements.  
Aside from being a fascinating scientific venture, understanding the 
mechanisms behind these phenomena may improve the practice and safety of clinical 
anaesthesia and potentially lead to the discovery of novel or more effective 
anaesthetic drugs. 
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1.1.2 Mechanisms of anaesthetic action 
One of the most interesting and baffling aspects of anaesthesia is how such a diverse 
array of drugs can induce the same qualitative endpoint. It was partly for this reason 
that anaesthetic drugs were proposed to act non-specifically, and various 
physiochemical theories were sought to explain how compounds as different as the 
opiate morphine and the inert atomic gas xenon could produce unconsciousness. 
 Evidence for the first major unitary theory of anaesthesia was independently 
provided by Hans Meyer and Charles Overton at the turn of the twentieth century 
(Meyer, 1899; Overton, 1901). The famed Meyer-Overton correlation shows an 
approximately linear relationship between the potency of an anaesthetic and its oil:gas 
partition coefficient, with the implication that anaesthetics affect the lipid bilayer of 
neurons in some way to impair brain function. 
Versions of this theory, including membrane expansion theories, predominated 
until the 1980s, when Nicholas Franks and William Lieb first showed that anaesthetic 
drugs bind to protein targets (Franks et al., 1984). A series of seminal studies first 
showed evidence that contradicted lipid theories of anaesthesia (Franks et al., 1978; 
Franks et al., 1981; Franks et al., 1982); and then came a paradigm shifting moment. 
Franks and Lieb (1984) purified a lipid-free extract of the bacterial enzyme luciferase 
and demonstrated a strong correlation between the ability of anaesthetic drugs to 
inhibit the light-producing enzymatic reaction and their anaesthetic potency (Figure 
1.1A) 
An especially important finding at that stage was that the inhibition of 
luciferase was competitive, demonstrating a generalizable mechanism for how 
anaesthetics might target other more clinically relevant protein targets.  
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1.1.3 Molecular targets of anaesthesia 
Following these early results, much activity was spent attempting to discover 
plausible molecular targets for anaesthetics. Franks and Lieb were again influential 
here. Out of forty patched neurons in the pond snail Lymnaea stagnalis they found 
just one that was sensitive to the volatile anaesthetic halothane (Franks et al., 1988). 
This result uncovered a novel anaesthetic-activated K
+
 current, dubbed IK(An), and the 
cellular specificity (i.e., one out of forty) provided further evidence against the lipid 
theory of anaesthesia (Figure 1.1B). 
 The finding that the enantiomers of chiral anaesthetic compounds had different 
anaesthetic potencies both in vitro (Huang et al., 1980) and in vivo (Dickinson et al., 
2000) also indicated that the targeting of specific molecular pockets (on proteins) was 
responsible for anaesthetic action. 
Since then, research has continued to focus on specific molecular targets – 
neuronal receptors and ion channels – in the nervous system (Rudolph et al., 2004). 
Three neuronal receptor families provide the main focus of this endeavour: (i) γ-
Figure 1.1 Evidence for a protein theory of anaesthesia, against a lipid one.   
A – There is a good correlation between the potency of anaesthetics and the extent 
to which they inhibit the protein luciferase. B – One neuron from Lymnaea 
stagnalis is sensitive to 1MAC halothane (top), while another is not (bottom).  
[Adapted from Franks et al. (1990)] 
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aminobutyric acid (GABA)A receptors, (ii) N-methyl-D-aspartate (NMDA) receptors 
and (iii) two pore-domain potassium (2PK) channels. 
 
GABAA receptors 
As the main inhibitory neurotransmitter in the central nervous system, GABA acts to 
modulate brain excitation through a number of receptors. The GABAA receptors in 
particular provide a prima facie target because their potentiation inhibits neuronal 
activity through an inward Cl
-
 current (Franks et al., 1994). 
 
NMDA receptors 
Whereas GABA acts to inhibit neurons, the endogenous neurotransmitter glutamate 
acts on a variety of receptors to excite neuronal activity. The NMDA receptor 
mediates the slow component of synaptic neurotransmission and therefore provides a 
potential anaesthetic target through its inhibition (Flohr et al., 1998). 
 
Two pore-domain potassium channels 
The two-pore-domain-potassium (2PK) channels are a family of related K
+
 “leak” 
channels that function independent of voltage and time to modulate the membrane 
resting potential and also affect the excitatory capacity of the cell. Their activation 
leads to inhibition (Ketchum et al., 1995). The 2PK channel member TASK-3 is the 
focus of this investigation.  
 
1.1.4 Anaesthetic systems 
As well as identifying primary molecular targets, research has also extended towards 
discovering how these receptors and channels are linked in cellular networks in the 
central nervous system, predominantly in the brain.  
In general, anaesthetic drugs inhibit neuronal firing to interfere with waking 
brain activity and ultimately induce LOC at a point where functionality ceases (Alkire 
et al., 2008). The human brain exists as a complex and dynamic system containing an 
estimated 100 billion neurons connected by potentially 100 trillion synapses. At any 
one time, a concert of neurotransmitter systems modulate brain activity and function, 
depending upon arousal state and ongoing external (sensual) and internal (perceptual) 
stimulation.  
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In William James’ terms, these systems ensure four characteristics: (i) that 
every “state” tends to be part of a personal consciousness, (ii) that within each 
personal consciousness, states are always changing, (iii) that each personal 
consciousness is sensibly continuous and (iv) that it is interested in some parts of its 
object to the exclusion of others (James, 1890). 
Various mechanisms for how exactly the awake brain achieves these 
characteristics, and how anaesthetics interrupt them, have been proposed; some 
arguing for common molecular targets (Eger et al., 2008), others for neurological 
models (John et al., 2005). Among the more gestalt network theories, there is 
argument to whether “bottom-up” or “top-down” inhibition is more relevant. 
One of the “bottom-up” theories proposes that anaesthetics act on brain 
processes involved in regulating the sleep-wake cycle; by either impairing arousal 
pathways or potentiating sleep-promoting pathways (Franks, 2008). Evidence for this 
theory is not purely intuitive. Electroencephalographic (EEG) recordings in humans 
and animals show that the low amplitude desynchronised activity present during 
wakefulness changes to spindling activity and higher amplitude lower frequency 
oscillations during both deep sleep and anaesthesia (Sloan, 1998), a process that also 
correlates with decreased blood flow to the thalamus (Hofle et al., 1997). 
The brain regions responsible for the sleep-wake transitions, residing primarily 
in the hypothalamus and brain stem, integrate and synchronise in complex feedback 
loops during the circadian cycle.  
Evidence for nuclei-specific anaesthetic targeting comes from the sedative 
drug dexmedetomidine, which is proposed to act selectively on α2A-adrenoceptors to 
inhibit firing of locus ceruleus (LC) neurons and their noradrenergic innervation of 
the forebrain. This disinhibits the sleep-active ventrolateral pre-optic nucleus (VLPO), 
which once released can inhibit the wake-active histaminergic cells of the 
tuberomammillary nucleus (TMN), which project widely throughout the cerebral 
cortex. Its mode of action is therefore more pharmacologically and regionally specific 
than other anaesthetics, such as propofol, which potentiates GABAA receptors 
expressed more widely throughout the brain. 
However there is the opposing viewpoint, that of “top-down” cortical 
suppression.  This view is backed up by an experiment that shows similarly marked 
suppression of cortical neurons at sedative doses of volatile anaesthetics both in the 
whole animal and in isolated cortical neurons (Hentschke et al., 2005). Other work, in 
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Parkinson’s patients showed that electrical signals in the cortex but not in the 
thalamus decreased at LOC, suggesting “top-down” effects. This could be due to the 
increased density of GABAA receptors in the cortex, and thus of inhibitory anaesthetic 
currents in this region, being more fundamental to anaesthesia (Velly et al., 2007). 
Positron Emission Tomography (PET) scanning shows that in addition to a global 
depression of neuronal activation with anaesthesia, there is a further relative decrease 
in activity in higher cortical centres such as the precuneus and posterior cingulate, 
while primary sensory areas remain labile to stimulation (Fiset et al., 1999; Laitio et 
al., 2007). This points toward LOC being mediated through the disintegration of 
higher functioning processing modules, as opposed to simply shutting off all sensory 
inputs.  
Other theories argue that interactions between the thalamus and the cortex 
mediate the most important facets of consciousness and that disruption of normal 
connectivity between these two areas is responsible for anaesthetic action. Indeed the 
thalamus is thought to be responsible for the sleep-related delta oscillation (Steriade, 
2003). 
 
The Jamesian definition of consciousness given above clearly has its limits when 
applied to the empirical study of anaesthesia and especially when applied to the study 
of animals other than adult humans. Attempts have been made to describe the effects 
of anaesthetics in more objective terms, and Paul Flecknell’s important reference 
manual Laboratory Animal Anaesthesia (Flecknell, 2009) gives the following 
anaesthesia-related definitions: 
 
- Sedation (light, medium or heavy): The animal will have reduced activity and may 
become completely immobile, but easily aroused, particularly by painful stimuli. 
- Analgesia: Some pain-alleviating effect is present. 
- Immobilization: The animal is immobilized but still responds to painful stimuli. 
- Light anaesthesia: The animal is immobile and unconscious, but still responsive to 
even minor surgical procedures. 
- Medium anaesthesia: Most surgical procedures (e.g., laparotomy) may be carried 
out without causing any response, but the animal may still respond to major 
surgical stimuli (e.g., orthopaedic surgery). 
- Deep anaesthesia: The animal is unresponsive to all surgical stimuli. 
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These classifications can be used to give an anaesthetic score, but in that instance a 
linear scale is not representative of the complex systems at work in the live animal. 
Effective doses (ED) of anaesthetic drugs to a certain endpoint – immobility, defined 
pain threshold, unconsciousness, etc. – are often used to more accurately define 
anaesthetic sensitivity. Potencies of anaesthetic vapours are often compared using 
minimum alveolar concentration (MAC), a term devised by Edmond Eger and 
colleagues (1965), which defines the concentration of vapour in the lungs required to 
prevent movement in 50% of subjects in response to surgical stimulus. 
But the question of how to suitably compare the point of LOC between 
animals and humans still remains. First though, a measure of LOC in humans is 
needed. To this end, human LOC has been defined as the inability to respond 
meaningfully to a verbal stimulus (Franks, 2008), something that cannot be applied to 
animals. The most common comparative measure in animals is the loss of righting 
reflex (LORR). When an animal (including mice and rats) is turned on its back its 
natural reaction is to get back on its feet. This righting reflex is sensitive to 
anaesthesia and at a certain anaesthetic concentration the animal will lose its righting 
reflex. Thus LORR can be used as binary measure to score anaesthetic sensitivity 
which can be repeated in any laboratory by a trained technician or scientist. One of 
the most significant reasons for adopting LORR as an anaesthetic measure is the 
pharmacological correspondence between LOC in humans and LORR in other 
animals (Figure 1.2).  
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Figure 1.2 The pharmacological correlation between LOC in humans and 
LORR in rodents.  
This indicates that they measure similar physiological processes. [Re-drawn with 
data from Franks (2008)] 
INTRODUCTION 
21 
 
 
 
 
1.2 Two pore-domain potassium channels 
 
1.2.1 History 
The existence of a hypothetical group of potassium channels that provide a membrane 
leak conductance was predicted by Alan Hodgkin and Andrew Huxley through their 
work on the squid giant axon (Hodgkin et al., 1952). Functioning independent of 
voltage and time, these channels were proposed to regulate the excitatory capacity of 
the cell through a “leak” conductance, and were later confirmed to modulate the 
membrane resting potential (Hille, 1973). 
While still not identified molecularly, a role for this potassium current in 
anaesthetic action was indicated in rat hippocampal pyramidal cells (Nicoll et al., 
1982) and a ganglion of the pond snail (Franks et al., 1988). The currents were 
insensitive to the traditional K
+
 channel blockers and activated at clinically relevant 
concentrations of anaesthetic drugs, suggesting a new molecular mechanism of 
anaesthesia.  
By searching genomic databases for the pore domain of potassium channels, 
Ketchum et al. (1995) identified a novel class of channels in Saccharomyces 
cerevisiae that, once subsequently cloned and expressed in Xenopus oocytes, 
displayed the physiological characteristics of the hypothesised channel. Interestingly, 
the functional channel appeared to consist of two subunits, rather than the four 
associated with voltage-gated potassium channels, with each having two pore 
domains; hence the channels being classified as two pore-domain potassium channels 
(or 2PK channels). Soon afterwards, homologous channels were identified in 
Drosophila melanogaster, providing more evidence for the “leak” model of 
membrane regulation (Goldstein et al., 1996), before being identified in mammals 
(Fink et al., 1996; Lesage et al., 1996). Several studies soon confirmed that these 
channels were indeed sensitive to volatile anaesthetics such as halothane (Patel et al., 
1999; Sirois et al., 2000). 
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More recently, the crystal structures of two human 2PK channels have been 
reported, revealing fenestrations that provide a structural basis for how anaesthetics 
might interact with the channels (Brohawn et al., 2012; Miller et al., 2012). 
 
1.2.2 Physiology and pharmacology 
There exist over 70 genes for K
+
 channels divided into four major subfamilies: (i) the 
voltage-gated K
+
 channels, (ii) the inwardly-rectifying K
+
 channels, (iii) Ca
2+
-
activated and K
+
-activated channels and (iv) the 2PK channels. 
 The voltage-gated K
+
 channels comprise four subunits, each of which has six 
transmembrane (TM) spanning domains. A re-entrant helix between the fifth and sixth 
TM domains forms the basis for the selectivity filter and charged amino acids on the 
fourth TM domain confer voltage sensitivity. 
 Inwardly rectifying K
+
 channels are also formed from four subunits, with the P 
domain situated between the two TM domains on each one. Some members of this 
family are open at rest, while others are regulated by G-protein coupled receptors 
(GPCRs) and other modulators. 
2PK channels, on the other hand, form from the dimerisation of two subunits; 
each having four TM domains and two pore domains (Figure 1.3A). The 2PK family, 
given the genetic identification KCNK and named according to their physiochemical 
attributes (see footnotes), can be further divided into groups based on sequence 
homology and functional similarity: TWIK
1
 channels (TWIK-1, TWIK-2, and the 
non-functional KCNK7) are weakly inwardly rectifying; THIK-1
2
 channels are 
inhibited by halothane and are related to non-functional THIK-2; TREK
3
 channels 
(TREK-1, TREK-2, and TRAAK
4
) are sensitive to arachidonic acid and stretch; 
TALK
5
 channels (TASK-2, TALK-1, and TALK-2/TASK-4) are alkaline-activated; 
TRESK
6
 channels are specifically located in the spinal cord; and TASK
7
 channels 
(TASK-1, TASK-3, and the non-functional TASK-5) are acid-sensitive. 
Usually open at membrane resting potential, 2PK channels are responsible for 
the K
+
 leak current and act to hyperpolarise the cell. This takes the resting potential 
                                                 
1
 TWIK channel: tandem of P domains in a weak inwardly rectifying K+ channel 
2
 THIK channel:  tandem pore domain halothane-inhibited K+ channel  
3
 TREK channel: TWIK-related K+ channel 
4
 TRAAK channel: TWIK-related arachidonic acid-stimulated K+ channel 
5
 TALK channel: TWIK-related alkaline pH activated K+ channel 
6
 TRESK channel: TWIK-related spinal cord K+ channel 
7
 TASK channel: TWIK-related acid-sensitive K+ channel 
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away from the action potential threshold thereby limiting neuronal excitability. 
However, the full story is not so simple: expressed pre-synaptically on inhibitory 
neurons, TREK-1 channel activation reduces GABA release, potentially causing 
excitation of downstream neurons (Westphalen et al., 2007); and additionally, TASK-
3 channels play an important role in mediating increased firing rates of cerebellar 
granule cells due to their rapid repolarisation of the cell (Brickley et al., 2007). 
2PK channels are insensitive to the conventional K
+
 channel blockers 
tetraethylammonium (TEA), 4-aminopyridine, Cs
+
 and Ba
2+
 (Bayliss et al., 2003) and 
are regulated by GPCRs in a subtype specific manner (Mathie, 2007). Widely and 
differentially expressed throughout the body, 2PK channels are thought to be 
important in immune, heart and kidney function, and may play other as yet unknown 
physiological roles. Several members of the 2PK family – TREK-1, TREK-2, TASK-
1, TASK-3 and TRESK – are sensitive to volatile anaesthetics, and as such have 
become a focus for research into anaesthetic mechanisms (Figure 1.3B). 
Recently acquired crystallographic structures of the human TWIK-1 channel 
(Miller et al., 2012) and TRAAK channel (Brohawn et al., 2012) show that 2PK 
channel dimers afford four-fold symmetry in the pore-forming region. Marked 
fenestrations between the TM domains also suggest target sites for hydrophobic 
modulators such as arachidonic acid and anaesthetics, which may achieve access via 
the lipid membrane. 
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1.2.3 TASK channels 
The TASK-1 and TASK-3 subtypes generate pH-sensitive whole-cell K
+
 currents 
with extremely fast kinetics and weak rectification. Much interest has focused on 
these channels due to their widespread expression in the brain and the key role they 
play in maintaining neuronal function. Furthermore, TASK channels are sensitive to a 
number of anaesthetics, as demonstrated firstly in heterologous expression systems 
(Patel et al., 1999) and then in rodent neurons (Sirois et al., 2000). 
Recent research has proceeded on several related fronts: (i) identifying 
endogenous TASK-like conductances in the murine brain slice preparation before (ii) 
knocking out the TASK genes to observe electrophysiological changes that may 
explain (iii) any pharmacological and behavioural phenotypes. 
In mice, TASK-1 channels are strongly expressed in the cerebellar granule 
cells, motor neurons, pontine nuclei, interpeduncular nucleus, locus coeruleus and 
medial mammillary nucleus and also the olfactory bulb granule cells (Bayliss et al., 
2003; Kang et al., 2004). There is a smaller proportion of TASK-1 gene expression in 
the neocortex, raphe nuclei, reticular thalamus, certain central thalamic nuclei, 
parafascicular thalamic nucleus and medial geniculate nucleus (Bayliss et al., 2003). 
Figure 1.3 Two-pore domain potassium (2PK) channels are sensitive to 
anaesthetics.  
A – One TASK-3 subunit of the 2PK channel dimer has four transmembrane 
domains and 2 pore-forming regions. B – The M159A mutation in TASK-3 ablates 
the activation of the channel by halothane and isoflurane. [Adapted from Franks 
(2008)] 
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The expression of TASK-3 differs in some thalamic, hypothalamic and 
pontine nuclei although there is coexpression in the cerebellar granule cells, locus 
coeruleus, motor neurons, pontine nuclei, some cells in the neocortex, habenula, 
olfactory bulb granule cells, and cells in the external plexiform layer of the olfactory 
bulb (Bayliss et al., 2003). TASK-3 channels are also expressed in the hippocampus; 
both on pyramidal cells and interneurons (Torborg et al., 2006). The channels form 
homodimers and may form heterodimers where their expressions co-localise (Berg et 
al., 2004; Kang et al., 2004).  
TASK-1 KO mice display a relatively normal behavioural phenotype as 
judged by standardised behavioural testing (Linden et al., 2006). However, TASK-1 
KO mice have a reduced sensitivity to inhalation anaesthetics: they are less sensitive 
to halothane as judged by the loss of tail withdrawal (LOTW), less sensitive to 
isoflurane as judged by loss of righting reflex (LORR), and less sensitive to the 
sedative action of dexmedetomidine. 
While knock-out of the TASK-1 gene in mice does not have a significant 
effect on the expression of other 2PK channels or GABAA receptors, TASK-1 KO 
mice show increased sensitivity to the ataxic and hypnotic effects of GABAA receptor 
ligands, indicative of a functional GABAA receptor upregulation (Linden et al., 2008). 
TASK-3 KO mice have reduced sensitivity to inhalation anaesthetics (Figure 
1.4A), exaggerated nocturnal activity, and cognitive deficits (Linden et al., 2007; 
Pang et al., 2009), as well as significantly increased appetite and weight gain 
(Robledo-Zapico, 2008). A role for TASK-3 channels in neuronal network 
oscillations has also been described: TASK-3 KO mice lack the atropine-sensitive 
halothane-induced theta oscillation (4-7 Hz) from the hippocampus (Figure 1.4C&D) 
and are unable to maintain theta oscillations during rapid eye movement (REM) sleep 
(Pang et al., 2009). 
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The sequelae of physiological phenotypes in the TASK-3 KO mouse suggest 
specific deficits in hypothalamic and limbic brain regions. One cellular mechanism 
that could explain some of the circadian and metabolic differences is the orexinergic 
system of the lateral hypothalamus. Here, TASK-3 channels are important in 
mediating inhibition of orexinergic neurons in response to glucose (Burdakov et al., 
2006) so, in their absence, animals might over-eat and hence gain more weight. 
Orexinergic neurons are also hypothesised to play a role as a “flip-flop” switch in the 
sleep-wake circuitry to “lock-down” sleep state and prevent aberrant state-switching 
(Lu et al., 2006). Indeed, TASK-3 KO mice also show subtle changes in their sleep-
wake architecture but they do not show signs of a narcoleptic phenotype (Robledo-
Zapico, 2008) as might be expected from orexinergic mutants (Lin et al., 1999). 
Figure 1.4 TASK-3 channel deletion reduces halothane sensitivity and 
ablates an anaesthetic type-2 theta oscillation.  
A – TASK-3 KO mice are less sensitive to halothane. B – Cyclopropane sensitivity 
remains intact in TASK-3 KO mice. C – In wild-type mice halothane causes an 
atropine sensitive theta oscillation. D – The atropine sensitive theta oscillation is 
absent in TASK-3 KO mice. [Adapted from Pang et al. (2009)] 
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That TASK-3 KO mice show changes in sleep and anaesthetic sensitivity 
points towards overlapping mechanisms between these processes, possibly also in the 
hypothalamus. However, there is evidence that halothane exerts its immobility effects 
through TASK-3 channels in motoneurons. In a comprehensive study, the effects of 
isoflurane and halothane were tested on TASK-1 KO mice, TASK-3 KO mice and the 
double mutant (Lazarenko et al., 2010). Each genotype showed reduced sensitivity to 
halothane in measures of immobility (as tested by LOTW), hypnosis (LORR) and 
sedation. However, only sensitivity to LOTW was reduced for isoflurane.  
When TASK channels were knocked out of cholinergic neurons only, the 
sensitivity to halothane and isoflurane was the same as the global double mutant apart 
from LORR by halothane (Lazarenko et al., 2010). Thus, other systems, such as the 
aminergic system (Washburn et al., 2002) or the thalamocortical system (Meuth et al., 
2006; Meuth et al., 2003), are important in TASK-mediated hypnosis. 
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1.3 The hippocampal theta oscillation 
 
1.3.1 Electroencephalography 
The electrical activity of the human brain was first recorded in 1924 by Hans Berger, 
who, after an apparent telepathic experience as a child, was attempting to discover 
evidence for the psychic possibilities of the mind. The voltages he recorded in the 
electroencephalogram (EEG; also used for elecroencephalography, 
elecroencephalographic) were far too low to be transmitted from one person to 
another, but the observation that the activity changes even with simple behaviour such 
as opening and closing the eyes demonstrated the possibilities of this technique for 
observing the brain in action. 
The scalp electrodes used in EEG are unable to detect the activity of single 
neurons; rather, they measure the synchronous activity of thousands or millions of 
neurons oscillating at the same frequency, as in figure 1.5 (Buzsaki et al., 2012). In a 
laminar structure such as the cortical mantle or the hippocampus, the electrical dipoles 
of functionally related neurons can oscillate at the same frequency, causing detectable 
changes in a nearby electrode. EEG is therefore particularly suited to measuring gross 
changes in the network state of the brain over millisecond time scales, such as 
between waking and the different stages of sleep, where large parts of the brain are 
coordinated to produce a specific functional state. 
The first state measured, with the subject closing their eyes, showed 
oscillatory activity between 8 and 12 cycles per second (Hertz: Hz) and was dubbed 
the alpha range, whereas opening the eyes typically shifts the activity to the beta 
range, between 12 and 30 Hz. In keeping with the Greek alphabet, the gamma range 
was identified between 30 and 100 Hz, the delta range between 0 and 4 Hz and the 
theta range between 4 and 8 Hz. 
Over time, EEG has been a useful technique in the clinic and the laboratory to 
measure both normal and abnormal brain activity. More invasive methods have also 
been developed in humans and animals to record activity on the surface of the cortex, 
known as electrocorticography (ECoG), and can be used chronically to measure brain 
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activity over long durations. This makes EEG a useful tool for investigating 
anaesthetic mechanisms in the mammalian brain, where large scale network changes, 
detectable as changes in EEG characteristics, are likely to have some role in 
mediating different anaesthetic states. 
 
 
 
 
1.3.2 The theta oscillation 
The theta oscillation is one of the most robust patterns observable in the EEG of the 
rodent, as well as other mammals, including humans. Expanded to cover a range of 
frequencies from 4 to 12 Hz, the theta rhythm is a nearly sinusoidal oscillation 
observable during rapid eye movement (REM) sleep and in a number of voluntary 
behaviours. 
While many brain regions can oscillate at theta frequencies, the major source 
of the theta oscillation is the hippocampus; a cortical convolution in the shape of a 
ram’s horn that makes up part of the limbic system (Figure 1.6A). The hippocampus 
plays an important role in memory processes (Lisman, 2005) and thus the 
hippocampal theta oscillation has come under intense research as a functional 
correlate of memory. 
Figure 1.5 Electrical recording from the surface of the brain reflects deeper 
activity.  
Note the correspondence between the activity of a single cell and local field 
potentials (LFPs) during the slow waves in the depth recording. [Adapted from 
Buzsaki et al. (2012)]  
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The dynamics of the theta oscillation are mediated by a number of different 
neurotransmitters and neuronal subtypes that set the frequency and amplitude 
differentially across the hippocampal formation. The largest amplitude theta 
oscillations are recorded in the stratum locunosum-moleculare of the CA1 region and 
there is a relative phase shift across the dorso-ventral axis of the hippocampus, such 
that the peak of theta in the stratum pyramidale is synchronous with the trough of 
theta in the hippocampal fissure, as in figure 1.6B (Bland et al., 1976).  
Much of the first research into theta oscillations was originally done in the 
rabbit, where the theta oscillation was divided into two distinct types (Kramis et al., 
1975). Type-1 theta typically occupies the higher end of the frequency spectrum (~7-
12 Hz) and is present during volitional movements: there is also a good positive 
correlation between the frequency of the type-1 theta oscillation and running speed of 
the animal. Pharmacologically, type-1 theta is sensitive to anaesthetics but resistant to 
cholinergic antagonism by atropine. Type-2 theta, on the other hand, is found at the 
lower end of the frequency spectrum (~4-7 Hz) and, present during alert immobility, 
is resistant to anaesthetics but sensitive to atropine. 
The prevailing view is that the type-1 theta oscillation is mediated through 
glutamatergic inputs from the entorhinal cortex (Buzsaki, 2002), whereas the key 
region in the generation of the type-2 theta oscillation is the medial septum-diagonal 
band of Broca (henceforth: medial septum, MS). Classically thought of as the major 
pacemaker, lesions of the medial septum in rabbits eliminate the theta rhythm in the 
hippocampal formation and associated cortical structures (Petsche et al., 1962). The 
MS contains a number of different cell types, including cholinergic, GABAergic and 
glutamatergic cells, all of which have been shown to be important in regulating the 
theta oscillation (Bland et al., 2007a; Yoder et al., 2005).  
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In the rat, pharmacological modulation of the cholinergic and GABAergic 
systems in the medial septum had significant effects on the theta oscillation observed 
during urethane anaesthesia (Smythe et al., 1991) and during alert immobility 
(Lawson et al., 1993). An important contribution to understanding theta regulation 
was made by Yoder and Pang (2005), who used neurotransmitter-specific lesions to 
reveal a dynamic concert of cholinergic and GABAergic neurotransmission in the 
medial septum. 192 IgG-Saporin destruction of cholinergic neurons and kainic acid 
destruction of GABAergic neurons, individually and in combination, vastly reduced 
Figure 1.6 The hippocampus and theta oscillations.  
A – A rodent brain showing the hippocampus (HC) and medial septum (MS), and 
associated fornix (fx) and fimbria (fi). B – The theta oscillation and superimposed 
gamma rhythm changes through the layers of the hippocampus. [Adapted from 
Buzsaki (2002)]  
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the power of the type-2 theta oscillation during urethane anaesthesia (Yoder et al., 
2005). These results support the view that theta activity requires a fine balance of 
excitation and inhibition. 
A third, glutamatergic pathway also exists in the septohippocampal system, 
and may act as a bridge between type-1 and type-2 theta systems. Injections of 
NMDA into the hippocampus increased theta amplitude without affecting frequency, 
whereas NMDA infusions in the MS increased frequency and not amplitude (Bland et 
al., 2007a). Correspondingly, MS infusions of the NMDA antagonist AP5 into the MS 
attenuated theta activity. 
The exact mechanism for how systemic atropine blocks type-2 theta is unclear, 
since the temporal dynamics of muscarinic receptor activation in pyramidal cells is 
too slow to be a direct target (Hasselmo et al., 2001). A more plausible target for 
muscarinic blockade are inhibitory interneurons in the MS (Freund et al., 1988). In 
fact, the essential factor in type-2 theta might be cholinergically-mediated excitation 
of medial septum GABAergic cell bodies (via PLC and TASK-3 dependent 
intracellular mechanisms), which have been shown to lead hippocampal activity 
during the theta oscillation (Hangya et al., 2009). This inhibition of hippocampal 
interneurons (Wu et al., 2000) releases their inhibition on pyramidal cells so they can 
oscillate at theta frequencies.  
 
1.3.3 The hippocampus and anaesthesia 
Since the type-2 theta oscillation was first described in rodents anaesthetised with 
urethane, many studies have used the anaesthetised animal as a model system for an 
oscillating network, attempting to piece out the major molecular and cellular 
regulatory components. 
 However, the type-2 theta oscillation also appears during exposure to the 
volatile anaesthetic halothane, leading to the interesting hypothesis that the oscillation 
might have a functional relevance to inducing the anaesthetic state. 
The Bland group has extensively studied the type-2 theta oscillation in 
response to halothane, showing that incremental increases in halothane concentration 
resulted in decreasing frequencies and increasing amplitudes of theta (Bland et al., 
2003). Importantly, this theta rhythm could be abolished by the muscarinic antagonist 
atropine indicating the involvement of cholinergic neurotransmission; however, 
INTRODUCTION 
33 
 
GABA-mediated inhibition by interneurons is also predicted to have a facilitatory 
role. 
To maintain the type-2 theta oscillation over long periods or cycle between 
theta and non-theta states, a balance between excitatory cholinergic activity and 
inhibitory GABAergic activity must be reached during halothane anaesthesia. Since 
halothane uncouples gap junctions, direct electrical coupling between interneurons 
can be ruled out as a facilitatory mechanism for hippocampal synchrony. 
 
A role for the hippocampus and the septohippocampal system in directly mediating 
anaesthetic states has not been extensively studied; however, there are several studies 
that suggest that might be the case. Potentiating GABAergic neurotransmission with 
muscimol injections in the MS or the hippocampus increased the potency of propofol, 
isoflurane and halothane (Ma et al., 2002). That study also showed that the 
behavioural excitation induced on initial exposure to an anaesthetic (stage II or the 
delirium phase) and accompanying neurophysiological activation are attenuated by 
septohippocampal inactivation. 
 Further work in that lab showed that muscimol injections into the nucleus 
accumbens (NAc), ventral pallidum, supramammillary nucleus (SUM) and the ventral 
tegmental area (VTA) all potentiated the effects of anaesthesia. Interestingly though, 
inactivation of the median raphe had no effect (Ma et al., 2006). Taken together, these 
results indicate a role for the entire limbic system in supporting the anaesthetic state; 
however, these studies measured anaesthetic potency on the basis of duration of loss 
of righting reflex, which has a significant pharmokokinetic component meaning that 
drug effects on respiration and metabolism cannot be ruled out. Indeed, there is 
evidence that anaesthetic induction and emergence comprise two asymmetric 
processes. 
 The major component of this theory is the orexinergic wake switch. 
Orexinergic neurons in the lateral hypothalamus are inhibited under isoflurane and 
sevoflurane anaesthesia to the same degree as in sleep, but selective ablation of 
orexinergic neurons does not affect anaesthetic induction. However, ablated 
orexinergic output delays emergence time, suggesting that orexinergic 
neurotransmission is an asymmetric wake switch (Kelz et al., 2008). 
 The issue is slightly more complicated with the finding that halothane 
anaesthesia is neither accompanied by a reduction in orexinergic cell activity nor a 
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delayed emergence when these neurons are ablated (Gompf et al., 2009). 
Additionally, there was no decrease in locus coeruleus firing rate during halothane 
anaesthesia, an effect considered fundamental to non-orexinergic dexmedetomidine 
anaesthesia, suggesting a different mechanism of action for halothane. 
 One potential target for halothane, as well as other anaesthetics, is the 
cholinergic system of the basal forebrain. One study showed that cholinergic lesions 
in the medial septum but not in the nucleus basalis magnocellularis (NBM) caused 
reduced acetylcholinesterase staining in the hippocampus and in the cortex and 
increased sensitivity to propofol (Laalou et al., 2008). In contrast, another study, using 
a different measure of anaesthetic sensitivity, indicated that NBM lesions did enhance 
the effect of propofol on righting reflex (Leung et al., 2011), whereas these lesions did 
not affect the duration of halothane LORR. 
 Muscimol injection into the same area increased the potency of propofol and 
halothane, as well as pentobarbital (Leung et al., 2011). In addition, the delirium 
phase of both propofol and halothane anaesthesia was blunted by physical and 
pharmacological blockade of the system. 
 The authors of this study also make the interesting observation that although 
muscimol injection into the NBM caused neocortical slow wave activity, there was no 
behavioural sign of anaesthesia. This phenomenon has also been observed with 
atropine injection into the pontine reticular formation (Vanderwolf, 1988), suggesting 
dissociation between these two phenomena. 
 
As well as inducing LOC, anaesthetics cause a range of other effects, including 
analgesia, immobility and amnesia. And here, there is evidence for the hippocampus 
and related theta oscillation as a functional target. Sub-anaesthetic doses of halothane 
impair contextual memory in fear conditioning with an EC50 of 0.14%, much lower 
than the concentration needed to induce LORR (Perouansky et al., 2010). 
Accompanying this impairment was a reduction in hippocampal network frequency 
from 7.4 Hz to 6.9 Hz, which is just in the type-1 theta range. However, since there is 
evidence that type-2 and type-1 theta can exist simultaneously and the authors of this 
study do not ablate type-2 theta with atropine, a role for the lower frequency 
oscillation cannot be ruled out.  
 Given that isoflurane and nitrous oxide had similar effects on contextual 
memory and the theta oscillation, but are proposed to act at different molecular 
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targets, it appears that anaesthetic compounds might converge at the network level to 
exert their similar functional effects. 
 At least one of these many anaesthetic target sites is likely to be inactivation of 
cholinergic forebrain-hippocampal-cortical projections, since potentiation of this 
system reverses the decrease in cross-approximate entropy in the EEG (a marker for 
the number of active brain modules) caused by isoflurane (Hudetz, 2002; Hudetz et 
al., 2003). How important this is in the direct switching between conscious states 
remains an open question. 
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1.4 Aims and hypotheses 
 
This study first sought to gain a clearer understanding of the role of the type-2 theta 
oscillation in halothane anaesthesia. So far, previous research has focused on the 
cellular mechanisms responsible for producing type-2 theta, but no studies have 
investigated whether the oscillation itself is involved in mediating an anaesthetic state 
per se. 
 Contained within chapter 3 of this report is an analysis of the mouse EEG in 
response to halothane with relation to LORR. The possibility that the type-2 theta 
oscillation represented a state of sensory awareness was investigated by blocking it 
with systemic or central cholinergic antagonism. Would halothane sensitivity change 
as a result? 
 
Chapter 4 set out to investigate the type-2 theta oscillation in TASK-3 KO mice. It is 
already known that TASK-3 KO mice have impairments in type-2 theta oscillations in 
response to halothane anaesthesia, but what about during normal behaviours? 
 The ability of TASK-3 KO mice to produce type-2 theta oscillations during 
the stereotyped behaviour of “alert immobility” was tested with predator-induced 
freezing. Working memory, object recognition and conditioning responses were also 
tested in TASK-3 KO mice. 
 
The next part of this report aimed to investigate the role of septohippocampal TASK-3 
channel expression in type-2 theta oscillations. Chapter 5 details the construction and 
validation of two Adeno-associated viruses (AAVs) that would express the TASK-3 
gene in selective regions of the KO mouse brain. Would putting TASK-3 channels 
back into either the medial septum or the hippocampus (key regions in the type-2 
theta mechanism) be enough to rescue the oscillation? 
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2.1 Animals 
 
2.1.1 Basics 
All experiments were carried out in accordance with the United Kingdom Animals 
(Scientific Procedures) Act of 1986 and have been approved by the Ethical Review 
Committee of Imperial College London. All mice were of at least 8 weeks of age and 
20 grams in weight before surgery. C57Bl6 ordered from off-site distributors served 
as wild-type. TASK-3 KO mice were bred in-house from a line originally provided by 
Professor William Wisden (Imperial College, UK). Animals were housed in standard 
Plexiglas cages in humidity and temperature controlled conditions under 12:12 hour 
light:dark cycle. Male mice only were used for experiments and food and water were 
available ad libitum. 
 In addition, every effort was made to implement the 3Rs of best in vivo 
practice; namely, reduction, replacement, and refinement. With that said, the only way 
to model anaesthetic mechanisms accurately is by using the live animal. 
 
2.1.2 Generation of TASK-3 knockout mice 
TASK-3 KO mice were created by the Wisden Laboratory at the Ruperto-Carola 
University of Heidelberg, Germany, prior to the studies in this report. As described in 
Brickley et al. (2007), the TASK-3 gene was inactivated by combined homologous 
and insertional recombination. While the intended strategy was to flank exon 1 of the 
TASK-3 gene with loxP sites in the same orientation by homologous recombination 
and insert an frt site-flanked neomycin resistance gene cassette to serve as a positive 
selection marker for embryonic stem (ES) cell culture, the actual targeting event 
produced an insertion of 4 copies of the neomycin cassette and inverted repeats of the 
TASK-3 exon 1 into the TASK-3 locus. Although unconventional, this served to 
knockout the TASK-3 gene, as confirmed by in situ hybridisation. 
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2.1.3 Genotyping 
DNA was extracted from ear punch samples by heating for 1 hour at 95°C in 50 µl 25 
mM NaOH, 0.2 mM ethylenediaminetetraacetic acid (EDTA) (pH 12) and, once 
cooled to room temperature (RT), 50µl 40mM Tris (pH 5) was added. Samples were 
used immediately or stored at -20°C. 
 1 µl of DNA extract was added to 12.5 µl “Go Taq Green Master Mix” 
(Promega, UK), 1 µl DMSO and 10 μM primer mix* in a total volume of 25 µl. DNA 
was amplified in standard PCR conditions as follows: 5 minutes at 95°C, followed by 
35 cycles of 1 minute at 95°C, 1 minute at 60°C and 1 minute at 72°C, then 5 minutes 
at 72°C and held at 4°C. 
Each sample was then run on a 1.3% agarose gel containing SYBR-Safe 
(Invitrogen, USA) using  TAE running buffer (from a 50x stock of 500 ml containing 
121 g Tris base, 28.55 ml glacial acetic acid, 50 ml 0.5 M EDTA) and compared 
against a 1500 bp DNA ladder (Promega, UK). Gels were run for 1 hour at 90 V and 
visualised using a Kodak DC290 camera (USA), as in figure 2.1. 
 
* TASK-3 genotyping primers: 
The following primers were designed to flank the 5’ loxP site of the TASK-3 
KO, producing a 350 base pair (bp) amplification product for littermate (LM) and a 
400 bp amplification product for TASK-3 KO. 
Forward:  
5’- CTC TGT CCC GGC TAC CGA TCC TGC-3’ 
Reverse:  
5’-TTC CGT GGG CGC AGC GGG TTC CGC-3’ 
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Figure 2.1 Genotyping results. 
Genotyping separates homozygous TASK-3 KOs (KO: -/-) from homozygous 
littermates (LM: +/+) by a 50bp difference in the PCR amplification product. 
Heterozygotes (+/-) display as a double band at both levels (data not shown). [L = 
DNA ladder] 
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2.2 Surgery 
 
2.2.1 Preparation 
All surgical tools were sterilized in an autoclave or disposable sterile items were used 
where appropriate and aseptic technique was used throughout. After weighing the 
animal, anaesthesia was induced via intra peritoneal (i.p.) injection of a ketamine (80 
mg/kg)/xylazine (15 mg/kg) mix or 2% halothane (Merial, UK). All drugs were made 
up in sterile physiological saline (0.9% w/v NaCl).  
After loss of pedal withdrawal reflex the hair over the skull was clipped and 
lubricant was applied to the eyes (Lacri-lube, Allergan, UK). The animal was placed 
in a stereotaxic frame (Harvard Instruments, USA) and 0.5 ml saline (0.9% w/v NaCl) 
was administered subcutaneously to compensate for fluid loss during surgery. An 
incision was made along the midline over the skull and the retracted skin was held in 
place by suture material. The periosteum was removed and the skull area was cleaned 
and dried. The stereotaxic frame and arm enabled the precise localisation of 
electrode/cannula/needle positions relative to bregma and lambda. 
 
2.2.2 ECoG instrumentation 
Mice were instrumented with ECoG and EMG (electromyography) recording 
electrodes. Using a stereotaxically-mounted drill (Fordham, USA) three holes were 
drilled for the EEG electrode 1 (-1.5 mm Lambda, 0 midline), EEG electrode 2 (+1.5 
mm Bregma, -1.5 mm midline) and reference electrode (-1.5 mm Bregma, +1.5 mm 
midline). Gold-plated screws were inserted into the holes and connected to an 
electrode rig via insulated wires, as in figure 2.2A. Three flexible insulated wires with 
the tip exposed were sutured into the nuchal muscles of the neck and served as EMG 
electrodes. The exposed area was sealed and protected with Orthoresin dental cement 
(Dentsply, Australia).  
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2.2.3 Medial septum cannulation 
For acute administration of drugs to the septohippocampal system, mice were 
instrumented with cannulas into the area above the medial septum. 27-gauge stainless 
steel tubing (Small Parts Inc., USA) was cut to 13 mm and stereotaxically implanted 
so that the tip was located 3 mm above the medial septum itself (+0.80 mm Bregma, 
midline, -2.0 mm DV). The exposed tip of the cannula was protected by a plastic 
guard and a 32-gauge stainless steel stylet was placed into the cannula. Correct 
cannula placement was confirmed in fixed and sliced tissue after the experiments. 
 
2.2.4 Adeno-associated virus (AAV) delivery 
AAVs were prepared for injection by mixing the purified sample (See 2.6.4) with an 
equal volume of 20% D-mannitol (to aid virus dispersion) and a small amount of blue 
dye (to aid visualisation) and drawn into a glass tip. After securing the animal in a 
stereotaxic frame attached to a PC, Leica Angle Two software (Germany) enabled the 
calibration of the whole brain with a built-in mouse brain atlas. Using bregma and 
lambda as reference points, holes were drilled over the injection sites and the glass tip 
was lowered into the correct position according to the coordinates below (mm relative 
to bregma). 
 
   Mediolateral  Anterioposteriar Dorsoventral 
Medial septum: 0.00   +0.86   -4.70 
Left hippocampus: -1.35   -1.94   -1.49 
Right hippocampus: +1.35   -1.94   -1.49 
 
2.2.5 Post-operative care 
Prior to anaesthetic recovery 30 µg/kg buprenorphine (Alstoe Animal Health, UK) 
was administered subcutaneously for post-surgical analgesia. In addition, for 7 days 
following surgery, carprofen (Rimadyl, Pfizer Animal Health, USA) for analgesia and 
enrofloxacin (Baytril 2.5%, Bayer, Germany) for prophylaxis were diluted in the 
drinking water (100 ppm). At least 7 days was allowed for recovery before further 
experiments. 
 
METHODS & MATERIALS 
43 
 
 
 
  
Figure 2.2 Electrocorticography using the Neurologger.  
A – Stereotaxically implanted screw electrodes, marked with an “x”, detect activity 
from the surface of the cortex. B – The Neurologger is a tether-free recording 
device that can monitor brain and muscle activity in any environment. 
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2.3 Electrocorticographic (ECoG) recording 
 
2.3.1 Recording technique 
Electrocortigography (ECoG) is a subtype of electroencephalography (EGG) that 
involves recording global field potentials from the surface of the brain. ECoG 
provides a measure of the summated electrical activity of many thousands of neurons, 
depending upon the electrode configuration, giving a gross representation of the brain 
state over millisecond timescales.  
In this study, screws overlying the cortical dura (See 2.2.2) detected potentials 
representative of distributed cortical and subcortical activity, which were recorded on 
a lightweight and tetherless device, the Neurologger (NewBehaviour, Switzerland). 
The Neurologger (Figure 2.2B), designed and built by Dr Alexei Vyssotski 
(University of Zurich, Switzerland), is an autonomous wireless device capable of 
recording up to four electrical signals in an internal 256 Mb memory chip. Weighing 
only 2 grams, the Neurologger can be docked onto the electrode rig of the animal to 
provide in excess of 24 hours of recordings. The Neurologger has a sampling 
frequency of 200 Hz and has an internal bandpass filter between 1 and 70 Hz. After 
collection, data was transferred to a PC for analysis using Spike2 Version 5.14 
(Cambridge Electronic Design, UK). 
Typically, two ECoG signals were recorded from screw electrodes over the 
frontal and parietal cortices, relative to a common reference electrode over the 
occipital lobe. Two EMG signals were recorded from solder-tipped wire electrodes 
fixed into the nuchal muscles of the neck, relative to an adjacently positioned 
reference electrode wire. 
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2.3.2 ECoG data analysis using fast Fourier transforms 
When plotted as a time series of potential differences, the recorded ECoG signal 
shows characteristic oscillatory patterns depending on behavioural and arousal state 
that can be defined by frequency (in Hertz), relative and absolute amplitude (in Volts) 
and shape (Figure 2.3A). The frequency component (as well as the attendant 
amplitude) can be analysed by the fast Fourier transform (FFT).  
The FFT is a computationally faster version of the discrete Fourier transform 
(DFT), both of which are algorithms that decompose a sequence of values, which in 
the case of ECoG is a time series of potential differences, into its component 
frequencies. Depending upon the parameters of the algorithm, the power (square of 
the amplitude) of the signal in defined frequency bins can be plotted as a power 
spectrum. The power spectrum provides a visual representation of the proportions of 
recorded brain frequencies present within the defined time epoch (Figure 2.3B). 
The ECoG recordings in this study were analysed using the Hanning window 
FFT in Spike2 Version 5.14 (Cambridge Electronic Design, UK). Frequency binning 
depended upon the length of the time epoch. Stable, long term oscillations, in the 
minutes range, were analysed using 512 bins over 100 Hz giving a frequency 
resolution of 0.1953 seconds. Very short epochs, on the order of a few seconds, 
sacrificed frequency resolution for time resolution, as appropriate. Lorentzian curves 
were fitted to the power spectra using Origin 5.0 (Microcal, USA). 
 
  
Figure 2.3 Fast Fourier transforms of the electrocorticogram provide a 
visual way to inspect the prominent resonant oscillatory frequencies.  
A – The electrocortical waveform of a running mouse shows activity of varying 
frequency and amplitude. B – Deconvoluting the electrocortical time-series using 
FFTs shows a prominent oscillation at 9 Hz indicative of a moving animal. 
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2.4 Anaesthetic experiments 
 
2.4.1 Halothane LORR 
Six wild-type mice were used to test the effect of increasing halothane 
(C2HBrClF3)
 
concentration on the ECoG. After docking the Neurologger onto the 
animal, and i.p. injection of saline or 50 mg/kg atropine sulphate (a muscarinic 
antagonist), the animal was placed in a cylindrical glass jar (volume ~1000 ml). 
Medical oxygen (BOC, UK) was fed through a vaporiser at a flow rate of 2 L/min, 
controlled by a regulator. After 10 minutes, the halothane concentration was increased 
to 0.4% and then further increased by 0.1% every 10 minutes until 1.5%. At the end 
of each concentration step the ability of the animal to right itself after being placed in 
the supine position was tested by gently turning the glass jar until the animal was on 
its back (Figure 2.4). The score was judged as a negative righting response if the 
animal remained on its back for 30 seconds or longer. Experiments on the same 
animal were separated by at least one week. Anaesthetic concentrations were 
measured throughout by a Capnomac II (Datex, Finland). 
 
2.4.2 Medial septum injections 
The ECoG was recorded in six wild-type mice that received medial septum 
microinjections of various pharmacological agents while anaesthetised with 
halothane. After 10 minutes of baseline recording in the glass jar, halothane was 
introduced at a sub-anaesthetic concentration; e.g., 0.6%. After 10 minutes the 
halothane concentration was increased to anaesthetic levels, that is, for LORR to 
occur; e.g., 0.8-1.0%. After ~20 minutes at this level, either 40 µg lidocaine or 50 µg 
atropine sulfate or artificial cerebrospinal fluid (aCSF) vehicle was injected into the 
medial septum. The animal was swiftly returned to the anaesthetic vapour and left for 
up to 1 hour. One week was allowed between drug exposures. 
 The halothane LORR in response to pre-administration of medial septum 
aCSF or 50 µg atropine sulfate was measured as described above (See 2.4.1), with 
simultaneous ECoG recording. 
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2.4.3 Halothane delirium 
The effect of modulating systemic cholinergic neurotransmission on halothane-
induced behavioural excitability was investigated as follows. Wild-type mice were 
injected i.p. with either saline vehicle (control), 50 mg/kg atropine sulfate or 0.2 
mg/kg eserine/physostigmine (a cholinergic enhancer) and placed into a sealed Med 
Associates Activity Monitor System (USA) for 30 minutes before 2% halothane in 
medical oxygen was introduced at a rate of 4 L/min for a further 10 minutes. 
The activity monitor consists of a 28 cm x 28 cm x 20 cm box with 
perpendicular infrared beams running along the base, which are broken as the animal 
moves around the box and are recorded as a series of coordinates. The distance 
travelled was binned into 30 second epochs and correlated with ECoG activity. 
 
 
 
 
 
 
  
Figure 2.4 The loss of righting reflex is tested in response to increasing 
concentrations of halothane.  
A – The thermoregulated cylindrical chamber is turned gently to measure loss of 
righting reflex in response to the application of halothane (B). 
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2.5 Behavioural experiments 
 
2.5.1 Video tracking and Neurologger synchronizing 
In addition to locomotor tracking using the Activity Monitor (Med Associates, USA), 
video tracking methods were also developed. The advantages of video tracking are 
numerous: firstly, video tracking is more accurate; and secondly, the locomotion arena 
can be changed to any shape required.  
Videos were recorded using a Logitech webcam (Switzerland) on Debut Video 
Capture (NCH Software, USA). Video files were analysed using SwisTrack tracking 
software (Switzerland) which uses contrast separation to find the centre of mass of a 
moving object over time. The “real world” dimensions and speed of the mouse can be 
calculated from these co-ordinates.  
This tracking data can be synchronised with the neurophysiological data 
collected on the Neurologger by exposing the grounded Neurologger to an 
electromagnetic pulse from a signal generator that simultaneously turns on a light 
emitting diode (LED). The “spike” created in the Neurologger signal can then be 
aligned with the light that appears on the video. In this way, the ECoG trace can be 
analysed according to periods of different behaviour selected from the video, tracking 
output and EMG information. 
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2.5.2 Rat exposure test 
The rat exposure test is a validated paradigm for measuring natural defensive 
behaviours in mice (Yang et al., 2004). The test involves exposing a mouse to the 
sight and smell of a natural predator, i.e. a rat, to illicit stereotyped behaviour. 
Different strains of mice have different responses to the test indicating a strong 
genetic predisposition. The test apparatus, modified from Yang et al. (2004), consists 
of a transparent glass tank measuring 60 cm x 30 cm x 30 cm, housed in a sound 
attenuating chamber under low background light levels, separated into two 
compartments by a wire mesh grill and removable black screen (Figure 2.5). 
Each test session was video-recorded as described previously and saved on a 
PC. Neurologgers were attached to five TASK-3 KO mice and seven littermate mice 
before being individually habituated to one of the compartments for 10 minutes for 
four consecutive days. On the next day, each mouse was again placed in the same 
compartment. A Sprague Dawley rat was introduced to the other compartment behind 
a screen and after 2 minutes the screen was removed. The test continued for another 
10 minutes. The amount of behavioural freezing of the mice was compared in the pre- 
and post-stimulus sessions and between genotypes. The cage was cleaned with a 10% 
ethanol solution between animals. All tests were conducted during the dark phase of 
the light/dark cycle under low level ceiling lights. 
Freezing was scored blinded using a threefold method after the experiment. 
Once the data file for the video tracking had been aligned with the Neurologger data, 
episodes of movement and freezing could be isolated. Movement was scored when the 
(filtered and smoothed) EMG was high and the speed of the animal was above 2 cm/s, 
whereas freezing was scored when the EMG was flat and the speed was 0 cm/s. The 
video was double-checked to ensure that correct behaviours had been identified. 
Three 2-second epochs of ECoG for each behaviour and animal were analysed using 
FFT, giving an average power spectrum for each genotype and behaviour. 
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Figure 2.5 The rat exposure test elicits freezing behaviour in mice.  
On exposure to a rat in a previously neutral environment a mouse will perform a 
variety of defensive behaviours including freezing (alert immobility). [Adapted 
from Albieri (2009)] 
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2.5.3 Spontaneous alternation in the T-maze 
The spontaneous alternation test utilises the mouse’s innate disposition to explore 
novelty. Using a T-shaped maze, a normal animal, when released from a holding 
chamber at the base of the T, will spontaneously alternate between two choice-arms at 
the top of the T and deficits in working memory manifest as a reduction in alternation 
rate (Gerlai, 1998).  
The T-maze was made bespoke in grey plastic and consists of three horizontal 
arms in the shape of a T surrounded by a wall 15 cm high. The start arm (the base of a 
T-shape) measures 50 cm before splitting into two perpendicular arms, each 
measuring 50 cm. Slotted panels allow guillotine doors to be placed as desired 
throughout the maze. 
Animals were acclimatised to a featureless test room for two consecutive days 
prior to the test. On the test day, animals were run individually and the maze was 
cleaned with 10% ethanol and thoroughly dried before the next subject. The mouse 
was placed in the base of the start arm in a compartment made by a guillotine door 15 
cm along the arm. After 30 seconds, the door was opened and the mouse was free to 
explore one arm of the T-Maze in a “training” trial (the other being blocked off by a 
door). Once the animal returned to the start position, the door was closed behind it. 
After 15 seconds, the door was re-opened allowing the animal to explore either arm in 
the “test” trial (the blocking door having being opened). Once the animal entered one 
arm it was briefly confined to allow the other door to be blocked off, preventing entry 
to this arm. The animal was released and the process was repeated for 10 similar 
“test” trials (Figure 2.6). 
A correct score consisted of the animal choosing the arm that it did not enter 
on the last trial and, after validation in C57Bl6 mice, the percentage correct 
alternation was compared between 9 TASK-3 KOs and 11 littermate controls, with the 
genotypes blinded to the experimenter.  
It was especially important in this test to avoid giving any unconscious cues 
that might bias the decision of the mouse. To ensure that this was the case, the maze 
was set up in a featureless alcove, with symmetrical surroundings and uniform 
lighting conditions. The experimenter also made symmetrical movements when 
removing the doors from each arm (one being a “fake” door removal). 
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Figure 2.6 The spontaneous alternation T-maze measures working memory.  
If the mouse chooses left (a), the opposite arm is blocked (b) and it returns to the 
start with a free choice (c). With an intact working memory the mouse will seek to 
explore the novel right arm (d) before repeating the process. [Adapted from Gerlai 
(1998)] 
METHODS & MATERIALS 
53 
 
2.5.4 Object recognition test 
The object recognition test is designed to evaluate object memory, a hippocampus-
dependent task. The test consists of three phases, all recorded on video: in the first 
session mice were habituated to an open field (i.e., the Activity Monitor) for 10 
minutes and then placed in a holding cage for an inter-trial period; in the second 
session two identical novel objects were placed in the open field and the mouse was 
returned for 10 minutes exploration before being placed in the holding cage; in the 
third session – either on the same day, to measure short term memory, or on the next 
day, to measure long term memory – one of the objects was changed and the mouse 
returned for a further 10 minutes exploration (Figure 2.7). 
Object interaction – classified as nose touching the object – was scored using 
Ethom behavioural analysis software (Taiwan) and the total time of interaction was 
compared between objects, sessions and genotype. The resulting interaction ratio 
between the novel and familiar object (Tnovel object / (Tnovel object + Tfamiliar object)) provides 
a measure of learning, with increased interaction with the novel object deemed to be 
the best performance. The cage was cleaned with a 10% ethanol solution between 
animals. All tests were conducted during the dark phase of the light/dark cycle under 
low level ceiling lights. 
The test was first validated using four C57Bl6 mice, a process that took 
several cohort iterations to produce the strongest results. It was found to be important 
to handle the mice for several days before the test. This acclimatised the animals to 
being transferred from cage to arena, desensitising them to smells and surroundings 
that might provoke anxiety, a confounding factor to any experiment that relies on 
investigation of novelty. 
The choice of objects also required optimisation for maximising interaction. 
This was achieved by choosing objects with angles and drilling holes into the sides of 
the objects, to create interesting areas that would elicit exploration. Another major 
consideration was to make sure that one object was not more interesting than the 
other. A separate cohort of mice was tested for object preference, ensuring that each 
object was of equal interest 
Only then was it possible to investigate TASK-3 KO (n = 14) and littermate 
mice (n = 10) in a double-blind protocol. 
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Figure 2.7 The object recognition test measures short-term and long-term 
memory function.  
In the training phase, the mouse is exposed to two identical objects. When one of 
the objects is swapped for a novel one in the test phase, a mouse that recognises 
the change will interact with the new object for longer. 
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2.5.5 Spatial recognition test 
The spatial recognition test is a variant of the object recognition test that exposes the 
animal to five different objects instead of two identical ones and then displaces one or 
more of the objects. Objects in a novel location are expected to attract greater 
attention and interaction (Figure 2.8). 
 After several days of handling to reduce the mice’s anxiety levels, the test was 
validated in four C57Bl6 mice and then performed in TASK-3 KOs and littermates (n 
= 7), in a double-blind protocol. Each mouse was exposed to the circular test arena 
(60 cm diameter) five times for 10 minutes each, separated by 3 minutes inter-trial 
time in the home cage. The first exposure consisted of the empty arena; in the second, 
third and fourth exposures the animals were free to explore five novel objects in fixed 
positions in the arena. On the fifth and final exposure, two of the objects were moved 
into new locations.  
 Interaction with the objects was scored as for the object recognition test, in all 
phases of the experiment. In the test phase, increased interaction with the objects in 
new spatial locations was judged as intact memory processing. However, there is also 
information in the training phase of the experiment, since any impairment in memory 
acquisition may manifest as a failure to habituate to the objects.  
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Figure 2.8 The spatial recognition test measures the response of a mouse to a 
changed topographic environment.  
After exposure to the test arena, a mouse with intact hippocampal function should 
explore the displaced objects for longer than the non-displaced objects. 
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2.5.6 Dropbox 
The dropbox is a novel Pavlovian conditioning paradigm that involves training the 
animal over two days to associate a 10 kHz tone and the contextual environment with 
the release of a trapdoor and a plunge into a water pool. This aversive unconditioned 
stimulus is similar to the electric shock of traditional fear conditioning tests but is 
preferable because it is a more naturalistic stimulation and avoids painful and stressful 
manipulations. A probe test is performed on the third day to measure long-term 
contextual and cued learning. The proportion of alert immobility correlates with 
environmental awareness and memory recall (Figure 2.9). 
The test apparatus consists of a bespoke dropbox (10 cm x 10 cm x 30 cm) 
made from red transparent plastic, and housed in a sound attenuating chamber under 
red light. On training days 1 and 2, individual mice were placed inside the dropbox 
and after 180 seconds of acclimatisation a 10 kHz tone was presented for 10 seconds. 
With the cessation of the tone, a “trapdoor” was released, dropping the animal into a 6 
cm deep pool of water. White tempura paint masked the bottom of the box. After 5 
seconds of swimming the trapdoor was replaced and the mouse was “rescued”. After 
an inter-trial period of 30 seconds, there was another tone and drop, and this was 
repeated for 6 tones in total. A probe test was performed on day 3 with a similar 
acclimatisation phase of 180 seconds in the drop-box. Freezing behaviour in this 
phase correlates with contextual memory recall. To test cued conditioning, four 30 
second tones are presented with 30 second intervals in a novel chamber. Solid 
surfaces were cleaned with a 10% ethanol solution prior to the first animal and 
between subsequent animals in each case. 
Freezing was scored on video playback by a blinded observer and, after 
validation in C57Bl6 mice (n = 4/6), the test was performed in TASK-3 KO mice (n = 
6) and littermate controls (n = 7). Additionally, the effect of cholinergic blockade on 
dropbox memory acquisition was tested by pre-treating one group of C57Bl6 mice 
with 50 mg/kg atropine sulfate i.p. prior to each training day. To confirm that the 
dropbox environment itself did not elicit freezing, a cohort of mice were placed in the 
dropbox without the water drop. 
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Figure 2.9 The dropbox measures aversive memory behaviour.  
A mouse learns to associate a tone and an environmental context with a water-
drop and will freeze when placed in the same context or exposed to the tone in 
expectation (fear) of the aversive stimulus. 
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2.5.7 Orientation response test 
To test the homeostatic orientation response, purported to involve type-2 theta-related 
processes (Shin, 2010), a bespoke motorised circular platform was made. The 
platform consisted of a plastic turntable with a diameter of 10 cm, which was driven 
inside a stationary drum measuring 12 cm high, by a 3 V bi-directional motor. 
 Mice were habituated to the apparatus for a few minutes on several days 
before the test and then the platform was rotated at 20 rpm for one minute each in the 
clockwise and anti-clockwise direction. The extent of the orientation response was 
measured by the turns in the same direction as the rotation in TASK-3 KO (n = 5) and 
littermate mice (n = 4). One week later, the same mice were pre-treated with 50 mg/kg 
atropine sulfate i.p. to elucidate the effect of antagonising cholinergic 
neurotransmission on turning behaviour. 
 
 
 
 
  
Figure 2.10 The orientation response is a homeostatic behaviour indicative of 
normal sensorimotor processing.  
A – The mouse is placed in a rotating drum and its behaviour is monitored. B – 
Normal mice will perform an “orientation response” in the direction of the 
movement, whereas atropine-treated mice lack this behaviour. [Adapted from Shin 
(2010)] 
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2.6 Adeno-associated virus production 
 
2.6.1 Overview 
To introduce the TASK-3 gene back into discrete regions of the TASK-3 KO mouse 
brain two recombinant Adeno-associated viruses (rAAVs) were designed and made. 
One of them would express, under a pan-promoter, the TASK-3 gene and an enhanced 
green fluorescent protein (eGFP) marker (eGFP-2A-TASK-3 rAAV); the second 
would contain cyclization recombinase (Cre) and flippase (Flp) transgenic elements 
that aimed to restore endogenous expression levels (Cre-2A-Flp rAAV). 
 
2.6.2 eGFP-2A-TASK-3 rAAV 
 
Overview 
The TASK-3 gene was amplified from a pDNA3 plasmid using polymerase chain 
reaction (PCR) with primers containing ApaI and HindIII restriction endonuclease 
(RE) sites and the purified product was digested with the appropriate RE and ligated 
into a similarly cut plasmid adjoining a 2A co-translation cassette and eGFP. The 
eGFP-2A-TASK-3 fragment was amplified by PCR using primers with NotI and 
HindIII sites in the forward and reverse primers, respectively. This fragment was then 
ligated into an AAV vector between inverted terminal repeat (ITR) motifs. 
 This new plasmid construct was co-transfected with pFΔ6, pH21 and pRV1 
helper plasmids into human embryonic kidney (HEK)-293 cells that act as a 
“production factory” for the rAAV particles. The cells were harvested, lysed and the 
rAAV particles were captured on a heparin sulphate column before collection. 
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TASK-3 amplification 
The TASK-3 gene was amplified from a pDNA3 plasmid using PCR with primers 
containing ApaI and HindIII RE sites.  
1µl plasmid template (mTASK-3 in pDNA3) was added to 25 µl “Go Taq 
Green Master Mix” (Promega, UK), and 10 μM primer mix* in a total volume of 50 
µl. DNA was amplified in standard PCR conditions as follows: 5 minutes at 95°C, 
followed by 30 cycles of 1 minute at 95°C, 1 minute at 55°C and 1.5 minutes at 72°C, 
then 5 minutes at 72°C and held at 4°C until later use. 
5 µl of each sample was then run on a 0.8% agarose gel containing SYBR-
Safe (Invitrogen, USA) using 1x TAE running buffer and compared against a 1500 bp 
DNA ladder (Promega, UK). Gels were run for 1 hour at 90 V and visualised using a 
Kodak DC290 camera (USA). 
The amplified product was purified using MinElute gel extraction kit (Qiagen, 
Netherlands) and, since Taq polymerase adds an adenine nucleotide onto the PCR 
product, it was then ligated into TOPO vector (Invitrogen, USA). The TASK-3 TOPO 
vector was transformed into E.coli XL-1 blue competent cells (Agilent Technologies, 
USA) via the heat shock method (30-60 s at 42°C and 2 minutes on ice) and grown on 
Luria broth (LB) agar plates with 100µl/ml ampicillin overnight at 37°C. Single 
colonies were selected and innoculated in LB broth for overnight incubation at 37°C. 
Cells were spun down at 4100 rpm, the supernatant was discarded and the 
vector DNA was collected using Genelute plasmid miniprep kit (Sigma, USA). 
Correct TASK-3 TOPO vectors were confirmed through gel electrophoresis of 
ApaI/HindIII double digests and DNA sequencing (Eurofins MWG Operon). 
   
Further details of the TASK-3 gene can be found at: 
http://www.ensembl.org/Mus_musculus/Gene/Summary?g=ENSMUSG00000036760
;r=15:72342549-72376709;t=ENSMUST00000044624 
METHODS & MATERIALS 
62 
 
*TASK-3 amplification primers: 
 All primers were manufactured by Sigma (USA). The following primers 
contain the beginning and end of the TASK-3 transcript, as shown by the italicised 
nucleotides, in the forward and reverse primers, respectively. Emboldened nucleotides 
represent the ApaI RE site in the forward primer and the HindIII RE site in the reverse 
primer. Extra A and T nucleotides were added to the extremities to improve RE 
activity. 
Forward primer:  
5’-ATA TAT GGG CCC ATG AAG CGG CAG AAC GTG C-3’ 
Reverse primer:  
5’-ATA TAT AAG CTT TTA GAT GGA CTT GCG ACG GAG GTG C–3’ 
 
TASK-3 sub-cloning 
The next step involved sub-cloning the TASK-3 into a vector containing eGFP, to 
allow for visualisation of expression. This vector, peGFP-2A-GABAA-γ2, was 
constructed in-house to contain eGFP linked to a 2A co-translation cassette linked to 
GABAA-γ2. By design, the GABAA-γ2 component contained at its beginning an ApaI 
RE site and at its end a HindIII RE site to allow for easy sub-cloning. 
 Two separate digestions, (1) with the TASK-3 TOPO vector and (2) with the 
peGFP-2A-GABAA-γ2, were carried out under the same conditions. The respective 
vectors were incubated for 2 hours at 37°C with ApaI and HindIII (NEB, USA) and 
then the enzymes were inactivated by heating to 65°C for 20 minutes. Then, to 
prevent re-ligation of the peGFP-2A-GABAA-γ2 with its digestion product, the 
peGFP-2A-GABAA-γ2 mixture only was dephosphorylated with shrimp alkaline 
phosphatase (NEB, USA) for 1 hour at 37°C, before another heat inactivation step. 
 Samples of the mixtures were run on gels to confirm complete digestion and 
then the digestion products were mixed in a total volume of 10µl ddH20 in a ratio of 
3:1, TASK-3 insert:peGFP-2A backbone, such that the total DNA did not exceed 
200ng. T4 ligase was added as part of the “Rapid Ligation Kit” procedure (Roche, 
Germany) and the mixture was incubated at room temperature (RT) for 20 minutes, 
before transformation into competent E.coli cells. DNA was prepared as discussed 
previously and correct ligation products confirmed through digestion and sequencing.  
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eGFP-2A-TASK-3 sub-cloning 
The eGFP-2A-TASK-3 fragment was amplified by PCR using primers* containing a 
NotI RE site in the forward direction and the previously used reverse primer 
containing a HindIII RE site. After purification, the PCR fragment was ligated into the 
multiple cloning site of an empty pAM-flex AAV vector (originally provided by K. 
Deisseroth, Stanford University, USA) following similar procedures as outlined 
previously and correct ligation products confirmed through digestion and sequencing. 
The pAM-flex AAV vector contains two loxP sites flanking the transgenes to allow 
for Cre-based switching. This means that a transgene inserted in the reverse 
(nonsense) orientation can be turned on conditionally in the presence of Cre (which is 
itself usually under the control of a cell-specific promoter). Transgenes inserted in the 
forward (sense) position will be expressed constitutively as per the pAM-flex 
promoter. 
 A schematic of the workflow for the eGFP-2A-TASK-3 rAAV can be found in 
figure 5.2 in the results and discussion section. 
 
* eGFP-2A-TASK-3 amplification primers: 
 The following primers contain the beginning of the eGFP transcript and the 
end of the TASK-3 transcript, as shown by the italicised nucleotides, in the forward 
and reverse primers, respectively. Emboldened nucleotides represent the NotI RE site 
in the forward primer and the HindIII RE site in the reverse primer. An extra cytosine 
nucleotide was added to the forward primer to reproduce the Kozac sequence that 
improves translational recognition. Extra A and T nucleotides were added to the 
extremities to improve RE activity. 
Forward primer:  
5’-ATA TAT GCG GCC GCC ATG GTG AGC AAG GGC GAG G-3’ 
Reverse primer:  
5’-ATA TAT AAG CTT TTA GAT GGA CTT GCG ACG GAG GTG C–3’ 
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2.6.3 Cre-2A-Flp rAAV 
 
Overview 
As an alternative strategy, the nature of the TASK-3 knockout (Figure 2.11) meant 
that it had the potential to be rescued by Cre and Flp genetic modification; and so, an 
rAAV containing Cre and Flp was made (See results section for further details). 
Briefly, an rAAV plasmid containing Cre linked to Venus by a 2A cassette was 
acquired and the Venus element was excised and replaced by the Flp gene, creating a 
Cre-2A-Flp rAAV plasmid. Similar methodology was used as for eGFP-2A-TASK-3 
rAAV plasmid production and hence some details have been omitted in the following 
section for the Cre-2A-Flp rAAV production. 
 
 
 
 
Flp amplification 
The Flp sequence was amplified from pPGUFLPobpA using primers* with a BamHI 
restriction site in the forward direction and a NotI restriction site in the reverse 
direction, using similar PCR conditions as previously. The sample was then digested 
by both of the enzymes and, after confirmation of the correct product by gel 
electrophoresis, was purified for subsequent use. 
 
Figure 2.11 TASK-3 gene inactivation in the knockout. 
The TASK-3 gene is inactivated by a series of multiple neomycin (NEO) inserts. 
Serendipitously, the TASK-3 gene can be “activated” through Cre- and Flp- based 
transgenesis. [Adapted from Sandu (2006)] 
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*Flp amplification primers: 
Emboldened nucleotides represent the BamHI RE site in the forward primer 
and the NotI RE site in the reverse primer. 
Forward primer: 
5’-ATA TAT GGA TCC ACC ATG GCT CCT AAG AAG AAG-3’ 
Reverse primer: 
5’-ATA TAT GCG GCC GCT CAG ATC CGC CTG TTG ATG-3’ 
 
Removing Cre-2A 
The rAAV plasmid was digested with BamHI for 2 hours at 37°C and then the Cre-
2A element was gel purified and stored for later use. The rAAV plasmid was then re-
ligated using the Roche kit to form a Venus rAAV, whose integrity was confirmed by 
gel electrophoresis. 
 
Switching Venus for Flp 
The Venus rAAV was digested with NotI and BamHI for 2 hours at 37°C and treated 
with shrimp alkaline phosphatase to prevent re-ligation. The digestions and the 
digested Flp PCR product were mixed in a 1:3 vector:insert ratio for the Roche Rapid 
ligation reaction. After transforming E. coli and purifying the amplified plasmids, the 
correct insertion product was confirmed with gel electrophoresis. 
 
Reinserting Cre-2A 
The Flp rAAV plasmid was linearised with BamHI and mixed in a 1:10 vector:insert 
ratio with the previously purified Cre-2A element for the Roche Rapid ligation 
reaction. After transforming E. coli and purifying the amplified plasmids, the correct 
insertion product was confirmed with gel electrophoresis. 
A schematic of the workflow for the Cre-2A-Flp rAAV can be found in figure 
5.4 in the results and discussion section. 
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2.6.4 Virus production for both rAAVs 
To produce the virus particles, the pAM-flex eGFP-2A-TASK-3 rAAV or the Cre-
2A-Flp rAAV was co-transfected into HEK-293 cells with pFΔ6, pH21, and pRV1 
helper plasmids following the protocol of McClure et al. (2011). 
Five 200 ml culture flasks were plated with HEK-293 cells and incubated for 
24 hours in trypticase soy agar (TSA) media (Dulbecco’s Modified Eagles Medium 
(DMEM) supplemented with 10% heat inactivated foetal bovine serum, 2% 200 mM 
L-Glu, 1% non-essential amino acid solution, and 1% penicillin-streptomycin) at 
37°C. Having reached ~70% confluence, media was removed and replaced with fresh 
pre-warmed media. Three hours later, a plasmid mixture was made of 62.5 µg eGFP-
2A-TASK-3 plasmid, 125 µg pFΔ6, 31.25 µg pH21 and 31.25 µg pRV1 in 1650 µl 
2.5 M CaCl2 and 12 ml ddH20. After filtering through a 0.2 µm syringe filter 
(Sartorius Stedim, France), 13 ml 2x HEPES-buffered saline (HBS) was added while 
vortexing. A white precipitate formed after two minutes and 5 ml of the mixture was 
added to each flask. 16 hours later, the medium was replaced with 25 ml fresh 
medium and then the cells were incubated for a further 60-65 hours before harvesting. 
Media was removed and cells were washed once with warm phosphate-
buffered saline (PBS), before detachment in PBS. Cells were centrifuged at 800g for 
10 minutes and cell pellets were resuspended in 150 mM NaCl, 20 mM Tris (pH 8.0). 
Cells were solubilised with 0.5% sodium deoxychloate and 50 U/ml benzonase 
endonuclease was added to digest RNA. The contents were mixed thoroughly and 
incubated at 37°C for 1 hour and then centrifuged at 3000g for 15 minutes at 4°C. The 
supernatant was collected for purification. 
A 1 ml HiTrap Heparin column (GE Healthcare, USA) was pre-equilibrated 
with150 mM NaCl, 20 mM Tris (pH 8.0) and then the supernatant was loaded onto 
the column at a rate of 1 ml/minute. The coat proteins of the AAV2 allow affinity 
binding of the virus to the heparin sulphate in the column. The column was washed 
with 100 mM NaCl, 20 mM Tris (pH 8.0) and then the virus was eluted with 
increasing salt concentrations, of which the first two eluants were discarded and the 
last three collected for concentration: 1 ml 200 mM NaCl, 20 mM Tris (pH 8.0); 1 ml 
300 mM NaCl, 20 mM Tris (pH 8.0); 1.5 ml 400 mM NaCl, 20 mM Tris (pH 8.0); 3 
ml 450 mM NaCl, 20 mM Tris (pH 8.0); 1.5 ml 500 mM NaCl, 20 mM Tris (pH 8.0). 
The 6 ml sample was centrifuged at 2000g in a concentrator with a 100,000 molecular 
weight cut-off (Sartorius Stedim, France) to a volume of 250 µl. A further 250 µl PBS 
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was added before filtration through a 0.2 µm syringe filter and then the sample was 
aliquoted and stored at -80°C until required. 
 
 
 
Figure 2.12 rAAV production via a HEK-293 cell “production factory”.  
1) HEK-293 cells are plated and grown to ~70% confluence and 2) are transfected 
with the plasmids. 3) Media is changed after 16 hours and the cells are incubated 
for a further 56 hours. 4) Cells are harvested, lysed and the rAAVs are separated 
from cell debris by centrifugation. 5) The rAAV particles are purified on a heparin 
column and concentrated. [Adapted from McClure et al. (2011)] 
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2.6.5 Expression assays 
 
HEK-293 cell transfection 
To verify the expression of the rAAV transgenes, the peGFP-2A-TASK-3 was 
transfected individually and the pCre-2A-Flp was transfected with a marker plasmid 
(see Results section). Fluorescence was visualised with a Nikon Eclipse 80i camera 
(Japan) using QCapture Pro software (QImaging, UK). 
The HEK-293 cell line was maintained in TSA media at a constant 37°C and 
5% CO2 in a humidified incubator and plated into 15 mm well plates containing glass 
coverslips coated with poly-D-lysine (1 mg/ml) to facilitate cell adhesion.   
Depending upon the experimental strategy, between 0.1 μg and 1 μg of the 
plasmids were transfected (or multiply co-transfected) using the calcium phosphate 
technique.  Briefly; 5.6 μl of 2M CaCl2, plasmid cDNA and H20 (up to 25 μl/15 mm 
well) were mixed in a sterile Eppendorf tube.  To this, an equal volume of HBS plus 
45 μl of phosphate was added.  The contents of the tube were mixed by gentle 
agitation and incubated for 20 minutes at room temperature before adding dropwise to 
the plated cells.  Cells were then incubated for 7-9 hours at 37°C and 3% CO2 before 
washing twice with PBS.  After washing and the addition of fresh culture media, the 
cells were incubated at 37°C and 5% CO2 for up to one week. 
 
The expression of the transgenes in the rAAV particles was also confirmed in HEK-
293 cells. Briefly, HEK-293 cells were plated as before, and serial dilutions of the 
eGFP-2A-TASK-3 rAAV and Cre-2A-Flp rAAV were added to duplicate wells. 
Fluorescence was monitored every few days for the eGFP-2A-TASK-3 rAAV and the 
cells were fixed in 4% paraformaldehyde for both rAAVs after 5 days.  
Cre-2A-Flp rAAV-infected cells were incubated overnight at 4°C with 1:1000 
rabbit polyclonal anti-Cre antibody (Novagen, USA) in PBS. The next day, cells were 
incubated with 1:1000 AlexaFluor 488 goat anti-rabbit secondary antibody 
(Invitrogen, USA) in PBS, for 2.5 hours at room temperature, before washing and 
imaging. 
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Organotypic slices 
The expression of the eGFP-2A-TASK-3 rAAV and a control Cre-Venus rAAV were 
also tested on organotypic hippocampal slices. Briefly, 400 µm thick hippocampal 
slices of 2-day old mice were attached to a porous membrane and the organotypic 
cultures were incubated overlying TSA media for 14 days in 5% CO2 at 37°C. 1 µl of 
the viruses were added and the slices were monitored for fluorescence for several 
weeks. 
 
2.6.6 DNA sequencing 
Plasmid samples were prepared as 0.1 μg/μl DNA in 15 μl total volume and 
sequenced by Eurofins MWG Operon. The sequencing primers were designed in-
house and are listed below: 
 
TASK-3 
1) ATCCGCCACAACATCGAGGA 
 
eGFP-2A-TASK3 
1) GCCATACGGGAAGCAATAGC 
2) CGTTGGGGTCTTTGCTCAGGGC 
3) CAGCGTAGAACATACAGAAGGC 
4) GGTTCTGCCGTATTTCCTGAGG 
 
Cre-2A-Flp 
1) CCTTCTTCTTTTTCCTACAGCTCC 
2) GGAGAATGTGGATGCTGGGGAG 
3) AGAGTGGGTGCTGCCAGGGACAT 
4) CATCCCTTACAACGGCCAGAAGC 
5) CTGAAGAAGAACGCCCCCTACCC 
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2.7 Ex vivo brain analysis 
 
2.7.1 Perfusion fixing 
Mice were anaesthetised with pentobarbital (Merial,UK) and, following loss of pedal 
reflex, the chest cavity was opened to reveal the heart. A needle was inserted into the 
left ventricle and the right atrium was cut open. Ice cold PBS was infused at 2 ml/min 
and, when the exsanguinate ran clear, was exchanged for cold 4% paraformaldehyde 
in PBS. The whole brain was then carefully removed and post-fixed overnight at 4°C 
in 4% paraformaldehyde in PBS, before cryo-protection in 30% sucrose in PBS at 4°C 
until the brain sank to the bottom of the vial. 
 
2.7.2 Brain slicing 
Fixed and cryo-protected brains were mounted on a pre-chilled platform and snap 
frozen in dry ice. 40 µm slices were sectioned on a Leica SM microtome (Germany) 
and stored free-floating in PBS at 4°C. 
 
2.7.3 Immunhistochemistry for GFP 
Brain slices were permeabilised in PBS + 0.4% Triton X-100 at RT for 30 mins and 
then non-specific binding was blocked by incubation in PBS + 4% normal goat serum 
(NGS) and 0.2% Triton X-100 at RT for 30 mins. Slices were then incubated in PBS 
+ 2% NGS and 0.1% Triton X-100 containing rabbit anti-GFP primary antibody 
(Invitrogen, 1:1000 dilution) overnight at 4°C. 
 After overnight incubation, the slices were washed three times in PBS + 1% 
NGS at RT for 10 minutes each. Then the slices were incubated with PBS containing 
Alexa Fluor goat anti rabbit 488 secondary antibody (Invitrogen, 1:1000 dilution) at 
RT for 2.5 hours. Slices were then washed twice in PBS + 1% NGS and once in PBS 
at RT for 10 minutes before mounting on Superfrost slides (Thermo Scientific, USA). 
 Fluorescence was imaged on a Nikon Eclipse 80i camera (Japan) using 
QCapture Pro software (QImaging, UK). 
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2.8 Graphics and statistics 
 
Graphs were drawn using Microsoft Excel, GraphPad Prism and Systat SigmaPlot. 
Student’s t-test – paired or unpaired as appropriate – was used for statistical 
comparisons, unless stated otherwise. In such cases, where more than two groups 
were compared or where there were multiple comparisons, either 1-way or 2-way 
ANOVAs were used. Where there was significance in the preliminary analyses, 
Bonferroni or Tukey post hoc tests were performed. Significance is displayed 
throughout as * = p < 0.5, ** = p < 0.01, *** = p < 0.001. 
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Halothane anaesthesia 
 
3.1 Background 
The search for the neural correlates of consciousness (NCC) began formally when 
Francis Crick joined Christof Koch on a quest to understand human phenomenal 
consciousness (Crick et al., 1998; 2003). The rubric entailed that even high-level 
conscious phenomena had their seat in the physical body and, in particular, the brain. 
Potential explanations of the problem have focused on oscillatory activity of the brain, 
especially in the gamma range of frequencies (>40 Hz) and specific time-sensitive 
interactions between different regions of the brain. 
 Researching anaesthetic mechanisms necessarily takes on parallel questions 
concerning what brain regions and what brain activity is involved in causing loss of 
consciousness. This study first sought to identify possible neural correlates of 
unconsciousness by recording the cortical activity of mice in response to the 
anaesthetic halothane. 
In this study, C57Bl6 mice had cortical screw electrodes and nuchal muscle 
wire electrodes chronically implanted for ECoG and EMG recording, respectively. 
The mice were placed in an anaesthetic chamber and exposed to increasing 
concentrations of halothane at 10 minute intervals. At each concentration, righting 
reflex was measured and recorded as intact or lost. Electrophysiological data was 
collected on a tetherless recording device during the entire procedure and the data 
were analysed by FFT. 
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3.2 A broad analysis of frequency in halothane anaesthesia 
To get a sense for how halothane affects the global activity of the brain, the total 
power contained in the ECoG in six C57Bl6 mice was plotted as a percentage of 
initial power over time (and therefore over increasing halothane concentration) in 
figure 3.1A. The power decreases from 100% at baseline to 40% at the end of the 
experiment in staggered jumps, but with a linear correlation R
2
 of 0.89. 
 The negative correlation between power and concentration indicates how 
halothane affects brain activity in at least one of two ways. Firstly, halothane may 
reduce the frequency of the ongoing electrical activity, consistent with its prolonging 
the time decay phase at inhibitory synapses (Kitamura et al., 2003); and secondly, 
halothane might also decrease the number of cells active at any one time, through the 
same or similar inhibitory mechanisms. 
 Dividing the power into discrete frequency bands, as in figure 3.1B, shows 
that at the start of the experiment, with no anaesthetic present, the majority of the 
power is contained within the theta range: approximately 70% of the power is 
between 4 Hz and 12 Hz, split between the higher frequency theta range of 8-12 Hz 
(~30% total) and the lower frequency theta range of 4-8 Hz (~40% total).  
When 0.4% halothane is introduced, the dominant power switches to the lower 
frequency theta band, which possesses approximately 70% of total power. 
Correspondingly, the power in the higher frequency band decreases to about 15% total 
power. Interestingly, there is no major change in power distribution after this initial 
“theta switch” and the power in the delta and alpha frequency bands are constantly 
low throughout the halothane exposure. 
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Figure 3.1 The power dynamics contained within the ECoG changes with 
increasing halothane concentration.  
A – Total power up to 25 Hz contained within the ECoG decreased from baseline 
by in excess of 50% over time, which correlates every 10 minutes with an increase 
in halothane concentration. B – The contribution to the ECoG of specific frequency 
bands had moderate changes over time/increasing halothane concentration. The 
major observation was a switch between the 8-12 Hz band and the 4-8 Hz band 
after 10 minutes with the introduction of halothane, indicating a shift from type-1 
to type-2 theta. The average of six animals without error bars has been shown for 
clarity. [Halothane steps indicated in blue; n = 6] 
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3.3 Characterising the spectral power of halothane anaesthesia 
To obtain a more detailed profile of the frequency distribution, the power spectra of 
the FFTs were compared across halothane concentrations. A typical ECoG response 
for one mouse is shown in figure 3.2. Under baseline conditions – 0.0% halothane – 
the power spectrum shows low power dispersed over a broad frequency range, with 
peak power at 7.5 Hz (Figure 3.2A), indicative of a freely behaving animal. The 
addition of 0.4% halothane to the chamber causes a powerful peak at 6 Hz (Figure 
3.2B), which reaches a maximum amplitude at 0.5% halothane (Figure 3.2C), before 
becoming tuned to lower frequencies up until 1.0% halothane (Figure 3.2D-E). At 
1.5% halothane the peak has disappeared, leaving low peak power in the delta range 
of frequencies (Figure 3.2F). 
 This prominent oscillation was found to be sensitive to systemic atropine 
sulfate, indicating the involvement of muscarinic receptors and identifying the activity 
as a type-2 theta oscillation (Kramis et al., 1975). So, the “theta switch” observed 
previously is a result of halothane shifting the activity from type-1 to type-2 
mechanisms.  
The hippocampal theta oscillation has been proposed to act as a conscious 
window, providing frames of time in which disparate brain processes can bind 
together as a possible NCC (Doesburg et al., 2009). The type-2 theta oscillation has 
the interesting property of being present both with anaesthetics and normal behaviour. 
The oscillation can be provoked by aversive stimuli such as a toe-pinch during 
halothane and urethane anaesthesia and also during alert immobility (Bland et al., 
2001). Could it be that the type-2 theta oscillation present during halothane 
anaesthesia represents a kind of “alert immobility”? If so, to what extent does the 
oscillation impinge upon conscious processes; and would modulating the oscillation 
affect sensitivity to halothane anaesthesia? 
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Figure 3.2 The ECoG response to halothane. 
The ECoG response of a single C57Bl6 mouse shows a prominent peak in the FFT 
power spectrum in the theta frequency range that changes with increasing 
concentrations of halothane. A – Baseline recording in 0.0% halothane shows a 
broad spectrum with the peak power at 7.5 Hz, typical of behavioural type-1 theta. 
B-D – Increasing doses of halothane from 0.4% to 0.8% cause a prominent peak in 
the lower type-2 theta range whose frequency decreases in a dose dependent 
manner. E-F – The theta peak decreases in intensity and disappears at 1.5% 
halothane, replaced by desynchronised lower power in the delta range of 
frequencies. 
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3.4 Correlating theta peak with anaesthetic sensitivity 
To answer whether or not the type-2 theta oscillation correlated with anaesthetic 
sensitivity, the LORR of six C57Bl6 mice was recorded over increasing halothane 
concentrations with simultaneous ECoG measurements. The peaks in the power 
spectra at each anaesthetic concentration were fitted to Lorentzian curves to smooth 
any noise and calculate the respective peak frequency and Q-factor. Figure 3.3A 
shows how the peak frequency changes with increasing halothane concentration. At 
baseline the peak frequency is over 7 Hz, and with each incremental increase in 
halothane concentration, with the exception of a slight increase at 1.0%, the frequency 
decreases to less than 5 Hz, following a first-order polynomial fit. 
 The Q-factor is a measure of peak shape; being the full width of the 
Lorentzian fit at half maximum amplitude, divided by the maximum frequency. So, 
the higher the Q-value, the more defined is the peak, which means that a narrow 
frequency band will have a large associated power. Figure 3.3B shows that the Q-
factor increases with each concentration until 0.7% halothane, and then the value dips 
and rises at higher concentrations, following a fourth-order polynomial. The Q-factors 
under all concentrations of halothane are greater than baseline, suggesting a more 
robustly synchronised oscillation with anaesthesia. 
 Simultaneously with electrophysiological recording, a behavioural correlate of 
consciousness was measured by testing the righting reflex. At each concentration, the 
animals were scored as being able to right themselves after being turned onto their 
backs or not. Quantal analysis (Waud, 1972) of the binary-scored data revealed a 
curve with a slope of 28.22 ± 12.57 and ED50 for LORR of 0.74 ± 0.02 % (Figure 
3.3C). 
 The general trend towards lower frequency oscillations with increasing 
halothane concentrations and the observation that the maximum Q-factor appears at 
around the righting reflex switch, was not bourn out in significant correlations 
between the average peak statistics and group LORR. 
 However, there is a significant difference between the average of all peak 
frequencies when the righting reflex is intact and when the righting reflex has been 
lost (p < 0.001). Figure 3.3D shows the frequencies plotted, intact against lost, 
revealing a threshold zone where certain frequencies are mutually exclusive to an 
“awake” state (that is, with intact righting reflex) or to an “asleep” state (that is, with a 
lost righting reflex).  
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Since there is also a range of frequencies between 5 Hz and 6 Hz when an 
animal can be in either of the two states, the switch between an intact righting reflex 
and a lost one is more subtle than an all or nothing phenomenon.  
 
 
 
 
Figure 3.3 Lorentzian analysis shows concentration-dependent changes of 
the type-2 theta peak in response to halothane.  
A – Peak frequency of the halothane-associated type-2 theta oscillation decreases 
with increasing halothane concentration from 7 Hz at 0.0% halothane to 5 Hz at 
1.5% halothane. B – A fourth-order polynomial fit of the Q-value shows peak 
definition increases to a maximum at 0.7% halothane. C – The righting reflex of 
the animals was measured at each concentration and Waud analysis revealed an 
ED50 of 0.74% ± 0.02 and slope of 28.22 ± 12.57. D – The peak frequencies when 
righting reflex was intact is significantly different to the peak frequencies when 
righting reflex was lost (p < 0.001). Thresholds could also be observed for ‘awake’ 
and ‘asleep’ frequencies. [n = 6] 
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3.5 Continuous spectral analysis as a visual tool 
Plotting individual power spectra for discrete time intervals (as in Figure 3.2) has a 
number of attractive features, but the technique cannot display the temporal dynamics 
of the ECoG; one of its most advantageous features. Therefore, further methods of 
analysis and data presentation were sought to fully characterize the changing ECoG in 
the time domain. 
 Figure 3.4 shows a matrix of serially plotted 30-second power spectra over 
100 minutes of ECoG recording in one representative mouse. The colour-coded z-axis 
represents the relative powers at each frequency, with warm colours (red) representing 
high power and cool colours (blue) representing low power. The plot has been 
smoothed to produce a contour plot that shows how the desynchronised baseline 
ECoG changes to a highly tuned type-2 theta peak with increasing concentrations of 
anaesthesia. At the highest concentrations of halothane, the theta power disappears, 
being replaced by power in the delta range of frequencies (1-4 Hz). 
 
 
 
Figure 3.4 Contour plot of serial FFT power spectra. 
Contour plotting of serial FFT power spectra shows the frequency and power 
changes of the ECoG in response to halothane. 30-second FFT power spectra were 
plotted successively over time for a single C57Bl6 mouse. The z-axis of the matrix 
shows high power frequencies in red and low power in blue. Note the immediate 
“tuning” to type-2 theta after halothane introduction and theta “drop-off” at the 
highest halothane concentrations. 
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3.6 Systemic cholinergic modulation of theta does not affect LORR 
The theta oscillation observed during halothane anaesthesia was found to be sensitive 
to i.p. injection of 50 mg/kg atropine sulfate (Figure 3.5A). This shows a key role for 
muscarinic cholinergic neurotransmission in the generation of the oscillation, 
indicative of the type-2 theta oscillation. 
 Even though previous results (as in Figure 3.3) demonstrate minimal 
relationship between theta and LORR, given that the theta oscillation is such a 
prominent ECoG feature of halothane anaesthesia, the effect of ablating theta through 
atropine on LORR was investigated. Recall that below a cut-off threshold of 5 Hz, no 
mouse is judged as conscious by LORR. So, shunting the dominant oscillation from 
theta towards delta frequencies, while not immediately anaesthetising the animal, 
might increase its sensitivity to anaesthetics. 
Figure 3.5B shows the LORR curves of six C57Bl6 mice, pre-treated with i.p. 
saline (solid line) or atropine sulfate (dashed line). The LORR curve for saline of 0.78 
± 0.01 % (slope, 342 ± 302) is not significantly different (p = 0.59 for EC50 & p = 
0.31 for slope, n = 6) to that for atropine sulfate of 0.76 ± 0.03 % (slope, 19 ± 8). 
In this case, muscarinic antagonism had no effect on sensitivity to halothane, 
indicating that the theta oscillation may not have a role in mediating those processes 
that are inhibited to cause LORR. 
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Figure 3.5 Systemic atropine sulfate administration ablates the halothane-
associated theta oscillation without affecting halothane sensitivity.  
A – The solid line shows a power spectrum of 30-seconds of ECoG recorded in a 
C57Bl6 mouse during 0.8% halothane exposure. The dashed line shows the same 
animal exposed the same halothane concentration after pre-administration of 50 
mg/kg i.p. atropine sulfate, demonstrating muscarinic sensitivity of the theta 
oscillation. B – The LORR EC50 between saline (solid) and atropine sulfate 
(dashed) pre-treated mice are not significantly different. [n = 6] 
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3.7 Blocking cholinergic neurotransmission in the medial septum 
The medial septum provides cholinergic and GABAergic input to the hippocampus 
and is thought to mediate the major component of the type-2 theta oscillation by 
relaying rhythmic activity from the supramammillary nucleus to the hippocampus 
(Yoder et al., 2005). The next experiment, in which atropine sulfate was administered 
directly into the cannulated medial septum of C57Bl6 mice, had two main objectives: 
1. To clarify with greater anatomical precision that the theta oscillation 
observed during the previous studies was due this type-2 mechanism. 
2. To test whether a more discrete antagonism would affect sensitivity to 
halothane anaesthesia. 
 Halothane, at a concentration of 1.0%, elicited a robust and continuous 
oscillation in the type-2 theta range, as shown by the representative power spectrum in 
figure 3.6A and the continuous contour plot in figure 3.7A. Once the oscillation 
became stable, aCSF alone or aCSF containing 50 μg atropine sulfate was injected 
into the medial septum. aCSF had no effect on the oscillation (Figure 3.7A), while the 
atropine sulfate bolus was sufficient to ablate the theta oscillation, as in figure 3.6A 
and figure 3.7B. Atropine sulfate ablates the theta oscillation, significantly shifting the 
dominant ECoG frequency from 5.03 ± 0.09 Hz to 2.82 ± 0.09 Hz (p < 0.05, n = 4); 
that is, from type-2 theta into the delta range of frequencies. The first objective was 
thus satisfied; type-2 cholinergic mechanisms are involved in the theta oscillation. 
 The ablation of the type-2 theta oscillation lasted for over an hour (Figure 
3.7B), enabling LORR experiments to be performed on atropine sulfate pre-treated 
animals. These experiments tested the hypothesis that specific antagonism of medial 
septum cholinergic neurotransmission would increase the sensitivity to halothane 
anaesthesia. The EC50 for halothane LORR with control aCSF injection was 0.94 ± 
0.03 % (slope, 36 ± 21), which was not significantly different (p = 0.62 for EC50 & p 
= 0.21 for slope, n = 6) to that for the atropine sulfate injection EC50 of 0.91 ± 0.05 % 
(slope, 8 ± 2). 
 It should be noted that the control aCSF EC50 appears to be substantially 
higher than that for the uncannulated mice that received i.p. saline or atropine sulfate 
in the previous study. It is therefore possible that the arousal of the cannulated mice in 
this experiment was heightened to a degree that may have masked the true effect of 
cholinergic antagonism in the medial septum. However, taking the results at face 
value indicates that, in answer to the second objective of this part of the study, 
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discrete antagonism of the medial septum cholinergic system does not affect 
sensitivity to halothane anaesthesia. Further, the type-2 theta oscillation appears to be 
unrelated to the processes that inhibit the righting reflex. 
 
 
 
 
Figure 3.6 Effect of atropine sulfate in the medial septum. 
Atropine sulfate administered into the medial septum ablates the halothane 
associated theta oscillation, but does not affect halothane sensitivity. A – The solid 
line shows a power spectrum of 30-seconds of ECoG recorded in a C57Bl6 mouse 
during 1.0% halothane exposure. The dashed line shows the same animal exposed 
to the same halothane concentration after administration of 50 mg medial septum 
atropine sulfate. B – The LORR EC50 between saline (solid) and atropine sulfate 
(dashed) pre-treated mice are not significantly different. [n = 6] 
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Figure 3.7 Atropine sulfate administered into the medial septum ablates the 
halothane associated theta oscillation.  
A – 1% halothane causes a robust and continuous theta oscillation, unaffected by 
medial septum injection of aCSF at 50 minutes. B – Atropine sulfate injection into 
the medial septum causes a complete and long-lasting ablation of the halothane-
induced type-2 theta oscillation. The transient theta “drop-out” at around 30 
minutes represents a previous unsuccessful injection. 
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As well as ruling out a possible role in the anaesthetic cascade, the fact that 
blocking the type-2 theta oscillation had no effect on halothane sensitivity raised the 
question of what other characteristic of the ECoG might be more relevant. Being such 
a prominent feature of halothane anaesthesia, theta tends to dominate the ECoG 
waveform, perhaps masking more relevant signatures of the anaesthetic state. Would 
removing it uncover another pattern? 
Figure 3.8A shows the ECoG response of a mouse pre-administered with 
aCSF into the medial septum to increasing concentrations of halothane, with the point 
of LORR indicated by a dashed line. The theta oscillation can clearly be seen to 
straddle the point of LORR, confirming the finding that it does not act to either impair 
or induce anaesthesia. In comparison, blocking the type-2 theta oscillation by medial 
septum atropine sulfate in the same mouse shunted the dominant frequency to the 
delta range, as in figure 3.8B. The point of LORR, marked with a dashed line, 
separates a conscious animal from an unconscious one, but in this case there does not 
appear to be a clear neurophysiological delimiter. 
In a few mice, there did seem to be a correlation between LORR and an 
increase in power in the delta range of frequencies, as represented in figure 3.8C. 
Here, atropine sulfate has completely ablated theta activity in response to halothane, 
with no dominant power until the point of LORR, which coincides with an increase in 
delta power. 
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Figure 3.8 Ablating theta oscillation does not affect loss of righting reflex. 
Atropine sulfate pre-administered into the medial septum ablates the halothane-
associated theta oscillation with no consistent effect on LORR. A – The theta 
oscillation “straddles” the LORR with medial septum aCSF in mouse #1. B – 
Medial septum atropine sulfate shunts the dominant ECoG frequency to the delta 
range without affecting LORR in mouse #1. C – After theta ablation with medial 
septum atropine sulfate in mouse #2, LORR coincides with an increase in delta-
band power. 
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Atropinization of the medial septum caused an absolute increase in delta 
power in all mice and a relative increase compared to the theta band at the highest 
concentrations of halothane (p < 0.05), as shown in figure 3.9. However, while there 
was a trend towards a higher delta/theta (0-4 Hz/4-8 Hz) ratio with increasing 
anaesthesia, there was not an obvious correlation between the change in delta power 
and LORR across the group of animals.  
 
 
 
 
 
Figure 3.9 Medial septum atropine sulfate increases the delta band power.  
The Delta/Theta ratio is significantly increased (p < 0.05) with atropine sulfate 
compared to control over all halothane concentrations. [n = 6] 
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3.8 Cholinergic modulation of halothane-induced delirium 
Prior to its hypnotic effects, halothane induces a transient period of behavioural 
excitation, correlating to the anaesthetic delirium phase in humans, which is 
associated with spasmodic movements and incomprehension. Since the cholinergic 
system has been implicated in mediating some of the delirium symptoms, the next 
experiments set out to test the effects of inhibiting and potentiating the theta 
oscillation on halothane-induced delirium. If the type-2 theta oscillation was not 
relevant to LORR, then it could be involved in mediating some of the cognitive 
effects of anaesthesia. 
 Normally, increases in running speed correlate with increases in type-1 theta 
frequency (Pang et al., 2009), so a mouse running at high speeds as in the excited 
delirium state should show theta oscillations of high frequency. However, halothane 
appears to shunt the dominant ECoG frequency from type-1 theta to the lower 
frequency type-2 theta. The working hypothesis, therefore, was that there would be a 
functional disjuncture between the internal spatio-temporal dynamics of the 
hippocampus and the behavioural environment. So, the slower frequency brain state 
of halothane-induced type-2 theta would be unable to process the fast-moving 
behaviour, embodying the cognitive impairments of the delirium state.  
Eight C57Bl6 mice were given i.p. injections of either saline, atropine sulfate 
(50 mg/kg) or the acetylcholinesterase inhibitor eserine (0.2 mg/kg), with each 
treatment separated by one week, and habituated to an activity monitor for 30 
minutes. The animals were then exposed to 2% halothane for 10 minutes. Figure 
3.10A shows that with saline pre-treatment (in black), the introduction of 2% 
halothane causes a transient increase in locomotion as recorded by horizontal infra-red 
beam breaks. 
2-way ANOVA revealed a significant effect of drug on the distance travelled 
(p < 0.001). Post hoc Bonferroni’s tests showed that mice pre-treated with atropine 
sulfate, to ablate muscarinic cholinergic neurotransmission, showed a similar activity 
profile (Figure 3.10A) and total distance travelled was not significantly different 
compared to saline control in either the 10 minutes before or after halothane exposure 
(Figure 3.10B). However, eserine reduced the locomotor excitation during halothane 
compared to both saline (p < 0.001) and atropine sulfate (p < 0.01), and also prior to 
halothane exposure (p < 0.001), indicating that the drug’s action may occur 
independently of halothane (Figure 3.10A&B). 
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Figure 3.10 Halothane-induced hyper-locomotion is largely resistant to 
cholinergic modulation.  
A - Halothane induces a transient increase in locomotion before sedation, hypnotic 
anaesthesia and behavioural immobility. B – Atropine sulfate pre-treatment has no 
effect on locomotion before or during the delirium phase. Eserine pre-treatment 
reduces locomotor activity prior to halothane exposure compared to both other 
treatments (p < 0.001) and during halothane exposure, compared to saline (p < 
0.001) and atropine sulfate (p < 0.01). [n = 8] 
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Figure 3.11 shows that the different drug pre-treatments significantly altered 
the dynamics of the ECoG, with particularly striking effects on the theta oscillation. 
As expected, in the saline condition the desynchronised frequency spectrum at 
baseline (0-10 minutes) rapidly tunes to a prominent theta frequency oscillation after 
introduction of halothane, reaching maximum power at the 15 minute mark (Figure 
3.11A). 
While atropine sulfate did not significantly affect locomotor activity, it did 
cause a more desynchronised ECoG profile in the baseline phase, compared to saline, 
and completely ablated the type-2 theta oscillation normally associated with halothane 
anaesthesia (Figure 3.11B). Eserine treatment also desynchronised the baseline ECoG, 
but in contrast to atropine sulfate, the halothane-associated theta oscillation contained 
much greater power (Figure 3.11C). 
Overall, these results indicate that while modulating cholinergic 
neurotransmission affects the theta oscillation, it is not solely responsible for 
halothane-induced behavioural excitation. 
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Figure 3.11 Cholinergic modulation of halothane-induced type-2 theta. 
The type-2 theta response to halothane is modulated by pre-treatment with 
atropine sulfate and eserine. A – A typical ECoG response to halothane after pre-
treatment with saline. B – Atropine sulfate ablates the type-2 theta oscillation. C – 
Eserine potentiates the type-2 theta oscillation in response to halothane. 
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3.9 Discussion 
The preceding experiments sought to understand whether the type-2 theta oscillation 
had a role in mediating LORR in response to halothane anaesthesia. After 
characterising the power and frequency dynamics of the ECoG in response to 
increasing doses of halothane, a clear correlation between type-2 theta and LORR 
could not be observed. However, since the oscillation was such a prominent feature of 
halothane anaesthesia – being variously described as “anaesthetic-resistant”, 
“anaesthetic-associated” and “anaesthetic-induced” – it was tantalising to suggest that 
modulating the oscillation would affect anaesthetic sensitivity. Further, type-2 theta 
oscillations are also present during paralysis with neuromuscular blockers (Whishaw, 
1976) and can be enhanced with tail-pinch during halothane (Bland et al., 2003) and 
urethane anaesthesia (Clement et al., 2008), hinting at a possible role for theta and 
cholinergic processes in sensory processing and movement intention, key components 
of the righting reflex (Kandel et al., 2000). 
 In the next part of this study, systemic atropine sulfate successfully ablated the 
theta oscillation without affecting the concentration of halothane required to induce 
LORR. The centrality of medial septum cholinergic activity to the theta oscillation 
was then confirmed through ablating type-2 theta with atropine sulfate in this area. 
Since systemic drug administration can have off-target effects, atropine sulfate was 
then delivered directly to the medial septum prior to a second analysis of halothane 
sensitivity. This treatment had no affect compared to a vehicle injection, supporting 
the previous finding that the type-2 theta oscillation is not involved in LORR. So what 
does it do? 
 Type-2 theta is usually described in physiological and behavioural terms: it is 
sensitive to muscarinic antagonism and occurs during type-2 behaviours such as alert 
immobility (Kramis et al., 1975). Since the theta observed in this study is blocked by 
atropine sulfate, it is presumably an active process involving cholinergic 
neurotransmission and not simply a trend to lower frequency oscillations as the 
concentration of halothane increases. But is the animal also in the alert immobile 
state? 
 Since the type-2 theta oscillation bridges both the LORR and LOTW 
thresholds, occurring with aversive stimuli even at concentrations of halothane that 
induce immobility (Bland et al., 2003), it is likely that it contains a sensory 
component of some kind. Bland et al. (2001) suggest that type-2 theta represents a 
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mode of sensory integration. As they see it, ascending pathways from the reticularis 
pontis oralis and the pedunculopontine tegmentum provide tonic type-2 sensory inputs 
to the posterior hypothalamus and supramammillary nucleus which synergise with 
type-1 inputs in the medial septum before transfer to the hippocampus. Here, type-2 
theta is proposed to modulate sensory input, especially when a motor response is 
anticipated. 
 Another theory suggests that theta acts as a filter for relevant information by 
suppressing non-relevant sensory processes (Sainsbury, 1998). This inhibitory 
interpretation views theta as essentially a static oscillation –  exponential increases in 
running speed only change the frequency by a few hertz – which is unable to process 
large amounts of information. And, in addition, it can explain how the two types of 
theta could combine onto the same neurons to mediate a cohesive output. 
 Either of these theories would be satisfied – but no one preferred – if 
habituation of the theta oscillation was observed after a long or repeated halothane 
exposure. For the sensory integration theory, type-2 theta would disappear because 
there is no successive motor output; and for the sensory inhibition theory, type-2 theta 
would disappear because there are no changes in the external environment. It would 
also be interesting to determine the concentration at which aversive stimulation fails 
to induce type-2 theta under halothane anaesthesia in a similar way to the use of 
evoked potentials for monitoring anaesthetic depth. 
 However, even if the animal is in sensory processing state, the fact that even 
very small decreases in theta frequency have been shown to cause amnesia 
(Perouansky et al., 2010) means that there is little conscious activity. 
 
In this study, LORR was used as a surrogate for LOC, based primarily on the 
pharmacological correlation between the two parameters over a variety of anaesthetics 
(Franks, 2008). The experiments here show that the type-2 theta oscillation plays no 
role in either maintenance of consciousness or loss of consciousness, as judged by 
LORR and therefore can be ruled out as a de facto neural correlate of consciousness.
8
 
 In comparison, the pioneers of hippocampal theta research Kramis, 
Vanderwolf and Bland (1975) argued that type-1 theta might be more important, 
                                                 
8
 However, high doses of atropine can produce unconsciousness, highlighting the cholinergic system as 
a whole as a possible NCC (Gadecki W, Majewski J (1969). New observations on atropine coma 
treatment in psychoses. Pol Med J 8(6): 1515-1517.). 
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saying that “[their] data raise the intriguing possibility that depression of the system 
producing atropine-resistant theta activity may be largely responsible for the 
production of the anaesthetic state.” However, although blocking type-1 theta is a 
necessary feature of anaesthesia, it is clearly not sufficient; otherwise, animals would 
fall asleep as soon as they stopped moving. But, if the two types of theta are more 
interdependent than the separatist schools imagine, there is the possibility of shutting 
them down at the same point with a forced walking test, which provides a new metric 
for analysing the point of LOC in mice (Hwang et al., 2010).  
In this test, trained mice are suspended on a moving treadmill during 
anaesthetic exposure, with the loss of movement (LOM) classified by an 
accelerometer-based motion detection system. LOM has a good pharmacological 
correlation with LORR, and has the potential advantage in the context of this study to 
ask whether the type-2 theta oscillation is a sensory product after the “depression of 
the system producing atropine-resistant theta activity”, which is necessarily active 
during movement (Hwang et al., 2010).  
 
There were several other reasons for choosing to investigate cholinergic modulation 
of halothane anaesthesia, and specifically the role of the medial septum. Firstly, 
cholinergic systems modulate during sleep and wake states (Lydic et al., 2005) and 
thus could mediate sleep-like states of anaesthesia; secondly, halothane anaesthesia 
affects the cholinergic system (Keifer et al., 1994); and thirdly, inactivation of the 
medial septum increases sensitivity to anaesthetics (Ma et al., 2002). 
 The cholinergic system is one component of the multiple arousal systems of 
the brain stem that control states of wakefulness over the circadian rhythm. More or 
less every neurotransmitter has a role in either promoting or maintaining REM, 
NREM or wake activity, as the list below shows. 
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NEUROTRANSMITTER BRAIN REGION 
 
Wake active noradrenaline  locus coeruleus (pontine brainstem)  
  neuropeptide S neuropeptide S cells (pontine brainstem)   
serotonin  raphe neurons (medial brainstem) 
dopamine  midbrain and brainstem 
histamine  TMN (posterior hypothalamus) 
hypocretin/orexin lateral hypothalamus 
acetylcholine  basal forebrain and pontine brainstem  
 
Sleep active  GABA   VLPO (preoptic area) 
  GABA   MnPO (preoptic area) 
 
Cholinergic neurons in the pedunculopontine and laterodorsal tegmental nuclei 
(PPT and LTD, respectively) project widely throughout the entire brain, innervating 
the thalamus, lateral hypothalamus, basal forebrain and prefrontal cortex (Saper et al., 
2010). PPT/LTD neurons are most active during wakefulness and REM sleep, and 
less so during NREM sleep, indicative of a role in maintaining cortical arousal 
(Steriade, 1993). However, that cholinergic neurons in the LTD increase their firing 
rates just before the transition from slow waves to faster frequencies (Boucetta et al., 
2009) suggests that these neurons might also play a causal role in sleep-to-wake 
transitions. 
The activity of LDT/PPT neurons is also reduced under halothane anaesthesia 
(Lydic et al., 1993), a phenomenon that is also accompanied by a decrease in 
acetylcholine levels in the pontine reticular formation (Keifer et al., 1994) and one 
that is vital for the production of NREM-like spindles (Keifer et al., 1996). 
Cholinergic basal forebrain neurons also play a role in sleep-like spontaneous 
alternations under urethane anaesthesia (Clement et al., 2008), again illustrating 
possible overlap between sleep and anaesthetic mechanisms. During the course of this 
study, both cyclic alternations and spindle activity were isolated in response to 
halothane anaesthesia, as shown in figure 3.12. 
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Since much anaesthetic research is focused on what occurs at the surgical 
plane, many experiments investigating the role of the cholinergic system in 
anaesthesia measure endpoints that are more relevant for their needs, such as MAC. In 
this context, systemic blockade of both nicotinic and muscarinic acetylcholine 
receptors had no effect on the concentration of the volatile anaesthetic isoflurane 
(Eger et al., 2002) or the intravenous drug etomidate (Zhang et al., 2007) needed to 
produce immobility in rats in response to tail clamp. However, there is some evidence 
that manipulating cholinergic neurotransmission changes anaesthetic sensitivity, 
although results seem to differ depending upon the method of drug delivery. 
Activation of the cholinergic system with systemic eserine reduced the 
duration of ketamine anaesthesia in rats (Mimura et al., 1990), antagonised halothane 
anaesthesia in dogs (Roy et al., 1981), and also increased the dose of propofol to 
induce unconsciousness in humans (Fassoulaki et al., 1997). 
Central administration of cholinergic drugs had contradictory results 
depending upon the location. Intracerebroventricular (ICV) injections of eserine 
Figure 3.12 Signs of cholinergic activity under halothane anaesthesia.  
A – Sleep-like spontaneous alternations are observed under halothane anaesthesia 
with a cycle of approximately 4 minutes. B – Spindling activity observed at 2% 
halothane. The boxed area and insert show three clear spindle waveforms. 
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increased the MAC for isoflurane (Zucker, 1991), but the blocker atropine sulfate had 
no effect. In another study, injection of the muscarinic agonist carbachol into the 
pontine reticular nucleus actually reduced halothane MAC, an effect that was reversed 
by atropine sulfate (Ishizawa, 2000).  
Other, lesion-based studies, showed that inactivating the basal forebrain 
increased the potency of propofol anaesthesia, in correspondence with decreased 
acetylcholinesterase staining in either the hippocampus (Laalou et al., 2008) or the 
frontal cortex (Leung et al., 2011). 
A similar result was also found by inactivating the hippocampus directly: 
muscimol injection into the hippocampus increased the duration of LORR and LOTW 
for propofol, isoflurane and halothane (Ma et al., 2002). And, in the same study, 
inactivation of the medial septum had the same affect. A broader analysis later 
identified the entire limbic system as being important in anaesthesia (Ma et al., 2006): 
inactivating those areas that activate the limbic cortices – the SUM and the VTA – or 
that mediate output of the hippocampus – NAc and ventral pallidum – all enhanced 
the effect of halothane and pentobarbital. 
 
The experiments in this study challenged the hypothesis that either cholinergic 
neurotransmission in general, or in particular to the type-2 theta oscillation, is 
important for LORR. This measure of anaesthesia has a strong relationship (simply in 
terms of pharmacological correlation) to human LOC; therefore, any understanding of 
the former will aid the understanding of the fundamental nature of the awake human 
brain and the behaving individual. As such, the study had two parallel aims: (i) to 
uncover a possible NCC, and (ii) to elucidate brain regions involved in anaesthetic 
action. Since systemic administration and medial septum delivery of atropine sulfate 
failed to change the point of LORR, the theta oscillation could be ruled out as a major 
NCC and it was deemed unnecessary to complement the analysis with the delivery of 
eserine before a LORR assay. The duration of LORR was not measured since by its 
very nature it involves excretory and metabolic processes, largely a factor of 
respiration, that may change independent of the central affects that mediate 
consciousness. Attempts to correlate the point of gain of righting reflex with ECoG 
signals were unsuccessful (data not shown), primarily because of the non-uniform 
hysteresis in anaesthetic emergence (Aouad et al., 2005). Thus only the use of LORR, 
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and therefore the experiments in this study, can adequately represent the transition to 
and the mechanisms that cause anaesthetic-induced unconsciousness. 
Medial septum-specific atropinization had the advantage over lesion studies in 
that only the type-2 theta system was affected. This acute and selective strategy 
avoided the damage to unrelated systems that can occur with brain lesioning 
approaches. It also had the advantage of testing only cholinergic neurotransmission 
through a pure antagonism. This is in contrast to the studies above that inactivated 
various regions of the brain with a GABAergic agonist (Ma et al., 2006). The word 
“inactivation” implies simply a cessation of firing, however, since muscimol actively 
inhibits a variety of cell types there can be a number of possible outcomes. For 
instance, GABAergic neurons downstream of the inactivated pathway might be 
disinhibited, meaning that the actual site of inhibition could be further away from the 
intended site. Another problem with this method is that halothane and propofol 
potentiate GABA neurotransmission themselves, so in combination with GABA 
agonists, the additive affects may well be non-specific (Kitamura et al., 2003). 
By blocking type-2 theta, judged to be an epiphenomenal event for halothane 
actions at LORR, the lesser power of the delta oscillation was found to increase with 
anaesthetic concentration (Figure 3.9), whereas in the control groups the ECoG 
signature was dominated by theta, with no obvious change in delta over the halothane 
ramp (Figure 3.1B). Present during anaesthesia and NREM sleep (Franks, 2008), 
these slower delta frequencies are thought to result from interactions between the 
thalamus and the cortex (Steriade et al., 1993). A complete analysis of the 
mechanisms involved in delta wave generation is beyond the scope of this report; 
however, that activating the thalamus directly by potassium channel inactivation 
(Alkire et al., 2009) or nicotinic stimulation  (Alkire et al., 2007) reverses anaesthesia 
points towards a possible common mechanism of anaesthesia involving the thalamus 
and delta frequencies. 
 
It should be noted that this study acquired its electrophysiological data from a pair of 
cortical screw electrodes. This technique is sufficient for analysing the general state of 
the brain and, in combination with monitoring muscle tone, is the prime method for 
scoring sleep states, making it quite amenable to measuring similar behavioural 
transitions between consciousness and unconsciousness. However, one electrode can 
only provide so much detail and the technique is therefore limited to making fairly 
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gross statements about the activity of the brain. And even here, brain activity alone 
cannot be used to delineate states of consciousness with complete confidence, as 
several studies have reported neocortical slow wave activity without behavioural signs 
of anaesthesia (Leung et al., 2011; Vanderwolf, 1988). 
 Ongoing global oscillations are indicative of phase-locked synchronously 
fluctuating membrane potentials, but are also reciprocally modulated by single cell 
firing (Buzsaki, 2002; 2012). The theta oscillation, therefore, is regulated not only at a 
relatively large-grained level via cholinergic and GABAergic burst firing in the 
medial septum, but also at a fine-grained cellular level in the hippocampus. Place 
cells, for instance, fire at specific locations in the animal’s environment and are 
temporally organised by phase precession (Jones et al., 2005). The precise timing 
dynamics of these, and other, cells is important for ongoing behaviour, but they are 
transparent to ECoG techniques. 
 Suggestions for possible NCC have included interactions at the whole-brain 
level (Edelman et al., 2011) to the molecular level (Hameroff, 2006); but, more likely, 
the NCC exist as co-dependent processes at multiple hierarchical levels and so 
complementary strategies, including ECoG, are necessary for research to progress in 
this area. 
 
While the hypothesis that cholinergic pathways have a role in anaesthetic actions that 
induce LORR was now ruled out, there remained the possibility that they were 
involved in other aspects of the anaesthetic cascade. Other work by Ma and Leung 
(2002) has indicated a role for the medial septum and the theta oscillation in the 
excitation induced by anaesthetic induction. They found that muscimol injections into 
the medial septum or hippocampus attenuated both type-2 theta oscillations and this 
behavioural excitation. 
 Studies in this report recapitulated halothane-induced delirium, with C57Bl6 
mice exhibiting exaggerated locomotion during anaesthetic induction (Figure 3.10). 
This effect was attenuated by eserine pre-administration (which also decreased 
baseline activity), suggesting that cholinergic facilitation of type-2 theta oscillations, 
rather than their ablation was responsible for blunting locomotor hyperactivity. 
 In addition to the behavioural excitation caused during induction of 
anaesthesia, hyperactivity was also observed during emergence from anaesthesia, as 
shown in an activity trace of three mice over the entire recording period (Figure 
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3.13A). Additionally, the longer it took for this phase to occur, the less extreme was 
the hyperactivity. 
 Under baseline conditions, the median frequency of the ECoG was found to 
positively correlate with running speed up until a maximum resonant frequency (R
2
 = 
0.60; second-order polynomial). High running speeds in the induction excitation 
phase fit this distribution, whereas low and high running speeds during emergence 
excitation were consistently lower than normal (Figure 3.13A). 
 Referring back to the original hypothesis, it appears that the hyperactivity 
associated with anaesthetic induction operates under normal type-1 theta dynamics. 
That is, locomotion speed positively correlates with theta frequency during delirium. 
Then, if normal theta activity persists during this phase, can it really be delirium? If 
this heightened activity is correlated to the confusional states in human delirium, then 
another mechanism must be more relevant. How, for instance, might hippocampal-
cortical transfer operate under these conditions? 
 Complementary to this, the hyperactivity observed in the emergence phase 
more closely fits with the confusional hypothesis. On these terms, the reduced theta 
frequencies cannot support the ongoing integration of environmental and sensorimotor 
processing, leading to confusional states that might correlate with the anaesthetic 
phenomenon of emergence agitation. This is particularly problematic in children, who 
often wake confused and extremely distressed, and is becoming increasingly common 
with the use of modern anaesthetics like sevoflurane and desflurane that have rapid 
excretion rates (Cravero et al., 2000). Qualitatively, this emergence confusion has 
been compared to the inconsolable crying that often accompanies waking from night 
terrors in the developing child (Johr, 1999), which again fits with possible 
overlapping mechanisms between sleep and anaesthesia (Franks, 2008).  
Confusional states like these – and indeed also Alzheimer’s disease, itself a 
risk-factor for emergence agitation – have been linked to a cholinergic deficit (Chaput 
et al., 2012), with cholinesterase inhibitors proving promising pharmacological tools 
(Field et al., 2012), although no direct mechanism has been found. It is possible then, 
that they could also be explained by a disjuncture in theta oscillation dynamics, be it 
either type-1 theta, type-2 theta, or most likely a combination of both.  
As the animals in these confused and hyperactive states will have an intact 
righting reflex, by the demarcation of LORR, they would be conscious. Similarly a 
child or adult in a state of delirium might react with intention to push someone away 
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or remove their anaesthetic mask in a meaningful gesture indicative of awareness. But 
how relevant is this to the consciousness sought-after in a description of the NCC? If 
aberrant hippocampal oscillatory dynamics are important in these states then Kramis, 
Vanderwolf and Bland might be right after all, and the hippocampal type-1 theta 
oscillation may well be an NCC. 
 
 
 
 
  
Figure 3.13 Emergence agitation correlates with theta frequency impairment.  
A – The response to 10 minutes exposure to 2% halothane (marked by the blue 
box) is shown in three C57Bl6 mice. Notice the large increase in activity at the 
onset of anaesthetic exposure, indicative of pre-hypnotic delirium, and the later 
increased activity when the animals emerge from the anaesthesia in a state of 
agitation (arrowheads). B – A representative example of one C57Bl6 mouse. 
Median theta frequency correlated with running speed in the anaesthetic chamber 
before halothane was introduced (Normal: black). Increased movement during 
induction was associated with a similar frequency distribution (Induction: blue), 
but theta frequency in the emergence state was lower than predicted by the model 
distribution (Emergence: red). 
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Behavioural experiments 
 
4.1 Background 
Previous studies have indicated a diverse array of mild to moderate behavioural 
phenotypes in TASK-3 KO mice. Compared to control mice, TASK-3 KOs have 
impaired performance in spontaneous alternation and in the Morris water maze 
(Linden et al., 2007). The finding that TASK-3 KO mice have aberrant type-2 theta 
oscillations (4-7 Hz) could explain the impaired performance in these hippocampal-
dependent cognitive tests. Further investigations, therefore, set out to (i) examine the 
behavioural type-2 theta in TASK-3 KO mice and (ii) examine other cognitive 
behaviours in TASK-3 KO mice. 
 During the course of the studies well-described behavioural tests were 
performed as well as more experimental and completely new paradigms. The T-maze 
investigates working memory, a fundamental process involving important interactions 
between the prefrontal cortex and the hippocampus (Jones et al., 2005). The object 
recognition test analyses the explicit memory over both short (minutes to hours) and 
long (days) time periods (Bevins et al., 2006). Hippocampal-dependent fear memory 
was investigated using an adaptation of traditional foot shock conditioning paradigms, 
the dropbox. 
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4.2 Eliciting alert immobility in the rat exposure test 
To discover if TASK-3 KO mice were able to produce type-2 theta activity during 
natural behaviour, a version of the rat exposure test was validated that should induce 
the freezing behaviour associated with the type-2 theta oscillation. Developed to 
investigate defensive behaviours in mice with a view to testing anxiety levels, the rat 
exposure test elicits robust freezing behaviour, as well as other mouse defensive 
activity like the stretch attend posture and digging behaviour (Yang et al., 2004). 
The original design consisted of a home chamber connected by a tunnel to an 
exposure chamber in which a rat was housed behind a wire mesh. Since this study was 
primarily concerned with freezing behaviour, the chamber was modified to a single 
exposure chamber with a small boxed-in “safe-zone”, separated from the rat by a wire 
mesh. 
Freezing behaviour was scored using a video recording and EMG analysis, in 
response to the sight and smell of a rat. The test was validated in C57Bl6 mice, which 
froze for an average of 24.1 ± 4.1 s (n = 9) and, importantly, this freezing behaviour 
co-occurred with an oscillation in the type-2 frequency range. 
TASK-3 KO mice showed a similar degree of freezing to littermate controls, 
both in terms of the number of separate freezing events and their duration (p = 0.20 
and p = 0.50, respectively). However, 2-way ANOVA of the ECoG revealed 
differences between the genotypes in the power spectra associated with both 
movement and freezing. Figure 4.1A shows the considerable overlap in the movement 
power spectra between genotypes and, correspondingly, post hoc Bonferroni’s tests 
comparing each 0.78 Hz bin up to 25 Hz showed that TASK-3 KOs had only a subtle 
increase in power during movement compared to littermates at 7.81 Hz (p < 0.05), In 
contrast, the power of the theta oscillation during freezing was deemed significantly 
lower (p < 0.001) in TASK-3 KO mice than in littermates for a much larger frequency 
range, between 6.25 Hz and 8.59 Hz (Figure 4.1B).  
These results indicate that as well as having aberrant type-2 theta oscillations 
with halothane anaesthesia, TASK-3 KO mice also have reduced power in type-2 
theta in a natural behavioural setting, while, as for the halothane condition, peak 
frequency remains unchanged (p = 0.53). 
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Figure 4.1 Type-2, but not type-1, theta power is reduced in TASK-3 KOs. 
A – Power spectral analysis of locomotion speeds above 2cm/s reveals that TASK-
3 KO mice have intact movement-related type-1 theta, compared to littermates. B – 
TASK-3 KO mice have reduced power in the type-2 theta oscillation during alert 
immobility induced by the rat exposure test. (For clarity, significance levels are 
not shown on graph) 
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4.3 Testing working memory in the spontaneous alternation T-maze 
Previous studies have shown that TASK-3 KO mice have impaired performance in the 
spontaneous alternation version of the T-maze (Linden et al., 2007). The T-maze is 
classically used to measure working memory performance in rodents: a mouse or rat 
placed into the trunk of a “walled-in” T-shape will choose to enter one of the arms of 
the T; after returning to the start – following an innate predisposition to explore 
novelty – the animal will, more often than not, enter the other previously blocked arm. 
Additional rewards and punishments can be added to probe motivational and other 
learning and attentional processes; however, the version of the test used in this study 
intended to exclusively explore working memory. 
 A modified version of the continuous alternation T-maze, first described by 
Gerlai (1998), was used in which, except on the first trial where one of the goal arms 
was blocked-off, the animals were free to choose either arm once they had returned to 
the start position. Since the animals make this return journey under their own volition, 
there is minimal interference by the investigator. 
 The test, with alternation scored as a percentage “correct” choice in a total of 
ten trials, was first validated in C57Bl6 mice, which showed an average of 80 ± 6 % 
correct choices, significantly different to a hypothetical mean of 50%, that for a 
random decision making process (p < 0.05).  
TASK-3 KO mice (n = 11) had an average of 60 ± 7 % correct choices, which 
was not significantly different to LM controls (n = 9), which had a slightly better 
performance with an average of 64 ± 6 % correct choices (p = 0.62). However, when 
the separate groups were compared to the hypothetical mean of 50%, the TASK-3 KO 
mice were not significantly different to chance (p = 0.19), whereas the LMs 
performed better than chance (p < 0.05). These divergent results can perhaps be 
explained by the increased spread of the TASK-3 KO data, as shown by the individual 
data points plotted in figure 4.2A, but taken together they show that TASK-3 KO 
mice have impaired performance in the T-maze. 
To test whether basal activity of the mice could have been a confounding 
factor, the latency to complete the ten trials was also compared between the two 
genotypes. As shown in figure 4.2B, there was no difference between the two groups 
(p = 0.65). Additionally, there was no correlation between the time it took to complete 
the ten trials and the percentage of correct choices for either genotype, with R
2
 of 0.03 
for TASK-3 KOs and R
2
 of 0.02 for littermates. 
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Figure 4.2  TASK-3 KO mice perform similarly to littermates in the T-maze.  
A – On average, TASK-3 KO mice perform the same number of “correct” choices 
in the alternation T-maze, but not significantly different to chance. B – The latency 
to complete 10 alternation trials is the same for TASK-3 KO and littermates. 
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4.4 Testing object recognition memory 
A role for the type-2 theta oscillation has been implicated in novelty detection 
(Myhrer et al., 1988) so any changes in this oscillation in TASK-3 KO mice might 
impair novelty salience and subsequent novelty recognition. To test this hypothesis, 
the object recognition test was validated in C57Bl6 mice and then performed on 
TASK-3 KO and control mice. 
 C57Bl6 mice were habituated to a novel open field environment for 10 
minutes and then, after a further 10 minute inter-trial period, they were exposed to 
two identical objects in a 10 minute training phase. Interaction time was scored as the 
time the mice spent with their noses touching the objects. Figure 4.3A shows that in 
the training phase the mice had no preference for either object (p = 0.36), spending an 
average of 16.8 ± 8.1 s interacting with the left object and 11.8 ± 4.0 s interacting with 
the right object. 
 After a second inter-trial period of 10 minutes, one object was swapped for a 
novel object and the mice were allowed 10 minutes of exploration in the new 
environment. In this test for short-term memory, the novel object should evoke a 
greater amount of interest and interaction. In this phase, the mice showed a significant 
preference for the novel object (p < 0.05), exploring the novelty for 22.5 ± 2.9 s, twice 
as much as the familiar one, which attracted only 11.3 ± 3.6 s of interaction (Figure 
4.3B). 
 
Figure 4.3 C57Bl6 mice recognise a novel object 10 minutes after exposure to 
two identical objects.  
A – Mice have no preference for either of two identical objects in the 10-minute 
trial phase of the object recognition test. B – A significant increase in interaction 
with the novel object in the test phase indicates intact object memory. (*p < 0.05) 
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Once the procedure was validated, TASK-3 KO and littermate controls (n = 14 
and n = 10, respectively) were run through the test. In the training phase, littermates 
interacted with both objects equally (20.2 ± 2.6 s vs. 20.4 ± 2.9 s; p = 0.91), as did 
TASK-3 KOs (26.1 ± 3.3 s vs. 25.1 ± 3.8 s; p = 0.68), as reflected in figure 4.4A. 
Although TASK-3 KO mice had a tendency for greater interaction, there was no 
significant difference between the genotypes (p = 0.26). 
 After one object was swapped for the novel object, the mice were allowed 10 
minutes of exploration in the new environment. In this phase, shown in figure 4.4B, 
the animals in both groups showed a statistically significant preference for the novel 
object, with littermates preferring the novel object to the familiar one by 22.4 ± 3.4 s 
to 13.6 ± 3.5 s, and TASK-3 KOs by 22.5 ± 2.8 s to 14.3 ± 3.1 s (p < 0.05 for both). 
The interaction score was not significantly different between genotypes (p = 0.81). 
 
 
 
Figure 4.4 TASK-3 KO mice perform normally in the short-term object 
recognition test.  
A – In the training phase TASK-3 KO mice and littermate controls explore two 
identical objects equally. B – Both genotypes have a similar preference for a novel 
object, indicating similarly intact object recognition memory. (*p < 0.05) 
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Further to this short-term test, long-term memory retention was investigated 
by exposing the mice to a second novel object 24 hours later, with the results in figure 
4.5. TASK-3 KO mice (n = 8) preferred the novel object by an average of 46.6 ± 3.5 s 
to 12.6 ± 2.8 s for the familiar object (p < 0.01). Littermates (n = 5) also showed a 
significant preference for the novel object (38.6 ± 6.8 s vs. 12.0 ± 2.2 s; p < 0.05). The 
interaction score was not different between the two genotypes (p = 0.50). 
 
 
Figure 4.5 TASK-3 KO mice perform normally in the long-term object 
recognition test.  
TASK-3 KO mice perform equally to littermates in recognising a second novel 
object 24 hours after the first presentation. (*p < 0.05; **p < 0.01) 
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4.5 Testing spatial recognition memory 
The spatial recognition test measures the ability of an animal to recognise its spatial 
surroundings. The test was validated in C57Bl6 mice (n = 4), which were habituated 
to five fixed objects over three 10 minute sessions. 1-way ANOVA revealed a 
significant effect of habituation session on object interaction (p < 0.001), as shown in 
figure 4.6A.  Bonferroni’s test was then used to analyse significance between 
sessions. In the first session, the animals interact with the five objects an average of 
41.5 ± 3.1 s, significantly more than in the second session, with 18.1 ± 2.7 s total 
interaction (p < 0.001), and the third session, with 10.6 ± 1.4 s interaction (p < 0.001). 
There was no significant decrease in interaction between the second and the third 
session (p > 0.05). This habituation of interaction time indicates intact object-place 
learning. Importantly, there was no difference in the interaction times between the 
objects, meaning that none of the objects was inherently more interesting that the 
others, a fundamental consideration for object preference studies. 
 After habituation, two of the objects were placed in new spatial locations and 
the animals were tested for their recognition of the change; evidenced by an increased 
interaction time with the displaced objects. Figure 4.6B shows that the animals 
favoured the displaced objects by interacting with them over 60% more than the non-
displaced objects (p < 0.01). 
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Figure 4.6 The spatial recognition test is validated in C57Bl6 mice.  
A – Over three exposure sessions the mice explore the 5 objects less, indicating 
habituation and learning. B – In the test phase the mice recognise the new spatial 
arrangement with increased preference for the displaced objects. ( **p < 0.01; 
***p < 0.001) 
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TASK-3 KOs and littermate controls (n = 7) were then run through the spatial 
recognition test, with both genotypes  showing significant modulation of interaction in 
the habituation phase (p < 0.01 for littermate and p < 0.05 for KOs; 1-way ANOVA). 
Littermates showed a significant reduction in object interaction in the second and 
third sessions compared to the first session, as judged by Bonferroni’s post hoc tests 
(p < 0.05), while there was only a significant reduction between the first and third 
sessions for TASK-3 KOs (p < 0.05), as shown in figure 4.7A. 
In the test phase, two objects were moved into new spatial locations and the 
time spent interacting with the displaced objects was compared to that for the non-
displaced objects. Figure 4.7B shows that neither genotype had a significant 
preference for the displaced objects (p = 0.71 for littermates and p = 0.49 for TASK-3 
KOs). Despite the TASK-3 KOs showing a slightly longer interaction time throughout 
the four sessions, there was no significant difference between the genotypes (e.g., p = 
0.46 for the test phase). Here, short-term recognition of the displaced spatial 
environment seems to be similarly impaired in both genotypes (interaction scores are 
no different, p = 0.57). Since a long-term consolidation test 24 hours later in C57Bl6 
mice revealed no significant preference for displaced objects (p = 0.48), a long-term 
test was not performed on TASK-3 KOs and littermates.  
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Figure 4.7 TASK-3 KO mice perform equally to littermates in the spatial 
recognition test.  
A – In the habituation phase, littermate mice have significantly reduced object 
interaction by the second session, whereas TASK-3 KO mice take until the third 
session. B – In the test phase, neither genotype interacts with the displaced objects 
for longer than the non-displaced objects. (*p < 0.05) 
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4.6 Testing emotional memory in the dropbox 
A novel Pavlovian conditioning paradigm was developed using the naturalistic fear of 
water instead of an electric shock. After habituation to the dropbox environment on 
the first day, a trace conditioning procedure was performed on two consecutive days 
where the unconditioned stimulus (dropping into water) was separated by a trace 
interval from the conditioned stimulus (10,000 Hz tone). On the fourth day, the mice 
were returned to the dropbox and contextual memory was assessed by the amount of 
freezing.  
The test was validated in three test groups of C57Bl6 mice (n = 4/6). Two of 
the groups were administered either saline vehicle or 50 mg/kg atropine sulfate prior 
to each conditioning session and a third group was subjected to the tone but no water 
drop. 1-way ANOVA of the data revealed a significant drug effect on freezing (p < 
0.01). 
Figure 4.8, and associated Tukey’s tests, show that when the mice are placed 
back into the context, the unconditioned control group, which had no previous water 
drop, show little freezing behaviour (11.8 ± 2.7 s). Dropbox conditioning causes a 
significant freezing phenotype (49.7 ± 7.5 s, p < 0.01), an effect that is sensitive to 
muscarinic antagonism by atropine sulfate (23.0 ± 6.7 s, p < 0.05). Further, there is no 
difference between the unconditioned control group and the atropine treated group (p 
= 0.20), suggesting complete dependence for memory acquisition on muscarinic-
cholinergic neurotransmission. 
When freezing was tested in response to the tone in a neutral context, there 
was no difference in freezing between the saline and the atropine sulfate-treated group 
(data not shown; p = 0.36). 
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Figure 4.8 C57Bl6 mice show significant freezing in the dropbox. 
The freezing response after aversive memory conditioning is attenuated with 
systemic atropine sulfate during the acquisition phase. (*p < 0.05; **p < 0.01) 
RESULTS & DISCUSSION 
117 
 
The test was repeated in TASK-3 KO mice (n = 6) and littermate controls (n = 
7), with the results shown in figure 4.9. Both genotypes displayed freezing behaviour 
when replaced in the conditioned context of the dropbox after training, TASK-3 KOs 
froze for an average of 34.5 ± 8.7 s, much less than littermates, which froze for an 
average of 55.4 ± 8.2 s. However, this difference was not statistically significant (p = 
0.11). TASK-3 KOs also spent less time exploring the environment during the trial 
phase, as in figure 4.9B, but again this difference was not statistically significant (p = 
0.10). Therefore, TASK-3 KO mice have a statistically normal freezing response to 
dropbox conditioning. 
 
 
 
Figure 4.9 TASK-3 KO mice perform similarly to littermates in the dropbox.  
A – The aversive conditioning of the dropbox elicits robust freezing in both 
genotypes. B – TASK-3 KOs have a non-significant trend towards lower 
exploration in the context of aversive conditioning. 
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4.7 Testing the homeostatic orientation response 
The ability for an animal to orient itself in space upon external dislocation has been 
associated with the vestibular system and the hippocampus (Tai et al., 2012). 
Specifically, the homeostatic orientation response has been shown to depend upon the 
type-2 theta oscillations (Shin, 2010). This ability was tested in TASK-3 KO mice in 
comparison to littermate controls. 
 The number of rotations in the same direction of the rotation was quantified 
during 2 minutes of rotation. With saline injection, TASK-3 KO mice (n = 5) 
performed 21 ± 2 rotations, which was not significantly different (p = 0.59) to 
littermate controls (n = 4), with 19 ± 4 rotations (Figure 4.10). Atropine sulfate had no 
effect on the orientation response in either genotype (p = 0.96 for littermates and p = 
0.34 for TASK-3 KOs), with TASK-3 KOs performing 18 ± 2 rotations and 
littermates 18 ± 4 rotations.  
 
 
 
Figure 4.10 TASK-3 KO mice have intact orientation response. 
TASK-3 KO mice have no deficits in the orientation response and none of the 
genotypes are affected by atropine sulfate pre-administration. 
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4.8 Discussion 
These studies first sought to clarify whether the type-2 theta impairments in TASK-3 
KO mice were limited to the anaesthetic condition. Previous studies had shown that 
TASK-3 deletion ablates the type-2 theta oscillation usually found in response to 
halothane anaesthesia, and that this oscillation was unaffected by atropine sulphate or 
eserine (Pang et al., 2009), suggesting serious deficits in the cholinergic system that 
mediates type-2 theta activity. In addition, it was possible that the sequelae of 
cognitive impairments suffered by TASK-3 KO mice could be explained by a type-2 
theta impairment during natural behaviours. 
The type-2 theta oscillation was identified in a series of seminal experiments 
along with the type-1 theta rhythm (Kramis et al., 1975; Usui et al., 1977). Recorded 
from the hippocampus of rodents, the theta rhythm is an oscillation of between 4 and 
12 Hz that changes depending upon the ongoing behaviour of the animal. The type-1 
theta oscillation results from glutamatergic and serotonergic inputs from the 
entorhinal cortex and predominates at the higher range of frequencies. The frequency 
also positively correlates with running speed of the animal and hippocampal place 
cells, which fire at a precise location in the spatial field of the animal, have been 
shown to be modulated by the hippocampal theta rhythm (Hasselmo, 2005).  
The type-2 theta oscillation is readily observed in rodents during anaesthesia 
with various drugs, including urethane and halothane (Bland et al., 2003; Clement et 
al., 2008), and less so during certain behavioural routines (Kramis et al., 1975; 
Sainsbury et al., 1987). Rabbits produce relatively long trains of type-2 theta activity 
in response to a wide range of sensory stimulations (Bland et al., 1981) and guinea 
pigs display type-2 theta in response to stimulation during situations of heightened 
arousal in the presence of predators such as snakes (Sainsbury et al., 1984). Rats also 
produce type-2 theta in the presence of predators such as the cat and ferret, and 
previously neutral stimuli can elicit type-2 theta oscillations during predator exposure, 
leading to the hypothesis that type-2 theta only occurs during sensory processing 
when the animal is in an aroused state (Sainsbury et al., 1987).  There is also evidence 
that immobility-related type-2 theta occurs during wider-scale environmental 
processing and initiation of motor programs (Oddie et al., 1997), as well as memory 
processing in fear conditioning paradigms (Seidenbecher et al., 2003). Other type-2 
behaviours such as the automatic motor activities associated with eating and 
RESULTS & DISCUSSION 
120 
 
copulating occur with a desynchronised brain activity with large irregular amplitude 
(LIA) when the animals presumably interact less with the wider environment. 
Different rodent species, therefore, have broadly similar type-2 theta 
stimulants, with the main difference appearing to be the arousal threshold. While 
rabbits have a well-known propensity to freeze with unpredictable but non-specific 
stimuli – even vehicle headlights will do, for example – in studying the mouse it 
became apparent that robust freezing behaviour could not simply be caused by 
unpredictable and aversive stimuli. Although there is some evidence that type-2 theta 
oscillations may be important in the freezing behaviour used as a measure of fear 
memory in Pavlovian conditioning paradigms, the finding that inescapable shock – 
essentially the definition of the foot-shock fear memory paradigm – is associated with 
a specific ablation of the type-2 theta oscillation (Balleine et al., 1991) contraindicates 
shock tactics. 
Therefore, the approach focused on more naturalistic ways to induce alert 
immobility, such as exposing the test subject to evidence of a predator. Fox odour, 
and its artificial analogue trimethylthiazoline (TMT), for instance, has been used to 
induce freezing behaviour in mice (Fendt et al., 2005). Interestingly, inactivation of 
the lateral septum, a structure adjoining the type-2 theta-related medial septum, blocks 
fox odour-induced fear behaviour (Endres et al., 2008). Evidence that the pertinent 
odour-processing oscillatory frequencies are in the beta range (Fendt et al., 2005) 
does not rule out the involvement of type-2 theta in the actual freezing behaviour. The 
simplicity of this test was an attractive feature, but the chemicals involved are 
extremely potent and have the potential to cause lasting effects in animals that are not 
involved in the study.  
Efforts then narrowed to the rat exposure test (Yang et al., 2004). This model 
of mouse defensive behaviours causes robust freezing behaviour among other threat-
related activity such as the stretch attend posture, stretch approach and threat contact 
reduction. The apparatus was modified to exclude the central tunnel and home area to 
maximize contact with the rat, and to counteract the possibility of ablating type-2 
theta, as occurs in inescapable conditions, a small “safe-zone” was created to which 
the mice could retreat. 
The test elicited robust freezing behaviour associated with type-2 theta in 
C57Bl6 mice, and also in TASK-3 KO mice and littermate controls. While the peak 
frequency of the theta oscillation was unchanged, the power of the theta frequency 
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was significantly reduced in the TASK-3 KOs. It has been proposed that the 
frequency of the oscillation is set by GABAergic projections into the hippocampus, 
with inhibitory interneurons more able to regulate timing of pyramidal cell firing, 
while the power of the oscillation is controlled by cholinergic projections, with 
muscarinic receptors more suited to slower state changes (Hasselmo et al., 2001). This 
is consistent with the previously proposed cholinergic system deficit in TASK-3 KO 
mice. 
 
The next studies sought to investigate a possible link between the cognitive 
impairments of TASK-3 KO mice and the newly described behavioural type-2 theta 
impairment. Previous studies had found memory impairments in TASK-3 KO mice in 
the T-maze and the Morris water maze (Linden et al., 2007). 
 In the Morris water maze TASK-3 KO mice were slower to find the platform 
throughout the training phase, but only TASK-3 KO females showed fewer platform 
crosses during the probe trial (Linden et al., 2007). No such sex differences were 
found in the T-maze and, overall, TASK-3 KO mice showed a working memory 
deficit as judged by a lower alternation rate compared to littermates.  
The study in this report, however, showed that TASK-3 KO mice performed 
with equal alternation rates to littermate controls. The different findings here can be 
explained by the time of day that the experiment was completed: Linden et al.’s 
(2007) study was performed during the light phase of the diurnal cycle, whereas the 
study reported here was performed in the dark phase. Being the active phase of the 
rodent circadian rhythm, the dark phase is cognitively more relevant, given the 
evolutionarily-disposed behavioural demands of a nocturnal species.  
Further studies by Gotter et al. (2011) add complexity to the situation with 
results indicating working memory deficits in the Y-maze in TASK-3 KO mice in the 
inactive phase but not in the active phase. A point worth noting is that few studies 
compare their alternation rates to the hypothetical null-hypothesis mean of 50%; so, in 
fact, it is not clear if even the control animals alternate at rates above chance. When 
this measure was taken in this study, littermates alternated at above chance level but 
TASK-3 KOs did not. Taken together, the data from three separate groups indicates 
that TASK-3 KO mice have subtle impairments in working memory in the active 
(wake) phase, which are accentuated in the inactive (sleep) phase, suggesting sleep-
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related cognitive bias. A direct comparison in working memory performance between 
controls in the active and inactive phase has not yet been made.  
Alternation rate in the T-maze has been variously impaired by hippocampal 
(Johnson et al., 1977) and septal lesions (Clody et al., 1969), consistent with a role for 
the septohippocampal system in mediating novelty-related working memory. A 
specific role for the cholinergic system is shown by anatgonism in the medial septum 
reducing alternation rates (Givens et al., 1995), whereas eserine enhances alternation 
(Egger et al., 1973). Complementary to this, lesions of the basal forebrain, which 
provides cholinergic input to the prefrontal cortex, also reduces alternation rate 
(Murray et al., 1986). The importance of this dual cholinergic system is also 
supported by a coupling of theta oscillations between the hippocampus (via medial 
septum) and the prefrontal cortex (via basal forebrain) during successful memory 
performances (Hyman et al., 2005; 2010). 
A specific role for medial septum-regulated type-2 theta in alternation working 
memory is highlighted by cholinergic antagonism reducing choice accuracy in the T-
maze (Givens et al., 1990). Here, the change in theta frequency correlated with the 
deficit in choice accuracy, but further studies showed that rather than a decrease in 
frequency, blocking muscarinic neurotransmission by intra-septal scopolamine caused 
in increase in theta frequency (Givens et al., 1995). 
While TASK-3 channels are widely expressed in the hippocampus (Talley et 
al., 2001; Torborg et al., 2006) and have a role in muscarinic neurotransmission in the 
thalamus (Meuth et al., 2003), the exact role of TASK-3 conductances in the septo-
hippocampal system in relation to theta activity and working memory is unknown. 
The relatively intact working memory of TASK-3 KO mice in this study could 
therefore be due to the pseudo-normal theta frequency dynamics in both moving 
(type-1 theta) and immobility (type-2 theta). 
 
A role for type-2 theta in environmental and sensory processing in states of high 
arousal has already been explicated (Bland et al., 2001; Oddie et al., 1998; Sainsbury, 
1998). It therefore follows that type-2 theta might also have a role in novel situations 
where the animal must be alert and ready to respond to potential threats. In an early 
study in this regard, when rats were exposed to a novel smell they exhibited 
oscillatory activity in the high theta frequency range, usually indicative of the type-1 
oscillation (Myhrer et al., 1988). However, since the animals were perfectly still at 
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this time, and although the response was only non-specifically blocked by atropine 
sulfate, the case was made for it being of the type-2 variety. 
 More recently, there has been some controversy as to which facet of the theta 
oscillation is more important in processing novelty. Jewajee et al. (2008) showed that, 
over several days of habituation to a novel environment, the frequency of the theta 
oscillation increased and then decreased sharply again with unexpected novelty. These 
findings were directly questioned by Sambeth et al. (2009), who argued that using 
foraging food-deprived rats undermined the study since food consumption and 
reinforcement increases hippocampal acetylcholine levels (Ghiani et al., 1998). 
Additionally, the Sambeth et al. study (2009) found novelty to correlate with an 
increase in power of the theta oscillation rather than a decrease in frequency. 
However, they were unable to replicate a positive correlation between running speed 
and theta frequency, which puts their own data into question. 
 Within the context of this relatively ambiguous situation, it made sense to test 
the ability of TASK-3 KOs to recognise novelty. Would a deficit in theta power 
translate to novelty recognition impairments in TASK-3 KO mice? 
 In fact, TASK-3 KO mice showed similar behaviour to littermate controls 
firstly in response to novelty, and then in subsequent recognition of novelty over the 
short-term and long-term. In the first object exposure, both genotypes showed little 
signs of anxiety and interacted with both novel objects equally. When one object was 
replaced for another, TASK-3 KOs and littermates both showed a significant 
preference for the novel object, with no difference between the genotypes as judged 
by the interaction ratio, which normalises for individual differences in activity.  
 As TASK-3 KO mice show sleep differences compared to controls (Pang et 
al., 2009), it was reasonable to predict that memory consolidation during sleep, and 
therefore retention of the object-memory, might be affected. Specifically, TASK-3 
KO mice show significantly reduced sleep in the first two hours of the lights-on sleep 
phase of their diurnal cycle and a fragmented sleep pattern when they finally do sleep. 
That is, they have more numerous but shorter length episodes of sleep, and they 
appear to be less able to support long trains of REM sleep (Pang, 2010). Other work, 
however, suggests that TASK-3 KOs have exaggerated nocturnal locomotor activity 
(Gotter et al., 2011; Linden et al., 2007), and a less, rather than a more, fragmented 
sleep pattern (Gotter et al., 2011). 
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 A point worth mentioning here though is that polysomnographic sleep scoring 
uses a template based on ECoG and EMG derivatives, which, if animals have 
inherently different neuronal oscillations – as TASK-3 KOs appear to have – may 
skew the interpretation of results. Therefore, any sleep stage scoring should also be 
accompanied by ECoG frequency distributions to clarify that the same sleep stage is 
being compared between animals. 
 When the TASK-3 KO mice were tested for object recognition 24 hours after 
training they performed as well as littermates. Moreover, the recognition appeared to 
be enhanced in TASK-3 KO mice as they, but not littermates, showed a significant 
increase (p < 0.01) in interaction score between the 10 minutes test and the 24 hour 
test, suggesting facilitated long-term (and sleep-dependent) memory consolidation. 
 Gotter et al. (2011) tested novelty recognition 3 hours after acquisition and 
also found a facilitation of object-memory in TASK-3 KO mice over controls. The 
authors make an attempt to explain this phenomenon through the trend towards 
increased interaction time in the acquisition phase for TASK-3 KO mice, consistent 
with a facilitatory role of novelty-induced immobility-related theta (Myhrer et al., 
1988).  It is not stated whether the animals in Gotter et al.’s study (2011) slept 
between the two exposures, but the inter-trial period is consistent with medium to 
long-term memory consolidation that can be enhanced by sleep (Binder et al., 2012). 
In fact, there is a reciprocal relationship between sleep and novelty recognition: novel 
object presentation increases the amount of REM sleep, and therefore theta frequency 
activity (Schiffelholz et al., 2002), and is impaired by sleep deprivation (Palchykova 
et al., 2006). So it possible that the fragmented REM sleep baseline in TASK-3 KO 
mice is more labile to the effects of novelty, leading to an enhanced memory 
consolidation. In any case, the sleep deficits in TASK-3 KO mice do not appear to 
impair object-memory. 
 To probe the memory of TASK-3 KOs further, their performance in a spatial 
recognition paradigm was measured. Performance in this version of the test has also 
been linked to the septohippocampal system and concurrent theta activity (Okada et 
al., 2010). The hippocampus has a long-known role in spatial memory, both in 
reinforced tests such as the Morris water maze and unreinforced tests like spatial 
recognition (Gerlai, 2001). Place cells, that fire in specific locations of the animals’ 
spatial field, are also linked to the theta oscillation (O'Keefe et al., 1978). 
RESULTS & DISCUSSION 
125 
 
The mice in this study were exposed to five objects over three habituation 
sessions, before two of the objects were displaced in a fourth trial (Save et al., 1992). 
If the mice recognised the change then they should spend more time interacting with 
the displaced objects. Both littermates and TASK-3 KOs showed habituation to the 
objects as measured by a decrease in interaction time over the course of the first three 
object exposures indicating intact object-place memory. The difference between the 
first two sessions for TASK-3 KO mice was not significantly different, possibly due 
to the tendency for increased exploration compared to littermates. 
In the probe test, neither genotype showed a preference for the displaced 
object, indicating that spatial recognition memory is impaired in both littermates and 
TASK-3 KO mice. However, a more likely explanation is that the test suffered from 
methodological problems. Despite the fact that the test was validated in this laboratory 
in C57Bl6 mice, with a significant preference for the displaced objects in the probe 
test, this was only in four individuals. Previous work using this five object format has 
been performed in rats rather than mice, and even then the effect was on the order of a 
few seconds of preference for the displaced object (Okada et al., 2010). Mouse studies 
have usually opted for using fewer objects to test spatial memory. Indeed, several 
studies use only two identical objects over the three habituation sessions, one of 
which is moved to a new location in the probe test (Florian et al., 2011; Palchykova et 
al., 2006). While overall the objects in this study elicited no group preference, some 
individual animals did appear to have a preference for one particular object, which 
they would favour even in the presence of an object in a novel spatial location. Future 
tests of this sort should be based on simplified versions of the spatial recognition test 
that may more precisely delineate any impairment in theta-dependent memory 
encoding. 
 
The next experiments sought to measure the emotional memory in TASK-3 KO mice. 
This is often tested in rodents using Pavlovian fear conditioning paradigms (Maren et 
al., 2004), which consist of a box that delivers a series of electric shocks to the 
animal, sometimes associated with a tone. When the animal is placed back into the 
box or hears the tone, even in a different context, the animal will have a freezing 
response in expectation of being shocked. The amount of freezing is suggested to act 
as a marker for emotional memory. 
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 The neuronal circuits involved in mediating this fear response include the 
amygdala, a part of the evolutionarily ancient limbic system of the brain (Kapp et al., 
1979) and the hippocampus (Berry et al., 2001). Conditioning to the tone stimulus 
itself is primarily associated with activity in the lateral amygdala (Quirk et al., 1995), 
whereas fear memory based on contextual (spatial) cues involves the hippocampus 
(Vazdarjanova et al., 1998). 
Further, cholinergic neurotransmission and the theta oscillation have been 
implicated in the hippocampal processing relevant to fear memory acquisition and 
retrieval. Blocking muscarinic neurotransmission through systemic scopolamine dose-
dependently reduced freezing in the acquisition phase, retrieval to context phase and 
retrieval to tone phase (Anagnostaras et al., 1999). More refined cholinergic 
antagonism in the rat hippocampus generally (Gale et al., 2001), and the CA3 region 
more specifically (Rogers et al., 2004), caused reduced freezing in the acquisition 
phase of the test and also when the animals were returned to the fear context 24 hours 
later. In addition, fear responses to tone conditioning were unchanged. These findings 
fit with computational models suggesting that enhanced cholinergic signalling is 
important for the acquisition of contextual fear memory (Hasselmo et al., 1995). 
In addition, that the cued conditioning was similar in saline and atropine-
treated groups indicates that the effect was specific to context conditioning and 
hippocampal processing (Vazdarjanova et al., 1998). 
 
A potential confound to these data is that the reduced freezing behaviour in the 
acquisition phase of the test raises the question of whether the drug affects (i) freezing 
behaviour or (ii) memory formation. As far as these studies report, they have not 
performed the retrieval test under drugged conditions, so it is not clear whether 
scopolamine reduces (i) the ability to freeze or (ii) mnemonic freezing behaviour. A 
corollary question, so far unanswered, is whether freezing itself – and increased type-
2 theta – enhances memory acquisition.  
Despite these ambiguities, to get a full memory profile, TASK-3 KO mice – 
having potential functional impairments in the type-2 theta oscillation – were tested in 
a novel fear conditioning paradigm. The dropbox was developed to avoid some of the 
facets of the traditional foot-shock that might confound the mechanism under 
investigation. The dropbox, fully described in Methods & Materials, consisted of a 
box with a platform over a pool of water. The platform could be rapidly removed 
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sending the mouse into the water below. After a brief swim, the mouse could be 
rescued by replacing the platform into its original position. 
The dropbox elicited a robust freezing response when the conditioned animals 
were replaced in the context, suggesting that the test functioned well to condition 
animals to an aversive stimulus. Atropinization prior to training caused a reduction in 
freezing behaviour in the off-drug context test 24 hours later, indicating that 
acquisition in the dropbox conditioning depends upon cholinergic neurotransmission, 
just like in traditional foot-shock paradigms (see above). 
TASK-3 KO mice showed less freezing on average than littermate controls, 
however, the difference did not reach significance. Exploratory behaviour during the 
retrieval phase was also not significantly different between the genotypes. While this 
study shows that TASK-3 KO mice have intact fear memory, any future experiments 
should investigate the relative effect of atropinization on the acquisition of dropbox 
fear memory between genotypes.  
Overall, the dropbox provides a novel and robust way of measuring fear 
behaviour in mice and has the potential to be improved from this developmental 
phase. While fear conditioning using electric shocks can elicit in excess of 70% 
freezing, the dropbox currently causes a more subtle effect (~20% freezing). Perhaps 
longer swim times or colder water might increase the aversive nature of the drop. 
Other issues might be harder to solve though: for example, freezing behaviour during 
the acquisition was difficult to measure since the animals spent much of the time 
grooming because they were wet. 
The dropbox has numerous advantages over traditional foot-shock methods, 
both for this study in particular and more generally speaking: the dropbox 
incorporates several key features of the alert immobile state as the animals process the 
environment and conditioned cues, retrieve memories, and prepare to execute an 
escape movement; the dropbox provides an escapable environment so, even though 
type-2 theta oscillations have been implicated in foot-shock conditioning (Narayanan 
et al., 2007; Pape et al., 2005; Seidenbecher et al., 2003), possible conditioned 
ablation of the theta oscillation is prevented (Balleine et al., 1991; Bland et al., 
2007b); the dropbox dissociates fear from pain (caused by electric shocks) meaning 
that the test could have value for testing emotional memory in depression or disease 
when pain thresholds can be changed (Robinson et al., 2009). 
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The final test measuring the effect of TASK-3 deletion on behaviour was the 
orientation response test. When turned in the horizontal plane, animals, including 
humans, will often turn towards the direction of motion in a homeostatic orientation 
response (Lackner et al., 2000a; 2000b). Studies have shown that passive rotation – 
when the animal is immobile in a sling – causes type-2 theta and, further, that ablating 
type-2 theta with atropine sulfate blocks the orientation response in mice (Shin, 2010). 
 In the study in this report, atropine sulfate pre-treatment failed to abolish the 
orientation response in either genotype and there was no difference between TASK-3 
KO and littermate performance, with or without the drug. This is consistent with work 
implicating type-1 theta oscillations as more relevant to the response, since the 
frequency of the oscillation during rotation tends to be in the higher frequency range 
(Gavrilov et al., 1995). Indeed, other work shows that atropine sulfate has no effect on 
the theta oscillation during passive translation (Xie et al., 2012), indicating that it is 
type-1 theta that processes motion. 
Interestingly, mice lacking the phospholipase C (PLC) β4 or β1subunit share a 
similar neuronal phenotype to TASK-3 KO mice in that they both lack a normal type-
2 theta oscillation in response to anaesthetics (Shin et al., 2009; 2005). PLC β4 KOs 
also have a reduced type-2 theta oscillation in response to passive rotation, which can 
be restored by cholinergic enhancer rivastigmine (Shin et al., 2009). It is not reported 
whether either PLC mutant has an intact orientation response, or if they were affected 
behaviourally by cholinergic modulation. However, the associated activities of PLC 
and TASK-3 channels in muscarinic neurotransmission (Mathie, 2007) points towards 
a common molecular mechanism for the generation of type-2 theta oscillations (see 
figure 4.11). 
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Figure 4.11 A molecular mechanism for the type-2 theta oscillation.  
The type-2 theta oscillation depends upon intact muscarinic neurotransmission 
since blocking mAChRs with atropine sulfate ablates theta. Knock out of other 
components of the metabotropic signalling pathway – PLC β or TASK-3 – also 
ablates type-2 theta. [Adapted from Mathie, 2007] 
RESULTS & DISCUSSION 
130 
 
  
 
 
 
Adeno-associated virus (AAV) experiments 
 
5.1 Background 
The first step in understanding the role of a protein in the live animal is often to 
observe the phenotypic effects in an animal knockout of the coding gene sequence. 
Indeed, since 2004, there has been an attempt to create null mutants for every gene in 
the mouse (Knockout Mouse Project). While some developmental genes are 
fundamental to life and their removal results in a non-viable foetus or severe health 
problems, many genes can be deleted without major physiological consequences, and 
therefore their specific function can be dissected with the right barrage of tests. 
 To this end, the TASK-3 allele was targeted for homologous recombination in 
mouse embryonic cells. Although the outcome was not exactly according to plan, a 
null mutant for TASK-3 was created (See Methods & Materials). The TASK-3 KO 
mouse showed a range of deficits, including a reduced sensitivity to anaesthetics 
(Pang et al., 2009). An unexpected finding was impairment in the hippocampal type-2 
theta oscillation that might explain some of the other cognitive deficits. 
 The regulation of the type-2 theta oscillation is dependent upon an intact 
septohippocampal network so, presumably, halothane-induced activation of TASK-3 
channels is important in this region. Further investigation into understanding the role 
of TASK-3 in type-2 theta oscillations could follow several approaches. 
 Molecular agonism or antagonism provides a useful way to acutely manipulate 
the action of a receptor or channel both in vitro and in vivo. If TASK-3 channels could 
be blocked in specific regions of the brain, such as the medial septum or 
hippocampus, its role in type-2 theta might be uncovered. However, the range of 
TASK-3 channel blockers which are freely available, such as zinc, are rather non-
specific and a recently discovered series of TASK-3 channel blockers based on a 
5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine high-throughput screening are not 
commercially available (Coburn et al., 2012). 
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 Another option would be to delete TASK-3 channels from specific regions of 
the brain. This conditional knockout technique has the added benefit that any off-
target effects are neutralised, while also sparing possible expression changes in other 
genes that may occur through developmental compensation. Typically, the gene of 
interest (or a single exon of the gene) is flanked by locus of crossover (lox) sites, 
creating a floxed allele. When this mouse is mated with another mouse that expresses 
cyclization recombinase (Cre) under a cell-specific promotor, the floxed allele will be 
excised and expression of the gene of interest ablated only in those cells (Wisden, 
2010). Advances in transgenesis also allow genes to be turned off at a temporal as 
well as a spatial dimension, using drug-activated gene deletion any time in the adult 
animal so as to avoid any developmental effects. 
 
This study utilised another method of manipulating gene expression in the adult 
mouse: Adeno-associated virus (AAV)-mediated gene transfer.  
AAVs have a single-stranded DNA genome of about 4.7 kb contained within a 
non-enveloped capsid, measuring 20 nm in diameter. Highly endemic among human, 
primate and other animal species, these viruses belong to the genus Dependovirus, a 
name that hints at their reliance on other helper viruses, such as adenoviruses or the 
herpes simplex virus, for replication of their genome. 
 The AAV genome consists of two genes, rep and cap, flanked by 145 
nucleotide palindromic sequences, called inverted terminal repeats (ITRs), which 
contain the cis-acting sequences vital for virus packaging, replication and integration. 
The rep gene codes for four non-structural Rep proteins, Rep78, Rep68, Rep72 and 
Rep40, that regulate replication, viral transcription, packaging of the AAV genomes 
and site-specific integration. The cap gene codes for three structural virion proteins, 
VP1, VP2 and VP3, which form the capsid of the virus (Osten et al., 2007). 
 Upon AAV infection in humans, the AAV genome either stays episomal or 
integrates into a specific locus on the human chromosome 19, where it remains in a 
repressed state until super-infection with a helper virus.  
Despite their limited genome capacity, their non-pathogenicity – insertional 
mutagenesis being highly unlikely (Daya et al., 2008) – makes AAVs a promising 
vehicle for gene therapy, and there have been many efforts in the clinic to cure 
diseases using recombinant versions (rAAVs) (Bartel et al., 2012). The use of rAAVs 
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is most common in basic research, particularly in brain sciences where site-specific 
infection can aid the dissection of neuronal circuitry. 
 Using a helper plasmid expression system, containing the rep and cap portion 
of the AAV genome, as well as the accessory adenoviral genes, exogenous DNA 
sequences of up to 5 kb can be introduced between the ITR sites for subsequent gene 
transfer. 
 
In trying to find out where the expression of TASK-3 is important for mediating type-
2 theta oscillations, AAVs were constructed with the view to reinsert TASK-3 in 
specific brain regions of the TASK-3 KO. If these regions were important in the 
TASK-3-mediated oscillations, then theta would be restored. On the other hand, it 
might be possible to restore the oscillation via a secondary ectopic pathway, where the 
channels are not usually expressed. 
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5.2 Making the rAAV plasmids 
 
eGFP-2A-TASK-3 rAAV 
One of the AAVs contained the TASK-3 coding sequence and a GFP sequence to act 
as a marker of expression, with the two linked by a 2A co-translation cassette. The 
TASK-3 sequence was successfully amplified from pDNA3 containing mouse TASK-
3 using primers that contained an ApaI restriction site in the forward direction and an 
HindIII restriction site in the reverse direction (Figure 5.1A). A possible strategy here 
could have been to digest the purified PCR product and immediately ligate into the 
plasmid containing GFP. However, initial attempts in this vein were unsuccessful, 
possibly because the short overhangs at the restriction sites prevented efficient 
digestion. Instead, at each amplification step, the DNA proof-reading capability of 
polymerases like Pfu was sacrificed for a unique feature of TAq polymerase, which 
adds an adenylated tail at the terminals. The purified PCR product could then be 
ligated relatively simply into the TOPO vector for convenient storage. Out of nine 
TOPO reactions, one contained the TASK-3 insert as shown by complete digestion 
with ApaI and HindIII (Figure 5.1B). 
It is a good idea to have some kind of reporter construct to confirm expression 
of the gene of interest. One way to do this is to directly tag the protein with a 
fluorescent marker such as GFP; however, the large size of the concatomer may 
interfere with the endogenous activity of the protein. Smaller peptide tags that act as 
specific antibody epitopes, such as the His-tag and AU1, can also be used; however, 
confirmation of expression relies on immunohistochemical techniques. 
To circumvent these issues the plan was to link the TASK-3 element to a 
fluorescent marker via a short co-translation cassette. In this way, two separate 
proteins would be produced, hypothetically in a 1:1 ratio, without affecting the 
activity of the TASK-3 channel. A plasmid containing eGFP linked to another gene 
by a 2A sequence, peGFP-2A-GABAA-γ2, was acquired for this purpose. The 2A 
sequence is a viral co-translation cassette of about 20 amino acids, with the consensus 
motif Asp-Val/Ile-Glu-X-Asn-Pro-Gly-Pro, which allows transcription of the full-
length sequence, but during translation prevents the formation of a peptide bond 
between the last glycine and proline. The resulting ribosome skipping creates two 
separate proteins; in this case, eGFP and TASK-3 (Donnelly et al., 1997; Trichas et 
al., 2008). 
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Figure 5.1 eGFP-2A-TASK-3 molecular biology.  
A – The mouse TASK-3 gene amplicon at ~1200bp was amplified from pDNA3 
with primers containing ApaI and HindIII restriction sites. B – One of twelve 
minipreps, marked with an arrow, contained the TOPO vector backbone 
(~4000bp) and the TASK-3 insert (~1200bp). C – ApaI and HindII double digests 
of peGFP-2A- GABAA-γ2 (sample 1), TASK-3 TOPO (sample 3) and the required 
ligation product peGFP-2A-TASK-3, marked with an arrow in sample 2. D – A 
~2000bp amplicon of two PCR reactions for eGFP-2A-TASK-3 before and after 
gel purification. E – Three ligation minipreps, with arrows, contain the pAM-flex 
band (sample 1) and the eGFP-2A-TASK-3 band, in sample 2. [L = DNA ladder.] 
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To subclone the TASK-3 element into the GFP-2A plasmid, the TOPO vector 
containing TASK-3 and peGFP-2A-GABAA-γ2 were digested with complementary 
restriction enzymes and the two digestion mixes were ligated using T4 ligase in a 
rapid ligation protocol.  
Here, certain precautions were taken to ensure successful ligation. Efforts to 
gel purify the required backbone and insert before ligation, a procedure that also 
removes restriction enzymes and other contaminants that may affect the reaction, 
resulted in low DNA yields and were largely unsuccessful. Instead, restriction 
enzymes were inactivated by heating to 65°C and one of the digestion mixtures was 
treated with shrimp alkaline phosphatase. This would dephosphorylate the digested 
DNA terminals, preventing re-circularisation of one of the original plasmids (though 
the other would remain labile to self-ligation), thus increasing the probability of a 
correct insertion. Since this strategy appeared to be the most efficient, it was followed 
throughout. 
Figure 5.1C shows the digestion product of peGFP-2A-GABAA-γ2 as sample 
1 and the digestion product of TASK-3 TOPO as sample 3. After transfection and 
DNA purification three peGFP-2A-TASK-3 positive clones out of twelve were 
identified, an example of which is shown as sample 2 of figure 5.1C. The top band 
corresponds to the peGFP-2A backbone and the bottom band corresponds to the 
TASK-3 insert, a result confirmed by DNA sequencing. 
The next step was to subclone the eGFP-2A-TASK-3 sequence into a suitable 
AAV vector. This was achieved by firstly amplifying the entire eGFP-2A-TASK-3 
sequence by PCR while simultaneously adding restriction sites for future ligation. The 
full sequence was amplified successfully and purified as shown in figure 5.1D. Again 
the product was ligated into TOPO before digestion and ligation into the pAM-flex 
AAV plasmid. 
The pAM flex contains elongation factor (EF)-2 alpha as a constitutive 
promoter and woodchuck hepatitis virus post-transcriptional regulatory element 
(WPRE) which improves intron-free transcription. In figure 5.1E, sample 1 shows the 
empty pAM-flex digested with NotI and HindIII while sample 2 shows a similarly 
digested eGFP-2A-TASK-3 TOPO. Three out of ten of the transfected ligation 
mixtures were positive for the pAM-flex backbone and the eGFP-2A-TASK-3 insert. 
After the sequences were confirmed, these plasmids could be taken forward to 
producing the rAAV particles. The entire strategy is laid out in figure 5.2. 
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Figure 5.2 Making the eGFP-2A-TASK-3 rAAV plasmid.  
TASK-3 was amplified and ligated into TOPO vector before subsequent digestion 
and ligation with similarly digested peGFP-2A- GABAA-γ2. This construct was 
then amplified to include compatible restriction sites for ligation between the ITR 
sites of the pAM-flex AAV vector. 
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Cre-2A-Flp rAAV 
During the construction of the TASK-3 KO it was realised that the TASK-3 allele was 
multiply reintegrated, but was ultimately and fortuitously not expressed. The manner 
of the genetic manipulations meant that crossing the TASK-3 KOs with a Cre-deletor 
mouse and then a flp mouse can turn on the TASK-3 gene and restore normal 
expression. Taking advantage of this, it might be possible to selectively restore 
TASK-3 expression in specific brain regions, such as the hippocampus or medial 
septum, by injecting rAAVs containing the Cre and Flp genes directly into these 
regions. 
 This type of gene manipulation has several benefits over the first non-selective 
method. If an rAAV cassette containing Cre and Flp was viable, the TASK-3 gene 
would be switched on only in those cells where it would normally be expressed. With 
the eGFP-TASK-3 rAAV, TASK-3 channels would be expressed in any cell that the 
virus infects, whether or not the cell-type would normally do so. This ectopic 
expression could have unknown effects on the physiology of the cell and in the 
cellular network. And since the eGFP-TASK-3 rAAV contains a constitutive 
promotor, expression levels could be far greater than normal. On the other hand, 
through Cre-Flp-mediated switching of the TASK-3 gene into the correct orientation, 
endogenous promotors would act to transcribe the gene as they would if it had never 
been modified; hypothetically to the correct mRNA expression levels. 
To this end, a Cre-2A-Flp rAAV plasmid containing the CMV enhancer and 
the chicken beta actin (CBA) promoter was made. Since a Cre-2A-Venus rAAV 
plasmid was available, the plan was to replace the Venus element with the Flp gene. 
However, the construct was not designed to easily excise and replace the Venus gene, 
which would normally be used as the expression marker, since one of the restriction 
sites flanking the Venus gene was not unique. So, in a more complex subcloning 
procedure, the Cre-2A segment was temporarily removed through digestion with 
BamH1 and the resulting plasmid re-ligated and subcloned in E. coli. Sample 1 in 
figure 5.3A shows a BamH1 and NotI digested plasmid containing the Venus gene but 
not the Cre-2A segment shown in sample 2. The Cre-2A segment was gel purified for 
later use.  
 
RESULTS & DISCUSSION 
138 
 
 
 
 
The Flp gene was amplified from pPGUFLPobpA with primers containing 
BamH1 and NotI restriction sites and digested with those enzymes, as shown in figure 
5.3B. The Flp fragment was then ligated with a similarly digested and phosphatase-
treated Venus plasmid, with the intention of replacing the Venus gene with the Flp 
gene. Figure 5.3C shows an “empty” plasmid in sample 1 and the plasmid with Flp in 
sample 2. 
At this point, the purified Cre-2A fragment could be re-introduced by ligating 
it with BamH1-cut Flp plasmid. Figure 5.3D shows both the Cre-2A digestion 
fragment (sample 3) and the Flp fragment (sample 2) together in sample 1, indicating 
ligation of the Cre-2A into the Flp plasmid. However, since the restriction sites 
flanking the Cre-2A were the same (BamHI), the ligation reaction could occur in 
either the correct (forward) orientation or the incorrect (reverse) orientation.  Out of 
six samples sent for sequencing, three were positive for the correct orientation and 
one of these had no mutations; and hence, was used to make the virus. The strategy is 
laid out in figure 5.4. 
Figure 5.3 Molecular biology of the Cre-2A-Flp rAAV plasmid.  
A – The Cre-2A portion of the original plasmid, shown by the arrowhead in sample 
2, has been removed from sample 1, where only the Venus gene is present. B – The 
Flp gene is shown successfully amplified, marked with the arrowhead. C – The Flp 
fragment has replaced the Venus gene in the CMV plasmid, marked with the 
arrowhead in sample 2. D – The Cre-2A fragment (as in sample 3) has successfully 
ligated to the CMV Flp plasmid (as in sample 2) to form the double band of the 
digested pCre-2A-Flp in sample 1. [L = DNA ladder.] 
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Figure 5.4 Strategy for the Cre-2A-Flp rAAV plasmid construction.  
The Cre-2A segment was excised and the Venus gene was swapped for the PCR-
amplified Flp gene. The Cre-2A segment was then ligated to the Flp plasmid to 
form the required pCre-2A-Flp vector. 
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5.3 Validating the rAAV plasmids 
 
eGFP-2A-TASK-3 rAAV 
The design of the eGFP-2A-TASK-3 rAAV plasmid incorporated an eGFP element to 
aid visual detection of gene expression. HEK-293 cells were transfected with the 
eGFP-2A-TASK-3 rAAV plasmid using the calcium chloride method and the cells 
were assessed for fluorescence after three days, revealing strong expression of eGFP, 
as shown in figure 5.5A. The endogenous fluorescent marker had the added advantage 
that cells could be checked for fluorescence each day to observe the time course of 
expression. 
 Assuming that the 2A co-translation element acts as required the presence of 
fluorescence in the transfected cells should also confirm expression of the TASK-3 
gene. However, it is possible that only one of the transgenes would be expressed, in 
this case just the eGFP as this is the first gene to be transcribed. One way to 
circumvent this issue would have been to design the plasmid with the TASK-3 
element first, followed by the 2A sequence and then the eGFP. Fluorescence in those 
conditions would certainly indicate the faithful transcription of TASK-3. In any case, 
further characterisation of TASK-3 expression was required. 
 To this end, HEK-293 cells were transfected with either the eGFP-2A-TASK-
3 rAAV plasmid or a control plasmid expressing GFP alone. The following day, 
whole-cell voltage clamp recording revealed a considerably higher outward current in 
the eGFP-2A-TASK-3 rAAV plasmid-transfected cells compared to control cells 
(Figure 5.5B; Electrophysiology performed by T. McGee). This result suggested that 
TASK-3 channels were expressed in transfected cells and correctly targeted to the 
plasma membrane, where they make a major contribution to cell permeability. 
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Figure 5.5 eGFP-2A-TASK-3 plasmid expression.  
A – Primary fluorescence from the eGFP reporter indicates robust expression of 
the eGFP-2A-TASK-2 plasmid in HEK-293 cells. [Scale bars = 0.1 mm]  B – 
eGFP-2A-TASK-3 expression causes a depolarisation in the holding current 
compared with GFP expression in HEK-293 cells. [Electrophysiology performed 
by T. McGee] 
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Cre-2A-Flp rAAV plasmid 
That the Cre-2A-Flp rAAV plasmid did not contain an endogenous marker of 
expression presented more of a problem for validation. Immunological staining 
provided one option, but since the two elements have transgenic functions, the activity 
of Cre and Flp were tested separately at a functional level. 
 To assess Cre function, the Cre-2A-Flp rAAV plasmid was co-transfected in 
HEK-293 cells with a plasmid that contained a dsRed element in the reverse direction 
between loxP sites. dsRed is a red fluorescent protein, that is not expressed in this 
native plasmid due to its reversed orientation. On being exposed to Cre, the floxed 
gene will be switched into the correct orientation and the gene will be expressed. The 
results of the co-transfection can be seen in figure 5.6A. There is no red fluorescence 
when the floxed and reversed dsRed plasmid is transfected alone, whereas when the 
Cre-2A-Flp rAAV plasmid is added, red fluorescence is strong in the majority of 
cells, indicating effective Cre activity. 
 Flp function was assessed through a second double transfection. The Cre-2A-
Flp rAAV plasmid was transfected with a plasmid that contained GFP between frt 
sites (LCMV:GFP(FRT)MCS: 5333 bp). This time, the native test plasmid would 
express GFP and fluoresce green in HEK-293 cells. Then, on the addition of the Cre-
2A-Flp rAAV plasmid, the Flp should inactivate the GFP gene by acting on the 
surrounding frt sites to reverse its orientation. Figure 5.6B shows that the Flp element 
of the Cre-2A-Flp rAAV plasmid worked exactly as planned. The possibility that the 
Cre-2A-Flp rAAV plasmid disrupted GFP expression merely through competition or a 
non-specific mechanism was ruled out through a control transfection of the GFP test 
plasmid and another plasmid, where fluorescence was unaffected (data not shown).  
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Figure 5.6 Testing the function of the Cre-2A-Flp plasmid.  
A – The Cre-recombinase component of the Cre-2A-Flp plasmid switches on dsRed 
expression in another co-transfected plasmid. B – The Flp element of the Cre-2A-
Flp plasmid turns off expression of FRT-flanked GFP from another co-transfected 
plasmid. [Scale bars = 0.1 mm] 
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5.4 Making the viral particles 
A helper plasmid expression system, containing the rep and cap portion of the AAV 
genome, as well as the accessory adenoviral genes, was used to produce a chimeric 
virion particle that would encapsulate the genetic elements of the eGFP-2A-TASK-3 
or Cre-2A-Flp plasmid between the ITRs. 
For each rAAV the capsid consisted of a chimera of AAV1 serotype and 
AAV2 serotype. AAV2 based vectors have the advantage of being readily purified by 
a heparin column (McClure et al., 2011); a much simpler procedure compared to 
purification via caesium chloride gradient. AAV1 vectors, on the other hand, have the 
advantage of robust infectivity of neuronal tissue (Royo et al., 2008). In order to 
generate this chimeric vector, two different helper plasmids were acquired: pRV1 
carries the cap and rep genes for AAV2; and pH21 carries the cap and rep genes for 
AAV1. Since HEK-293 cells already contain the adenoviral genes for E1A and E1B, a 
mini-adenovirus helper plasmid, pFΔ6, was sufficient to add the other adenoviral 
functions (E2A, E4ORF6 and VA RNAs). 
These plasmids were amplified using an E. coli expression system and then 
purified. Integrity of the plasmids was confirmed by restriction digestion, which 
produced the expected band pattern (Figure 5.7A). Virus production proceeded as in 
Methods & Materials and, after denaturing with heat and SDS, the viral coat proteins 
for each rAAV were run on an SDS-PAGE gel. 
Each AAV serotype has three structural proteins, with estimated molecular 
weights of 87,000 Da, 73,000 Da and 62,000 Da and a stoichiometry of 50:5:5, 
respectively (Rose et al., 1971). However, the denatured samples shown in figure 
5.7B do not recapitulate the expected results. Sample 1, eGFP-2A-TASK-3 rAAV, 
shows strongly staining bands at >100,000 Da and <60,000 Da, vastly different to 
those expected, while sample 2, Cre-2A-Flp rAAV, show only light staining of one 
unexpected band.  
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For further characterisation, the protein and DNA composition of the viral 
particles was estimated by the relative UV absorbance (at 260nm and 280 nm) of 
purified and denatured rAAV samples as in Sommer et al. (2003). The purified eGFP-
2A-TASK-3 rAAV sample contained 4.0×10
11 
viral genomes per ml and the Cre-2A-
Flp rAAV contained 1.8×10
12
 viral genomes per ml. The analysis also revealed 
capsid:genome ratios of 5.7:1 for eGFP-2A-TASK-3 rAAV and 2.4:1 for Cre-2A-Flp 
rAAV, reflective of the relative abundance of empty capsids in the purified viruses. 
Despite this, the rAAVs were taken on for further validation. 
 
 
 
Figure 5.7 Making the rAAVs.  
A – The integrity of the helper plasmids needed for rAAV production is confirmed 
through restriction digestion. Sample 1 is NotI & HindIII-digested eGFP-2A-
TASK-3 plasmid, sample 2 is EcoRI-digested pH21, sample 3 is HindIII-digested 
pFΔ6, and sample 4 is XbaI-digested pRV1. [L = DNA ladder] B – SDS-PAGE 
analysis of the purified viruses – eGFP-2A-TASK-3 rAAV in sample 1 and Cre-2A-
Flp rAAV in sample 2 – gives ambiguous results. [L = Protein ladder] 
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5.5 Validating the viral particles 
 
HEK-293 cell infection 
Activity of the viral particles was checked by infection in HEK-293 cells. Here, the 
infectivity of eGFP-2A-TASK-3 rAAV could be analysed by fluorescence of the 
endogenous eGFP marker, whereas the Cre-2A-Flp rAAV required a secondary 
marker. 
 Serial dilutions of the viruses were added to HEK-293 cells and, in the case of 
the eGFP-2A-TASK-3 rAAV, were checked every few days for fluorescence, with 
maximum expression at five days post-infection. At this point, cells were fixed and 
analysed. Based on maximum expression of this virus, the Cre-2A-Flp rAAV-infected 
cells were also fixed and analysed at one time-point, five days after the original 
infection. 
Cells infected with eGFP-2A-TASK-3 rAAV showed modest fluorescence in 
the cell body that varied in a dose-dependent manner, with the more dilute samples 
showing comparably less fluorescence than the maximum (data not shown; but see 
figure 5.9). 
The activity of Cre-2A-Flp rAAV was measured by anti-Cre 
immunocytochemistry with a fluorescent secondary antibody. Robust nuclear staining 
was observed, with fluorescence, and therefore the number of infected cells, scaling in 
a dose-dependent manner (Figure 5.8).  
The number of infected cells was calculated using ImageJ software (NIH) and 
viral titers were determined by multiplying the number of fluorescent cells (the 
average of two wells) by the dilution factor of the rAAV. The eGFP-2A-TASK-3 
rAAV titer was 2.0x10
5
 infectious particles per ml and the Cre-2A-Flp rAAV titer 
was 1.1x10
7
 infectious particles per ml, reflecting the differences in the earlier 
protein/DNA analysis. 
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Figure 5.8 Cre-2A-Flp rAAV expression. 
Cre-2A-Flp rAAV expression in HEK-293 cells is verified by anti-Cre 
immunocytochemistry. Nuclear staining increases as the amount of virus infected 
increases. [Scale bar = 0.1 mm] 
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Organotypic slice infection 
HEK-293 cell cultures are relatively short lived as the cells quickly become confluent 
and multiple fresh media changes decrease the health of the cells. This  means that 
expression assays are limited to only a few days and positive results do not 
necessarily predict the long-term and stable expression of the rAAV transgenes. This 
process, which may take in excess of two weeks (Ehrengruber et al., 2001), must 
ultimately be tested by in vivo infection. Prior to taking the virus into the live animal 
though, the infectivity of the eGFP-2A-TASK-3 rAAV was assessed in organotypic 
hippocampal slices from 15 day-old mouse pups (p15). These cultures can be 
maintained healthily for up to two weeks, where pseudo-normal cellular morphology 
is retained and differentiation processes occur as in the live animal (Stoppini et al., 
1991). 
 Figure 5.9 shows examples of control non-infected hippocampal slices and 
slices infected with eGFP-2A-TASK-3 rAAV or Cre-Venus rAAV (a high titer 
control virus). The Cre-Venus rAAV-infected slice shows robust expression of Venus 
(a yellow fluorescent protein) increasing in intensity up to 12 days post-infection, 
consistent with other work (Ehrengruber et al., 2001). Slices infected with eGFP-2A-
TASK-3 rAAV show a lesser degree of fluorescence, possibly due to the lower titer of 
this virus.  
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Figure 5.9 Organotypic hippocampal slices validate rAAV expression.  
A – The top panel shows bright-field images of the hippocampal slice and the 
bottom panel shows the green channel images. No fluorescence is observed in the 
control, while Cre-Venus rAAV infection causes strong fluorescent signal and 
eGFP-2A-TASK-3 rAAV causes a moderate fluorescent signal. [Scale bars = 1 
mm] B – Cre-Venus expresses in the nucleus, whereas the tips of the cellular 
processes express strong fluorescence in the eGFP-2A-TASK-3 rAAV-infected 
slice. [Scale bar = 0.1 mm] 
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In vivo infection 
As a first step, only the eGFP-2A-TASK-3 rAAV was taken on to in vivo studies. 
After confirming that it could be expressed in HEK-293 cells and organotypic slices, 
its infectivity was tested in vivo. The rAAV samples were prepared as in the methods, 
injected into the mouse brain and, three weeks later, expression was assessed through 
primary fluorescence of eGFP or secondary fluorescence of anti-GFP antibodies after 
immunohistochemistry. 
 Figure 5.10 shows a successful injection into the medial septum. The injection 
tract can be seen in figure 5.10A under the red filter, representative of a small amount 
of scar tissue. GFP expression is high in the medial septum (Figure 5.10B), with 
fluorescence in the soma and projections of neurons, as in figure 5.10C. 
 
 
 
 
Figure 5.10 Fluorescent microscopy of the eGFP-2A-TASK-3 rAAV in the 
medial septum.  
A – The injection tract is observable under the red filter as a line of scar tissue. 
[Scale bar = 1 mm] B – Cells in the medial septum – marked with the dotted line – 
appear to express eGFP. [Scale bar = 1 mm] C – A magnification of the square in 
the previous micrograph showing eGFP expression in the cell bodies and 
projections. [Scale bar = 0.1 mm] 
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eGFP-2A-TASK-3 rAAV injections into the hippocampus were unsuccessful, 
even after several attempts. Methodological problems concerning the correct 
placement of the injections could be ruled out because Cre-Venus rAAV showed 
excellent expression in this area, as in figure 5.11. Referring back to the hippocampal 
organotypic slices, where expression of the eGFP-2A-TASK-3 rAAV is markedly 
lower than that for the Cre-Venus rAAV, it could be that the viral titer was simply not 
high enough to infect these cells. Infectivity per se should not be compromised in the 
eGFP-2A-TASK-3 rAAV compared to the Cre-Venus rAAV, since both of these 
viruses use the same coat proteins. 
 
 
 
 
Figure 5.11 The Cre-Venus rAAV expresses strongly in the hippocampus. 
The left-panel shows nuclear staining by DAPI, highlighting the different cellular 
layers of the hippocampus. On the right, Venus fluoresces strongly in the dentate 
gyrus (top) and CA3 (bottom). [Scale bar = 1 mm] 
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5.6 Functional effect of TASK-3 channel AAV transfer 
 
Simultaneously with viral injections, littermate and TASK-3 KO mice were 
instrumented with ECoG/EMG recording electrodes. The animals were exposed to 
increasing concentrations of halothane and their brain activity was monitored using 
the Neurologger. 
 Lorentzian curves fitted to the FFT power spectra at each halothane 
concentration revealed an increasing Q-factor with increasing anaesthetic in sham-
littermate mice (n = 4), as in figure 5.12A. By contrast, sham-TASK-3 KOs (n = 6) 
showed a flat response; that is, the Q-factor did not change in response to increasing 
concentrations of halothane (Figure 5.12A). This vastly reduced type-2 theta 
oscillation compared to littermate, as analysed by 2-way ANOVA and Bonferroni’s 
test (p < 0.001 at 1.5% and 2.0%), is reflective of the deficit described previously 
(Pang et al., 2009). 
 With successful medial septum eGFP-2A-TASK-3 rAAV infection (n = 2), the 
Q-factor showed a significant increase from 7 days after infection to 21 days after 
infection, as in figure 5.12B, presumably as the rAAV reached full expression (p < 
0.05 at 1.5% and 2.0%). Medial septum TASK-3 channels are thus able to 
functionally restore, at least in part, the type-2 theta oscillation.  
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Figure 5.12 eGFP-2A-TASK-3 rAAV infection partially restores the type-2 
theta oscillation.  
A – TASK-3 KO mice lack the Q-factor modulation induced by halothane in 
littermates. B – 21-days after rAAV infection, the Q-factor is significantly 
increased compared to baseline at 7-days. (*p < 0.05; ***p < 0.001) 
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5.7 Discussion 
AAV-mediated genetic and functional rescue has proven to be a powerful technique 
for dissecting the structures and mechanisms important in a variety of physical 
processes and behaviours (Gerstein et al., 2012; Guillem et al., 2011). A particularly 
interesting use of this approach was able to restore normal attentional performance in 
nicotinic acetylcholine receptor (nAChR) β2-subunit KO mice by re-expression in the 
prelimbic area of the prefrontal cortex (Guillem et al., 2011). That study used a 
lentiviral expression system to restore acetylcholine sensitivity to this specific region 
only, proving that cholinergic tone in this area was sufficient to mediate normal 
performance in an attentional task. 
 TASK-3 KOs also have altered neuronal function, which manifests at the 
physiological level in an absence of type-2 theta oscillations (Pang et al., 2009) and at 
the behavioural level in impaired sleep and memory processes (Linden et al., 2007; 
Pang et al., 2009). TASK-3 channels are widely expressed through the brain, 
including the CA1 and dentate granule cell region of hippocampus (Brickley et al., 
2007), which is critically involved in mediating theta oscillations. Therefore, it was 
possible that impaired hippocampal function could explain the type-2 deficit in 
TASK-3 KO mice. 
 Work in this laboratory has indeed shown subtle changes in the 
electrophysiological characteristics of TASK-3 KO hippocampal pyramidal cells 
(Pang, 2010). While resting membrane potential was unchanged in TASK-3 KOs 
compared to controls, the action potential characteristics were modulated by halothane 
in controls but not in TASK-3 KOs. Specifically, control cells had a greater ability to 
sustain action potential firing than TASK-3 KOs during halothane exposure, 
consistent with work in cerebellar granule cells (Brickley et al., 2007). However, in 
addition to an impaired response to halothane in those cells (Brickley et al., 2007) and 
in motoneurons (Lazarenko et al., 2010), the resting membrane potential was found to 
be depolarized in TASK-3 KOs. Therefore, altered pyramidal cell characteristics in 
the TASK-3 KO probably play a limited role in the network impairment that causes 
reduced type-2 theta oscillations. 
 TASK-3 channels are also highly expressed in parvalbumin-positive (parv) 
GABAergic interneurons in the CA1 region of the hippocampus (Talley et al., 2001; 
Torborg et al., 2006). These cells, which include axo-axonic, basket, bistratified, and 
oriens-lacunosum moleculare interneurons, have all been implicated in theta 
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oscillations (Klausberger et al., 2008). So, perhaps the lack of TASK-3 channels in 
these cells is responsible for the network impairments of TASK-3 KO mice.  
Ongoing work in our lab aims to use Cre-based “flex switching” to generate 
transgenic mice that have (i) TASK-3 channels deleted from only parv-interneurons, 
or (ii) TASK-3 channels selectively restored in parv-interneurons. Similar approaches 
have been used to ablate GABA receptor γ2-subunits from parv-interneurons which 
interfered with theta-gamma rhythm coupling (Wulff et al., 2009). And, other viral-
based strategies ablated parv-interneuron output in the CA1 region of the 
hippocampus, causing working memory deficits (Murray et al., 2011). 
The hippocampus was therefore the primary target for TASK-3 rescue in this 
study. However, expression of the eGFP marker in this region could not be detected, 
even with secondary anti-GFP immunohistochemical labelling. These results are at 
odds with the expression observed in organotypic hippocampal slices, and work is 
ongoing to find a satisfactory explanation. It is possible that the rAAV injections were 
themselves unsuccessful; however, hippocampal cells were successfully infected with 
another virus using exactly the same technique. 
The secondary target was the medial septum, a region that provides a theta 
“pacemaker” through burst firing of GABAergic and cholinergic neurons into the 
hippocampus (Smythe et al., 1991). While TASK-3 expression is not particularly 
strong here, the fact that atropinization of this region affects the type-2 theta 
oscillation in the same way as TASK-3 deletion, was reason enough to suspect that 
TASK-3-dependent muscarinic neurotransmission might nevertheless be important. 
After in vivo expression of eGFP-2A-TASK-3 in the medial septum was 
confirmed in a cohort of mice, a second group, consisting of littermate mice with 
sham injections, TASK-3 KO mice with sham injections, and TASK-3 KO mice with 
medial septum eGFP-2A-TASK-3 rAAV injections, were instrumented for 
ECoG/EMG recording. Their response to halothane was measured one and three 
weeks after surgery; the latter when transgene expression is maximal. The TASK-3 
KO shams showed no ECoG modulation of the theta oscillation in response to 
halothane, while the littermate shams had a strongly tuned peak as evidenced by an 
increased Q-factor. TASK-3 KO mice with medial septum eGFP-2A-TASK-3 rAAV 
injections showed a significant increase in the Q-factor between 7 days and 21 days 
post-infection, indicating enhancement and partial rescue of the type-2 theta 
oscillation (Figure 5.12). 
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As the eGFP-2A-TASK-3 rAAV uses a pan-promoter, the transgenes could be 
expressed in any type of neuronal cell. This is a potential drawback for several 
reasons: firstly, at a glance, the identity of the cell-type is unknown; and secondly, the 
rAAV may infect cells unrelated to the study in question. However, while limited to a 
post-hoc evaluation, the first problem can be solved by co-labelling brain sections 
with neuronal markers such as cholineacetyltransferase, parvalbumin, calmodulin, etc. 
The second problem, on the other hand, may actually have its own advantages. 
Rescuing a (cellular or physiological) phenotype by introducing a gene back 
into one particular area rather than another where it would usually be expressed 
certainly provides quite specific mechanistic information, as in the β2-subunit study 
(Guillem et al., 2011). However, at a conceptual level, there is an argument that, of 
course, returning a gene into a hypothetically relevant brain circuit will restore normal 
function. But, if the function could be restored through a secondary route, to 
compensate indirectly for the deficit, then a novel mechanism might be unveiled, 
potentially identifying new therapeutic targets. Just recently, for example, a deficit in 
sodium channel function that caused various cognitive abnormalities could be 
reversed by treatment with a positive allosteric modulator of GABAA receptors (Han 
et al., 2012). 
The medial septum modestly expresses TASK-3 transcripts and strongly 
expresses TASK-1, as in figure 5.13, potentially forming homodimeric channels 
(Bayliss et al., 2003). However, it would appear that in the case of TASK-3 deletion, 
TASK-1 homodimers are unable to compensate for even the relatively low expression 
levels of TASK-3 required to maintain septohippocampal function and type-2 theta 
oscillations.  
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Figure 5.13 Heterogeneous distribution of TASK channels in the mouse brain.  
TASK-1 channels are expressed strongly in the medial septum (MS), whereas 
TASK-3 channels are expressed in the lateral septum (LS) and cholinergic neurons 
in the caudate putamen (CPu).  [Adapted from Talley et al. (2001); Scale bar = 1 
mm] 
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Further to this, a small-scale comparison between TASK-1 KO and wildtype 
mice revealed subtle differences in ECoG characteristics in response to halothane. 
The shape of the maximum halothane-induced type-2 theta peak is similar between 
the two genotypes (p = 0.92); however, the Q-factor is maximal in TASK-1 KO mice 
at a halothane concentration of 1.09 ± 0.04 %, which is significantly higher than that 
for wildtype mice of 0.80 ± 0.04 % halothane, as in figure 5.14A (p < 0.05, n = 3). 
And, in addition, the frequency of this maximum peak is significantly lower in TASK-
1 KO mice, being 3.99  ± 0.13 Hz compared to 4.69 ± 0.15 Hz in wildtype mice (p < 
0.05), as in figure 5.14B. 
 
 
Although the expression of other 2PK channels is purported to be unchanged 
as a result of TASK-1 deletion (Linden et al., 2006), functional upregulation of 
TASK-3 channels in the absence of TASK-1 – additional to that of GABAA receptors 
(Linden et al., 2008) – could explain how this region might be able to support type-2 
theta oscillations for longer and at lower resonant frequencies in the TASK-1 KO 
mice, consistent with the above results. Functional compensation by TASK-3 
channels in this instance could also explain why halothane LORR is unchanged in 
TASK-1 KO mice (Linden et al., 2006). 
Figure 5.14 TASK-1 KO theta statistics. 
TASK-1 KO (T1KO) mice have a longer-lasting and lower-frequency type-2 theta 
oscillation in response to halothane. A – The maximum Q-factor occurs at a higher 
concentration of halothane in TASK-1 KO mice compared to wildtype (WT). B – 
The maximum Q-factor occurs at a lower resonant frequency in TASK-1 KO mice. 
(*p < 0.05) 
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While other work in this report precludes the medial septum as having an involvement 
in halothane LORR, it would nevertheless be interesting to see how anaesthetic 
sensitivity changes in TASK-3 KO mice with restored TASK-3 expression in the 
medial septum. Future work would also seek to understand why hippocampal 
infection has been thus far unsuccessful. The AAV-1 serotype used in this study has 
been shown to efficiently infect neurons in the hippocampus (McClure et al., 2011); 
however, strong heparin-affinity – a quality possessed by the second AAV-2 serotype 
used in the chimeric capsid – has been shown to reduce transduction efficiency in 
neurons (Arnett et al., 2012). In fact, even single amino acid changes can affect the 
tissue tropism of AAV serotypes (Wu et al., 2006), so while the eGFP-2A-TASK-3 
rAAV could readily infect neurons in the medial septum, a small mutation in the 
capsid could explain why hippocampal cells were not infected. 
 Further work should clarify whether the large cell bodies infected in the 
medial septum are cholinergic or GABAergic using immunohistochemical techniques. 
Additionally, the electrophysiological characteristics – including the reversal potential 
and halothane sensitivity – of the GFP-positive cells need to be established to confirm 
membranous TASK-3 channel expression.  
 Another comparison to be made in future experiments would be to infect the 
medial septum with the Cre-2A-Flp rAAV. This will answer whether endogenous 
expression of the TASK-3 gene in the medial septum is enough to rescue type-2 theta, 
or if supra-normal levels are needed, as is a possible consequence of eGFP-2A-
TASK-3 rAAV infection. Furthermore, the Cre-2A-Flp rAAV could also be used to 
infect the hippocampus. 
 That the type-2 theta rescue was only partial with medial septum infection 
indicates that TASK-3 channels are required in other brain regions for normal 
oscillatory dynamics. Once hippocampal expression of the virus is validated then the 
entire septohippocampal network can be investigated. It is possible though that the 
remaining type-2 theta impairment exists because of a TASK-3 deficit in extra-
hippocampal regions. TASK-3 channels are expressed widely throughout all layers of 
the cortex, in the thalamus and in aminergic nuclei of the brainstem (Talley et al., 
2001). Moreover, as well as having a potential role in the type-2 theta oscillation 
(Maru et al., 1979), these brainstem areas, which include the raphe nucleus and the 
locus coeruleus, could be probed using the rAAVs to investigate the sleep and 
anaesthetic phenotypes of TASK-3 KO mice. 
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6.1 Linking anaesthesia, type-2 theta oscillations, and TASK-3 channels 
This study had several streams, interlinked by an overarching theme of anaesthesia. 
As explained in the introduction, the phenomenon of how anaesthetic drugs act to 
induce unconsciousness is not completely known. This in itself provides a reason to 
investigate the neurobiological mechanisms at play in the process and, additionally, 
investigations into unconsciousness might add to the understanding of what makes 
animals conscious. 
 The search for possible mechanisms of anaesthesia has included the analysis 
of synchronous brain activity by either electroencephalogram or more invasive 
recording techniques. Oscillations of this kind are representative of the ongoing 
activity of the brain and have long been known to correlate with different states of 
consciousness during, for example, the sleep-wake cycle, in epileptic seizures and in 
coma. 
 One of the most prominent of these oscillations is in the theta range of 
frequencies (4-12 Hz). Recorded from the hippocampus during waking activity and 
REM sleep, type-1 theta oscillations are sensitive to anaesthetics, whereas type-2 theta 
oscillations are present during immobility-related sensorimotor processing and during 
anaesthetics such as halothane, urethane and dexmedetomidine. 
 Two pieces of evidence warranted the further study of type-2 theta in relation 
to halothane anaesthesia: (i) type-2 theta has a sensorimotor role that might mediate 
resistance to anaesthesia; and (ii) mice lacking the two-pore potassium channel 
TASK-3 have no type-2 theta activity and a decreased sensitivity to halothane. 
In this study, no specific correlation was found between the dynamics of the 
theta oscillation in C57Bl6 mice and loss of righting reflex, a correlate of human loss 
of consciousness. Additionally, ablating the theta oscillation with muscarinic 
antagonism by atropine sulfate, both systemically and centrally, had no effect on 
sensitivity to halothane anaesthesia. Thus, the type-2 theta oscillation appears to be an 
epiphenomenal event in terms of loss of consciousness in halothane anaesthesia. 
Therefore, other mechanisms are responsible for the decreased sensitivity to halothane 
of TASK-3 KO mice. 
 Further investigations into the role of the type-2 theta oscillation in other 
aspects of anaesthesia revealed a possible link between altered theta dynamics and 
emergence agitation. This fits with the function of theta as being a mechanism for 
sensory integration, and future research in this area would be interesting. For example, 
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would TASK-3 KO mice exhibit the hyper-locomotion associated with emergence 
agitation? These studies should also incorporate multiple recording electrodes in 
specific brain regions, such as the hippocampus and prefrontal cortex, to understand 
how different brain regions interact during anaesthesia and cognitive dysfunction.  
The next part of the study investigated the behaviour of TASK-3 KO mice 
directly. The type-2 theta oscillation deficit of TASK-3 KO mice during halothane 
anaesthesia indicated impaired hippocampal function that could explain previously 
observed cognitive deficits in these mice. 
 This study shows that TASK-3 KO mice also have deficits in the type-2 theta 
oscillation during alert immobility, a state of behavioural arousal and sensorimotor 
processing. While TASK-3 KO mice showed normal object recognition and aversive 
context memory, they did show a mild working memory impairment in the T-maze. 
Future studies would aim to correlate this deficit to potential impairment in 
hippocampal-prefrontal theta synchrony, again using multiple brain region recordings. 
 The final section investigated the mechanism of the TASK-3-dependent type-2 
theta oscillations. Using an Adeno-associated virus-approach, TASK-3 channels were 
selectively expressed only in the medial septum. This was enough to partially rescue 
the type-2 theta oscillation recorded from the cortex, indicating that, whether or not 
TASK-3 channels are expressed in this region normally, their ectopic expression there 
can restore anaesthetic-related oscillations. Since the medial septum has been ruled 
out of mediating LORR, future studies involving rAAVs should investigate how 
septohippocampal TASK-3 expression might affect other anaesthetic endpoints like 
delirium and emergence agitation, as well as theta-dependent memory processing. 
 Additionally, the two rAAVs created in this study provide a way of 
manipulating various other pathways involved in anaesthesia, cognition, and disease. 
 
6.2 Main findings 
 
1. The type-2 theta oscillation plays no active role in halothane LORR. 
2. Emergence agitation correlates with altered theta oscillation dynamics. 
3. TASK-3 KO mice have reduced type-2 theta power during immobility. 
4. TASK-3 channel deletion causes mild impairments in working memory. 
5. The type-2 theta oscillation can be partially rescued in TASK-3 KO mice by 
medial septum TASK-3 channel expression. 
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